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ABSTRACT 
Fatigability during exercise is determined by a myriad of factors including 
characteristics of the task being performed and the individual performer. When the 
latter is considered, the sex of the individual can influence the physiological 
responses, and therefore the underpinnings of fatigue during a wide range of tasks. 
Typically, fatigability of males and females has been compared following tasks 
normalised to maximum capacity (e.g. maximum voluntary contraction). Whilst these 
approaches have identified that females might experience less fatigue, they cannot 
provide further insight into the differences between the two sexes, as they do not 
account for potential differences in metabolic thresholds. The aim of this thesis was 
to therefore compare fatigability of males and females during exercise normalised to 
the intensity-duration relationship. It was hypothesised that due to anatomical and 
physiological differences between males and females, greater critical intensities 
would be observed in females, however, when exercise was subsequently normalised 
to these thresholds fatigability would be similar. In Study 1, the neuromuscular 
function and fatigability of females was compared across the eumenorrheic menstrual 
cycle. Alterations in nervous system function were observed in line with changes in 
neuro-excitatory and inhibitory hormone concentrations, meaning that in subsequent 
Chapters, hormonal status had to be controlled. Study 2 then demonstrated that 
assessments of neuromuscular function and fatigability were repeatable in a 
hormonally-constant population of monophasic oral contraceptive pill users. This 
finding indicated the suitability of this population for comparison with males in studies 
involving repeated visits. In Study 3, the intensity-duration relationship was compared 
between males and females for intermittent, isometric exercise, then fatigability and 
physiological responses were observed for exercise normalised to the critical 
intensity. Females demonstrated a greater relative critical intensity, however contrary 
to the original hypothesis, still demonstrated greater fatigue-resistance during 
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metabolically-matched intensities. Near-infrared spectroscopy and neurostimulation 
data showed lesser deoxygenation and contractile dysfunction, respectively, within 
female knee-extensors during these normalised exercise trials, implying that the locus 
of the sex difference resided in the musculature. Study 4 then developed a novel 
method for assessment of subcortical excitability of descending tracts for the knee-
extensor muscles. This study confirmed that lumbar stimulation was capable of 
activating the corticospinal tract and evoking responses at rest and during 
contractions, for use in subsequent study. In a similar study design to Study 3, Study 
5 compared the intensity-duration relationship during cycling exercise between males 
and females, and assessed physiological responses and fatigability during 
metabolically-matched severe and heavy intensity exercise. In contrast to the original 
hypothesis, critical power was not different between sexes, however during exercise 
at 110 and 90% of critical power, time to task failure was the same between sexes. 
Despite similar exercise time at metabolically-matched intensities, females again 
demonstrated lesser deoxygenation and contractile dysfunction of the knee-
extensors following exercise. Collectively, the work in this thesis extends the 
understanding of the sex difference in fatigability during exercise, offering insight into 
the difference in metabolic and neuromuscular consequences of single-limb and 
locomotor exercise which can be used to explain previous observations. Furthermore, 
the data implies that for the same relative volume of exercise, female skeletal muscle 
experiences less disruption compared to males, which has consequences for acute 
and chronic exercise prescription in a range of populations.  
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CHAPTER 1 - INTRODUCTION 
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1.1 Introduction 
Fatigue is a universal phenomenon, defined by the Oxford Dictionary as “extreme tiredness 
resulting from mental or physical exertion or illness”. Throughout history, the underpinning 
causes and influences of fatigue have been at the forefront of scientific endeavour, with many 
investigators attempting to create an objective model of fatigue that can accurately describe 
its influence in an exercise model. Angelo Mosso published La Fatica in 1891 and following 
multiple experiments, concluded that exhaustion is a form of poisoning by waste material and 
can include impairments to aspects of both the central nervous system and working 
musculature (Mosso, 1891). Mosso’s interpretation was ahead of his time, as almost a century 
later, Gandevia (2001) suggested that the exercise-induced decrease in maximal voluntary 
muscle force (termed ‘muscle fatigue’) arises from both muscular (peripheral) and neural 
(central) factors. However, Gandevia proposed that reductions in supraspinal drive act to 
protect the working muscle from further peripheral dysfunction, avoiding a ‘catastrophic state’ 
and compromising other homeostatic process required for survival of the organism. More 
recently, Enoka & Duchateau (2016) proposed a taxonomy for understanding exercise-
induced fatigue derived and adjusted from a clinical perspective (Kluger et al., 2013). Stating 
that fatigue, defined as a symptom, is a result of interactions between two components: 
performance fatigability – the decline in an objective measure of performance over a discrete 
period of time; and perceived fatigability – changes in the sensations that regulate the integrity 
of the performer. Whilst these models of fatigue slightly differ in understanding and 
terminology, a consistent aspect is that fatigue, or fatigability, and the contributing processes, 
are modulated by the specificity of task performed and the characteristics of the muscle(s) or 
organism performing it. 
 
Within the field of exercise physiology, the sex of the individual performing a given exercise 
task has been shown to influence exercise tolerance and fatigability (Hunter, 2014). During 
3 
 
certain tasks, females are less fatigable than males, purportedly due to physiological and 
anatomical differences. At a muscular level, female and male tissues differ considerably, with 
a sexual dimorphism of gene expression (Welle et al., 2008) leading to differences in 
phenotypic expression (e.g. muscle mass; Janssen et al., 2000), substrate utilisation 
(Roepstorff et al., 2002), and fibre type distribution (Staron et al., 2000). Consequently, males 
are usually stronger and more powerful, however, for sustained or repeated contractions, 
females exhibit a greater tendency to be more fatigue-resistant than males (Hunter, 2016a). 
Importantly, this sex difference is muscle-specific, and the knee-extensors appear to be more 
fatigue-resistant in females.  The sex difference in knee extensor fatigability poses a dilemma 
for researchers and practitioners, for instance, if training or rehabilitation programming is 
based upon research conducted in male populations, then such conclusions would not apply 
to female counterparts. The knee extensors have obvious involvement in locomotor exercise, 
therefore understanding how adjustments in the neuromuscular properties of locomotor 
musculature underpin fatigue in males and females, could lead to better outcomes in terms of 
athletic performance and rehabilitation.  
 
Advances in technology and understanding have enabled physiologists to evaluate 
neuromuscular function in clinical (Hallett & Rothwell, 2011) and healthy (Goodall et al., 
2014a) populations, via the use of electrical and magnetic stimulation of muscle and/or 
nervous tissue. Using such techniques, sex differences in knee extensor properties have been 
shown. Specifically, lesser declines in contractile function have been shown in females 
compared to males following isometric exercise (Wüst et al., 2008), cycling (Glace et al., 
2013), and ultra-endurance running (Temesi et al., 2015). However, there is also literature to 
suggest that the central nervous system (CNS) plays a mediating role in the sex differences 
in fatigability. In an unfatigued state, maximal voluntary activation (VA) of skeletal muscle does 
not differ between sexes (Hunter et al., 2006a; Keller et al., 2011). However, during fatiguing 
isometric exercise of the knee extensors, males experience greater reductions in VA than 
4 
 
females (Russ & Kent-Braun, 2003; Martin & Rattey, 2007). Collectively, the aforementioned 
evidence suggests that any sex difference in knee extensor fatigability is likely a multi-factorial 
phenomenon involving several metabolic and physiological processes. However, the 
metabolic and physiological insight that previous investigations can offer is limited due to the 
fact that exercise intensities are either standardised to percentages of maximum capacity (e.g. 
% MVC), or self-paced in nature. 
 
In order to provide clarification on the underlying mechanisms behind the sex difference in 
fatigability, this thesis will firstly examine the influence of the menstrual cycle on female 
neuromuscular function and fatigability, then profile the ‘intensity-duration’ relationship in both 
sexes. This paradigm of exercise tolerance and fatigability defines exercise intensity domains, 
and the aetiology of fatigue elicited in each domain (Burnley & Jones, 2018). It provides 
information such as the maximal sustainable intensity (often termed critical intensity) and the 
finite work capacity above critical intensity (W’; Jones et al., 2010). Above the critical intensity, 
endurance performance can be predicted using the following equation: 
 
Tlim = W’ ÷ (I – CI) 
 
In which Tlim is time to task failure, W’ is the curvature constant parameter, I is the intensity of 
exercise and CI is critical intensity (expressed as power for cycling, velocity for running, or 
torque/force for isometric exercise). One advantage of modelling exercise tolerance using this 
framework is that the characteristics of fatigability can be compared between different 
populations during metabolically-matched exercise intensities.  
 
5 
 
The primary aim of this thesis was to investigate the underpinning mechanisms of the sex 
difference in exercise tolerance, relative to a metabolic threshold (the critical intensity) to 
ensure equivalence in the exercise task demand between males and females. Using non-
invasive neurostimulation in conjunction with cardiorespiratory and metabolic assessment 
before, during, and following exercise, the present thesis provides a comprehensive overview 
of the sex differences in the physiological underpinnings of exercise tolerance. Chapter 2 
reviews the literature pertaining to the study of fatigue, and the physiological differences 
between sexes that could contribute to a difference in exercise tolerance and fatigability. 
Before the two sexes can be compared, the influence of female sex hormones (the menstrual 
cycle) on neuromuscular function and fatigability is discerned (Chapter 4). Then, the 
repeatability of measures is quantified in Chapter 5, using a hormonally-constant female 
population. Consequently, the intensity-duration relationship is defined, using an isometric 
model, in both sexes (Chapter 6). Subsequently, a methods development section (Chapter 7) 
contains information about how non-invasive electrical stimulation of the spinal cord was 
adapted to facilitate lower limb motoneuron excitability quantification. The final experimental 
section (Chapter 8) details fatigability during cycling in both sexes using the power-duration 
relationship. Several additional techniques are employed to shed light on the mechanisms 
underpinning exercise tolerance in the intensity domains. Finally, the findings of the thesis are 
discussed collectively (Chapter 9), with practical implications and directions for future research 
closing this Chapter.  
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CHAPTER 2 - LITERATURE REVIEW 
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2.1. Introduction 
This chapter will provide a comprehensive synopsis of the literature pertaining to the 
mechanisms of exercise-induced fatigue in healthy adults, and how these might differ between 
males and females. Section 2.2 and 2.3 will define fatigue and outline the mechanisms that 
underpin central and peripheral neuromuscular adjustments to exercise. How these 
mechanisms of fatigue interact within distinct exercise intensity domains will be covered in 
Section 2.4. Following this, Section 2.5 will cover differences between males and females 
within the motor pathway, whilst literature on the topic of sex differences in fatigability will be 
critically discussed in section 2.6. Finally, the aims and hypotheses of the investigations will 
be presented in section 2.7. 
 
2.2. Defining fatigue 
The study of fatigue has troubled exercise physiologists for centuries. Even today, an 
unequivocal definition and understanding of the topic does not exist (Marino et al., 2011). The 
seminal work of Angelo Mosso published in his book La Fatica (Mosso, 1891) still underpins 
much of the present day’s understanding. Mosso suggested that fatigue entails two 
phenomena: “The first is the diminution of the muscular force. The second is fatigue as a 
sensation. That is to say, we have a physical fact which can be measured and compared, and 
a psychic fact which eludes measurement” (p154, cited in Marino et al., 2011). Typically, 
research concerned with fatigue in exercise physiology has focused on the measurable aspect 
of fatigue, applying definitions such as “a failure to maintain the required or expected force” 
(Edwards, 1981), “a loss of maximal force generating capacity” (Bigland-Ritchie et al., 1986; 
Gandevia, 2001), and “a reversible state of force depression” (Fitts & Holloszy, 1978). While 
the experiments that test hypotheses based upon these definitions all contribute to our 
understanding of the objective aspect of fatigue, they do little to aid the understanding of how 
these ‘force diminutions’ contribute to the sensation of fatigue that Mosso eluded to. Only more 
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recently have exercise scientists considered the effect that the sensations can have on 
exercise tolerance. St. Clair Gibson et al. (2003, p167) suggested that fatigue is an emotion 
based upon “a conscious awareness of changes in subconscious homeostatic control 
systems”. The authors also suggest that the emotion can be modulated by factors such as 
motivation, anger and fear. Thus, the same group suggested that exercise tolerance was 
regulated by a complex, dynamic, non-linear system, later termed the ‘central governor model’ 
(St. Clair Gibson & Noakes, 2004; Noakes et al., 2005). Whilst this model has been critiqued 
and reviewed (Weir et al., 2006; Marcora, 2008), it has created more of an awareness that 
fatigue is not a simple, linear process involving only objective declines in motor performance; 
something which the original definition of Mosso eluded to.  
 
A recent review proposed a new taxonomy for fatigue based upon the work of Mosso, but 
broadened to incorporate a more contemporary understanding (Enoka & Duchateau, 2016). 
The review stems from a similar classification proposed in clinical populations (Kluger et al., 
2013) but adjusted to relate to fatigue experienced by healthy performers of exercise. The 
authors suggest that fatigue consists of two main components: perceived fatigability and 
performance fatigability, with interactions between the two resulting in the disabling symptom 
of fatigue (Enoka & Duchateau, 2016).  
 
Figure 2-1: The proposed taxonomy from Enoka and Duchateau (2016) 
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Performance fatigability refers to the classically studied limiting factors of the neuromuscular 
system during exercise and is defined as “the decline in an objective measure of performance 
over a discrete period”. The mechanisms underpinning performance fatigability are dictated 
by the task demands, muscle group(s) involved, and characteristics of the performer(s) 
assessed (Hunter, 2018). Enoka & Duchateau (2016), and consequent authors using this 
definition (Hunter, 2018), suggest that performance fatigability is affected by contractile 
function of the muscles involved, as well as the level of activation of the muscles by the central 
nervous system, terms that have previously been classified as peripheral and central fatigue, 
respectively (Gandevia, 2001). Perceived fatigability refers to “changes in the sensations that 
regulate the integrity of the performer” and is modulated by homeostatic disturbances and the 
psychological state of the performer. The definition of perceived fatigability is similar to the 
description of fatigue by St. Clair Gibson et al. (2003), in that the sensation evoked from 
changes to homeostasis can be modulated by psychological aspects such as motivation or 
mood, etc. However, the model proposed by Enoka & Duchateau (2016) acknowledges that 
the two contributing factors (performance and perceived fatigability) are interdependent. One 
example the authors give is that the capacity of the central nervous system to voluntarily 
activate the muscle can be modulated by blood glucose (Nybo, 2003), core temperature 
(Nybo, 2008), arousal (Klass et al., 2012) and mood (Steens et al., 2012), all of which 
contribute to perceived fatigability, but have physiological consequences and affect 
performance fatigability as well. 
 
This thesis will utilise the taxonomy proposed by Enoka & Duchateau (2016) to describe 
fatigue and the mechanisms that contribute to the symptom. However, the notion that the term 
‘fatigue’ cannot be modified by an accompanying adjective (i.e. central fatigue) is not one this 
thesis will subscribe to. Modifying adjectives are commonly utilised in the literature 
investigating fatigue to refer to the locus of adjustment(s) within the motor pathway that limit 
force producing capacity. Performance fatigability during a given task is underpinned by 
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decreases in the performance of the neuromuscular system (neuromuscular fatigue), and as 
described by Enoka & Duchateau (2016), involves dysfunction within contractile apparatus 
(peripheral fatigue, Fitts, 2008) and/or muscle activation by the CNS (central fatigue, 
Gandevia, 2001). Therefore, for the purpose of clarity, this thesis will utilise modifying 
adjectives in front of the word fatigue when referring to specific mechanisms that contribute to 
the symptom of fatigue. The following section (2.3) will outline the contributing factors to 
fatigue from the beginning of the motor pathway to the resultant contraction of muscles. 
 
2.3. Mechanisms of exercise-induced neuromuscular fatigue 
Neuromuscular fatigue refers to suboptimal performance of the neuromuscular system, this  
manifests as a reduction in maximum force production (Gandevia, 2001). The production of 
voluntary force is result of multiple complex processes in the motor system (Figure 2-2). The 
process begins with the planning of movement in supra-cortical structures. Neural drive from 
the motor cortex travels via the descending tracts and innervates spinal motor neurons, which 
excite motor axons and lead to the recruitment of motor units. The result of this process is a 
muscle contraction, and force output. Adjustments in these processes as a result of activity 
can lead to a sub-optimal motor performance. Changes that occur proximal to the 
neuromuscular junction (above the red line in Figure 2-2) are termed central fatigue, whereas 
adjustments below the red line are termed peripheral fatigue. 
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Figure 2-2: The processes involved in voluntary force production. Central mechanisms of fatigue are shown above the red line, 
whereas peripheral mechanisms are shown below the red line. Adapted from Gandevia (2001) in Goodall (2011). 
 
2.3.1. Peripheral fatigue 
Contraction of the muscles involves excitation-contraction coupling resulting in force 
production via cross bridge cycling (Dulhunty, 2006). Peripheral fatigue refers to an exercise-
induced reduction in contractile function, this can be manifest as a reduction in maximal force 
output of muscle fibres, and can be caused by alterations in any process distal to the 
neuromuscular junction (Fitts, 2008). As seen in Figure 2-2, E-C coupling has multiple stages, 
and theoretically a change in any of the stages could lead to suboptimal performance 
(Sjøgaard, 1996). The following sub-sections will cover the quantification of these potential 
changes in the excitation-contraction coupling process that lead to peripheral fatigue. 
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2.3.1.1. Quantifying Peripheral Fatigue 
Alterations in the excitation-contraction processes can be quantified using non-invasive 
neurostimulation, specifically, by stimulating the motor nerve of a muscle at rest (Millet et al. 
2011). The amplitude of the mechanical response to nerve stimulation is typically used to 
assess E-C coupling, with decreases observed following both single-limb (Place et al., 2007; 
Goodall et al., 2010; Burnley et al., 2012; Gruet et al., 2014; Vernillo et al., 2018) and whole-
body (Thomas et al., 2014a, 2016; Temesi et al., 2017b) exercise commonly interpreted as 
an impairment distal to the neuromuscular junction.  
 
Stimulation of the motor nerve can be performed in multiple ways; a single stimulus evokes 
an electromyographical response termed the M-wave, as well as a mechanical response or 
‘twitch’. This method can only be used for muscles innervated by a motor nerve without 
simultaneous co-activation of the antagonist muscle(s), for example the knee-extensors 
(femoral nerve) can be assessed, but not the plantar flexors (tibial nerve). The M-wave is 
commonly considered to reflect propagation of the action potential across the sarcolemma 
(Bigland‐Ritchie & Woods, 1984; Place et al., 2010), a key step in the excitation and 
recruitment of motor units. However, this interpretation has been questioned previously 
(Dimitrova & Dimitrov, 2002; Rodriguez-Falces & Place, 2018). One factor to consider when 
using single electrical stimuli is the balance between potentiation and fatigue (Millet & Lepers, 
2004). The net mechanical output of the twitch, as well as the sensitivity to fatiguing tasks are 
influenced by the degree of potentiation (Place et al., 2007). Three prior maximum voluntary 
contractions (MVCs) are thought to be required for maximising potentiation of the twitch (Kufel 
et al., 2002), and thought to increase calcium ion (Ca2+) sensitivity (Rassier & MacIntosh, 
2000), and permit exercise-induced changes to be determined when twitch amplitudes are 
compared pre-post activity. 
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Other methods of motor nerve stimulation utilise the force-frequency relationship to infer 
different characteristics about E-C coupling, with trains of stimuli delivered at different 
frequencies permitting mechanistic insight into the aetiology of peripheral fatigue (Binder-
Macleod & McDermond, 1992). In vivo studies investigating human contractile function 
typically employ a combination of high (80-100 Hz) and low frequency (10-20 Hz) stimulations 
in the form of tetanic stimuli (Duchateau & Hainaut, 1984) or doublet pulses (Place et al., 2007; 
Verges et al., 2009). Tetanic stimuli are infrequently used, however, due to its ‘brutality’ (Millet 
et al., 2011) when applied to large muscle groups; indeed, a report of a dislocated knee-cap 
exists in the literature utilising this technique (Bigland-Ritchie et al., 1978). Low frequency 
stimulation is performed below the fusion frequency, and is therefore purported to reflect either 
impaired intracellular Ca2+ release (Hill et al., 2001; Westerblad et al., 2017) or reduced Ca2+ 
sensitivity of myofibrils (Bruton et al., 2008). High frequency stimulation is performed above 
the fusion frequency of muscle and is therefore not expected to be altered by Ca2+ properties, 
instead, extracellular potassium (K+) accumulation is implicated in force loss (Jones, 1996). 
Single stimulations are used as a global measure of peripheral fatigue, and are sensitive to 
detecting relatively small exercise-induced changes in contractile function (Mador et al., 2000); 
the limitation is, however, that mechanistic underpinnings of peripheral fatigue are difficult to 
discern, as the physiological alterations within exercising muscle often occur concurrently. The 
intricacies of the aforementioned ionic changes are discussed in further detail throughout the 
subsequent sections. 
 
2.3.1.2. Sodium (Na+) and Potassium (K+) activity 
The excitation-contraction coupling process begins with electrical excitement of the muscle 
fibre. This begins at the neuromuscular junction, in which the terminal branches of motor axons 
reach the motor unit. Action potentials are transmitted from axon to muscle via synapses, 
utilising the transmitter acetylcholine to rapidly propagate the action potential along the muscle 
fibre sarcolemma and throughout the t-tubule system (Pavelka & Roth, 2010). The action 
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potential travels throughout the t-tubules stimulating Ca2+ release, and consequent contraction 
(Westerblad et al., 1990). Intra and extracellular maintenance of Na+ and K+ ions are crucial 
to maintaining resting membrane potential, and propagation of action potentials occurs via 
rapid efflux of Na+, and K+ to a lesser extent, followed by an influx of K+ (Allen et al., 2008a).  
 
Repeated muscle activation causes net K+ efflux (Hodgkin & Horowicz, 1959; Clausen & 
Nielsen, 2007), with resting extracellular concentration thought to be ~4 mM (Overgaard & 
Nielsen, 2001) and over ~9 mM following repeated activity (Sejersted & Sjøgaard, 2000). This 
extracellular efflux causes a change in the electrochemical gradient of the sarcolemma that 
can lead to failures in excitation (Sjøgaard, 2011), and consequently, reduced force production 
(Nielsen & de Paoli, 2007). Another consequence of repeated muscle activity is a progressive 
dysfunction of Na+ channels, leading to reduced excitability due to inhibited Na+ efflux upon 
innervation (Ruff et al., 1988; Ruff, 1996; Filatov et al., 2005). Combined, these mechanisms 
cause a failure of action potential propagation throughout the sarcolemma and t-tubule 
system, leading to reduced force production (Chua & Dulhunty, 1988). It should be noted 
however, that this is not a linear process with impaired force production as an inevitable 
consequence of activity. Na+-K+ pumps act to restore the electrochemical gradients of Na+ and 
K+ (Clausen & Nielsen, 2007). Nevertheless, excitability is ultimately determined by the net 
result of the aforementioned passive ion leaks and Na+-K+ pump activity, with passive leaks 
often playing a dominant role during repeated activity (Clausen, 2003). 
 
2.3.1.3. Calcium (Ca2+) handling and Inorganic Phosphate (Pi) interactions 
In human skeletal muscle fibres, Ca2+ is stored within the sarcoplasmic reticulum (SR), and 
released for use in cross bridge cycling (Huxley & Niedergerke, 1954) upon stimulation by an 
action potential. In ‘fast-twitch’ fibres, Ca2+ release per action potential is ~3 times greater than 
‘slow-twitch’ fibres (Baylor & Hollingworth, 2003). As an action potential is detected by voltage-
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sensitive molecules in the t-tubules (dihydropyridine receptors, Araya et al., 2002), and 
ryanodine receptor-Ca2+ channels (RyR1) located in the SR are opened, causing an efflux of 
Ca2+. This causes an elevation of myoplasmic Ca2+ concentration, leading to Ca2+ binding with 
Troponin C, and initiating muscle contraction via cross bridges. The reuptake of Ca2+ into the 
SR via the SR-Ca2+ pump then causes muscle relaxation (Allen et al., 2008b). 
 
 
Figure 2-3: The relationship between force-Ca2+ release during fatigue. In a fatigued state, Ca2+ sensitivity is decreased, meaning 
less force is produced for the same magnitude of Ca2+ release. Ca2+ release from the sarcoplasmic reticulum is also impaired. 
Collectively these adjustments result in less force per cross bridge. Taken from Cheng et al (2017). 
 
In a fatigued state, there is a reduced free Ca2+ concentration, leading to less Ca2+ binding 
with troponin C, reduced cross bridge formation, and attenuated force output (Allen et al., 
1995; Macintosh & Rassier, 2002; Cheng et al., 2017). During repeated stimulation, Ca2+ 
stores within the SR are depleted, meaning that the amount released per action potential is 
diminished, reducing the force response (Posterino et al., 2000). Muscle fibres in vitro have 
shown that a ~35% decrease in SR Ca2+ content resulted in a 46% decrease in tetanic force 
(Dutka et al., 2005). 
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Increased ATP hydrolysis during high intensity activity results in a net decrease in ATP 
concentrations due to the inability of energy systems to synthesise ATP at an equal rate. This 
decrease in ATP limits the activity of RyR1 as adenosine monophosphate (AMP) and 
adenosine diphosphate (ADP, the resultants of ADP and ATP hydrolysis, respectively) are 
strong inhibitors (Dutka & Lamb, 2004). This inhibition of RyR1 channels leads to reduced 
Ca2+ release per action potential, and consequently, attenuated force production. Another way 
in which Ca2+ release is impaired is when Ca2+ within the SR forms a precipitate with a by-
product of ATP hydrolysis - inorganic phosphate (Pi), to form calcium phosphate (B in Figure 
2-, Ca2+-Pi), reducing the amount of available Ca2+ for release (Allen et al., 2008a). Inorganic 
phosphate may also impair force producing capacity through inhibition of the ryanodine 
receptor-Ca2+ channels (A in Figure 2-4), further reducing the amount of Ca2+ release per 
action potential (Allen et al., 2008b) . Additionally, Pi has also been reported to alter cross-
bridge function directly via the myosin-actin binding sites by reducing the myofibrillar sensitivity 
to Ca2+ (Fitts, 1994). Finally, reactive oxygen and nitrogen species (ROS/RNS) have been 
suggested to contribute to prolonged low-frequency force depression by RyR1 channel 
fragmentation (Place et al., 2015), impairing Ca2+ release. It has also been suggested that the 
accumulation ROS cause reduced myofibrillar Ca2+ sensitivity, attenuating force production by 
impairing cross bridge cycling (Cheng et al., 2016). These deleterious processes occur 
concurrently during high-intensity exercise, inducing reductions in the force production of the 
muscle (peripheral fatigue). 
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Figure 2-4: Cellular mechanisms of decreased sarcoplasmic reticulum Ca2+ release. (A) Inhibition of rynaodine receptor 1 (RyR1) 
channel opening. (B) Reduction in 'releasable' Ca2+ concentration ([Ca2+]SR) via Ca
2+-Pi precipitation. (C) Impaired action potential 
propagation via extracellular K+ accumulation. Taken from Cheng et al (2017). 
 
2.3.1.4. Acidosis 
The notion that lactic acid and the associated acidity of the muscle is a cause of fatigue during 
exercise stems from studies published in the early 20th century. Such studies observed 
elevated lactic acid concentration in skeletal muscles at exhaustion, and that the reversal of 
this accumulation would restore muscle function (Fletcher & Hopkins, 1907; Hill et al., 1924). 
During high intensity activity, the accumulation of H+ causes intracellular pH to decrease by 
~0.5 pH units, and correlational evidence would suggest that the temporal changes in pH 
mimic the reduction in force output of human muscle (Troup et al., 1986; Spriet et al., 1987; 
Cady et al., 1989). As ATP is hydrolysed, H+, that is utilised for oxidative phosphorylation in 
the mitochondria in the presence of oxygen, is not consumed during anaerobic processes, 
and can accumulate causing acidosis (Robergs et al., 2004). Indeed, low pH has been shown 
to reduce peak power of skeletal muscle fibres in vitro by ~18% (Knuth et al., 2006), and in 
combination with elevated Pi (a state mimicking exercise-induced fatigue) peak power was 
reduced by ~70% (Karatzaferi et al., 2008). Mechanisms purported to explain this effect are 
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that H+ compete with Ca2+ on Troponin C, lowering the sensitivity of contractile apparatus and 
reducing force output (Bolitho Donaldson et al., 1978; Fabiato & Fabiato, 1978). Additionally, 
it has been suggested that low pH also inhibits activity of muscle fibre ATPases (Fitts, 2016), 
meaning that the ATP cost of a given force output is elevated. However, the deleterious effects 
of acidosis on skeletal muscle performance are equivocal, with debate on the topic still a 
contemporary issue (Fitts, 2016; Westerblad, 2016). Conflicting evidence has been shown 
regarding the effects of acidosis on Ca2+ sensitivity, with ergogenic effects of acidosis being 
reported (Westerblad & Allen, 1993; Pedersen et al., 2004). The lack of association between 
H+ and impaired muscle performance is reinforced by the observation that recovery of muscle 
force is far more rapid than the recovery of pH (Sahlin & Ren, 1989). Whilst the detrimental 
effect of acidosis to the excitation-contraction coupling process is disputed, it might also 
potentially contribute to neuromuscular fatigue via stimulation of group III/IV afferent neurons, 
which have implications in the development of fatigue and exercise tolerance (Amann, 2011). 
 
2.3.2. Central Fatigue 
Processes within the CNS can reduce the capacity of the organism to activate skeletal muscle, 
a phenomenon commonly termed central fatigue (Gandevia, 2001). As Gandevia (2001, 
p1726) suggested, “if muscle is regarded as a motor, then the way it behaves depends not 
only on its intrinsic properties but also on the way that it is driven and the way feedback 
systems maintain its output”. The aetiology of these CNS impairments is dependent on the 
task(s) performed, but can be defined as a reduction in the voluntary activation of the muscle. 
 
2.3.2.1. Voluntary Activation 
Voluntary activation (VA) is typically quantified using the interpolated twitch technique (ITT) 
developed by Merton (1954). This involves the delivery of a stimulation during a maximal 
voluntary contraction, and is commonly performed by stimulating the nerve that innervates a 
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target muscle group. If extra force is elicited by the stimulation (a superimposed twitch, SIT), 
VA is considered sub-maximal, and some motor units were not recruited or firing at a high 
enough rate to produce tetanic contraction (Taylor & Gandevia, 2008). To quantify VA, the SIT 
is normalised to the response to the same stimulus delivered in the potentiated, relaxed 
muscle (potentiated twitch, Qtw,pot) using the formula shown in the equation below. 
 
VA = (1 – (SIT / POT)) × 100 
 
Whilst the ITT is subject to methodological (Folland & Williams, 2007) and conceptual 
(Contessa et al., 2016) debate, it is generally accepted as the most useful tool for assessing 
VA (Taylor, 2009). Pre-exercise, in the resting knee-extensors, typical values range between 
90-95% (Place et al., 2007). The ITT is considered to be a more accurate index of VA 
compared to the central activation ratio due to the effect that synergist co-contraction has on 
the CAR value, but not the ITT (Stackhouse et al., 2000). This leads to the CAR overestimating 
VA (Place et al., 2007) and being less sensitive to exercise-induced change when compared 
to the ITT (Bilodeau, 2006). Exercise-induced central fatigue is typically characterised by a 
decrease in VA (Bigland-Ritchie et al., 1978; Thomas et al., 1989), implying further 
decrements in the ability of the central nervous system to recruit and maximally fire the 
available motor units (Gandevia et al., 1995). One limitation of motor nerve-assessed ITT 
assessment is that it does not provide information about the locus or aetiology of central 
fatigue, therefore to discern information regarding the aetiology of central fatigue, further 
methods must be employed. 
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2.3.2.2. TMS-assessed Voluntary Activation 
Advances in the use of TMS in assessing exercise-induced change within the nervous system 
has permitted the assessment of VA from a different perspective. Stimulation of the primary 
motor cortex produces a motor response in the contralateral limb, first demonstrated using 
non-invasive electrical stimulation through the scalp (Merton & Morton, 1980), and later using 
electromagnetic stimulation (Barker et al., 1985). The latter method enabled investigation of 
the motor cortex without accompanying pain, and has drastically changed the state of human 
research, being widely adopted throughout neurophysiological investigations (Rothwell et al., 
1991). 
 
The mechanism in which TMS activates the motor cortex is electromagnetic conduction. An 
electrical current is passed through wire coils placed over the target muscle representation on 
the motor cortex, causing a rapidly-changing magnetic field along the winding of the coils 
(Terao & Ugawa, 2002). This magnetic current reaches a depth of 2-4 cm depending on the 
formation of the coil (Rudiak & Marg, 1994; Deng et al., 2013), with a trade-off between focality 
and depth apparent. As mentioned, the activation of cortical muscle representations elicits a 
motor response, or ‘twitch’, in the target muscle if a sufficient stimulus intensity is used, and 
when delivered during a maximum contraction a SIT is observed (Gandevia et al., 1996).  
 
A modified interpolated twitch technique is necessary for calculation of TMS-assessed VA 
(VATMS) as normalisation of the SIT to a resting twitch is not appropriate. As corticospinal and 
motoneuronal excitability is much lower at rest, TMS is unable to evoke an adequate twitch 
(Ugawa et al., 1995a; Di Lazzaro et al., 1998). This issue was resolved by Todd et al. (2003), 
who estimated the resting twitch via linear regression of SITs evoked at 50-100% of maximum, 
with the y-intercept of the regression used as the estimated resting twitch (ERT). First utilised 
in the elbow flexors (Todd et al., 2003, 2004), the method was subsequently validated and 
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refined in other muscle groups such as the knee extensors (Goodall et al., 2009; Sidhu et al., 
2009; Dekerle et al., 2019) 
 
As the SIT is evoked cortically in this context, it could imply submaximal output at the motor 
cortical level. Indeed, it has been suggested that an exercise-induced increase in SIT 
amplitude is caused by impairments within or upstream of the motor cortex (Gandevia et al., 
1996; Todd et al., 2004). However, as more recently acknowledged, an increased SIT could 
be caused by submaximal output at the motor cortical or motoneuronal level (Todd et al., 
2016). Regardless, the use of VATMS in addition to the ‘traditional’ ITT permits further detail 
about the aetiology of central fatigue, by stimulating prior to the corticospinal-motoneuronal 
synapse rather than the projecting motor nerve. Specific detail about the methodology can be 
found in Chapter 3, section 3.3.2. 
 
2.3.2.3. Corticospinal Excitability 
If TMS is delivered at a sufficient intensity, the axons of pyramidal neurons and cortical 
interneurons are depolarised in the area beneath the stimulation (Salvador et al., 2011). As a 
result, a single TMS pulse evokes a combination of both direct (D waves) and indirect (I waves) 
activation of pyramidal neurons (Di Lazzaro & Rothwell, 2014). This descending activation 
travels primarily via the corticospinal pathway, with implanted electrodes in the epidural space 
confirming this assumption (Di Lazzaro et al., 2012; Di Lazzaro & Rothwell, 2014). Using non-
invasive surface electromyography (EMG), the response to TMS (motor evoked potential, 
MEP) can be recorded on the targeted muscle(s). Whilst the MEP is not analogous to 
descending pathway activation via volitional motor command (Bestmann & Krakauer, 2015), 
it is commonly used as a quantitative marker for state, time, and task-dependent changes in 
the excitability of the corticospinal tract (Rothwell et al., 1991; Kalmar, 2018a). The MEP is 
frequently normalised to the maximum compound muscle action potential (Mmax), to account 
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for changes in peripheral neurotransmission, and is considered to reflect a net balance 
between faciliatory and inhibitory inputs at both cortical and spinal levels (Gruet et al., 2013). 
The link between excitability and exercise relates to the notion that an alteration in excitability 
changes the amount of synaptic input (i.e. neural drive/motor command) required to maintain 
a given task (Weavil & Amann, 2018). If an increase in neural drive is insufficient to overcome 
decreased corticospinal excitability, the ability of the CNS to activate the muscle will decrease 
(Martin, 2006). 
 
2.3.2.4. Spinal Excitability 
Distinguishing the cortical and spinal contributions to central fatigue is challenging as the 
organisation of spinal interneuron networks is not fully understood in humans (Nielsen, 2004). 
Excitability of the spinal portion of the corticospinal tract can be isolated however, with direct 
subcortical stimulation, and can permit segmental assessment of the motor pathway when 
used concurrently with TMS (Taylor & Gandevia, 2004). This technique was initially performed 
at the cervicomedullary junction, with a cervicomedullary evoked potential (CMEP) evoked 
(Taylor et al., 2002). Similar to a MEP, the size of a CMEP is dependent on the intensity of 
background contraction, an indication that it is evoked trans-synaptically (i.e. not direct 
activation of the motoneuron), via depolarization of the spinal tracts (Taylor et al., 2002). It is 
likely not possible to solely activate the corticospinal tract with direct spinal stimulation (McNeil 
et al., 2013), however evidence from studies investigating antidromic collisions from cortical 
and spinal stimulation suggest that CMEPs and similar stimulation at the thoracic spinal level 
(TMEPs) consist of a large corticospinal component (Taylor et al., 2002; Martin et al., 2008). 
Other methods exist to investigate the excitability of spinal structures, such as the H-reflex 
(Hoffman, 1918), F-wave (Eccles & Pritchard, 1937), and V-wave (Upton et al., 1971), with 
advantages and disadvantages to each one (McNeil et al., 2013). The responses to direct 
stimulation of the descending tract (i.e. CMEPs/TMEPs) are considered the most direct 
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assessment of spinal excitability, due to the fact that they are not affected by pre-synaptic 
inhibition (Jackson et al., 2006). 
 
2.3.2.5. Neural Inhibition 
In addition to the excitability of neural structures, TMS can be used to quantify the effects of 
inhibitory influences within the nervous system. When single-pulse TMS is delivered during a 
contraction, both excitatory (MEP), and an inhibitory responses are evoked. The inhibitory 
response manifests as a period of silence in the EMG signal following the MEP (Fuhr et al., 
1991; Uozumi et al., 1991; Wilson et al., 1993). Historically, the silent period was thought to 
reflect intracortical mechanisms of inhibition (Schnitzler & Benecke, 1994), however an 
abundance of evidence exists suggesting there are both spinal and cortical components (Fuhr 
et al., 1991; Ziemann et al., 1993). This notion was based on depression of H-reflexes evoked 
within the silent period, which as mentioned, is affected by pre-synaptic factors; however a 
recent investigation utilising CMEPs demonstrated the silent period has a longer spinal 
component than previously thought (Yacyshyn et al., 2016). A critical discussion of the 
underpinning mechanisms and confounding factors has been recently published (Škarabot et 
al., 2019), however the authors concluded that methodological confounds involved in data 
collection, as well as the lack of evidence for purported physiological inference could limit the 
comparability between studies and usefulness of the measure. 
 
Paired-pulse TMS can provide a reflection of the properties of the diverse populations of 
intracortical neurons that are implicated in the control of voluntary movement (Kujirai et al., 
1993). These intracortical neurons can be classified as either inhibitory of facilitatory based 
on their electrophysiological properties and how they affect post-synaptic neurons. Inhibitory 
neurons release neurotransmitters that increase the permeability of the post-synaptic 
membrane to K+ and Cl- ions, increasing the cell’s resting membrane potential. This has the 
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effect of hyperpolarising the post-synaptic neuron, and making it less likely to reach the action 
potential threshold in response to an excitatory input (Rosenthal et al., 1967). In the motor 
cortex, the most abundant inhibitory neurotransmitter is γ-aminobutyric acid (GABA; Jones, 
1993), with GABAA and GABAB receptor sub-types being the most commonly observed in the 
mammalian central nervous system (Watanabe et al., 2002). On the contrary, facilitatory 
intracortical neurons induce changes in post-synaptic membrane permeability so that Na+ can 
diffuse into the neuron. This moves the resting membrane potential closer to the action 
potential threshold, and increases the chance of that neuron firing in response to excitatory 
input.  
 
Using paired-pulse TMS, the effects of intracortical inhibitory neurons can be quantified when 
a sub-threshold conditioning stimulation is delivered 1-5 ms prior to a suprathreshold test 
stimulation, a phenomenon termed short-interval intracortical inhibition (SICI; Kujirai et al., 
1993). The neurotransmitter thought to mediate this inhibition is GABA, with the GABAA 
receptor responsible (Kujirai et al., 1993). The result is a reduced MEP amplitude in response 
to the test stimulation, when the conditioning stimulus is delivered at appropriate timings. 
Similarly, the influence of facilitatory intracortical neurons can be assessed with a 
subthreshold stimulus 6-20 ms prior to a test stimulation, a technique termed intracortical 
facilitation (ICF; Ziemann et al., 1996). The underpinning physiology of ICF is less clear, 
however, it has been suggested that the MEP facilitation could be mediated by glutamate-
mediated N-methyl-D-aspartate excitatory interneurons (Liepert et al., 1997; Nakamura et al., 
1997). Paired-pulse TMS has previously been used to quantify the changes in these neuronal 
populations following fatiguing isometric (Maruyama et al., 2006; Hunter et al., 2016; Goodall 
et al., 2018) and locomotor exercise (Tergau et al., 2000). Additionally, these techniques have 
recently been optimised in the knee-extensors, potentially facilitating research in a pertinent 
locomotor muscle (Brownstein et al., 2018b). 
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2.3.2.6. Mechanisms of Central Fatigue 
The aetiology of exercise-induced central fatigue can be multi-factorial, with alterations in 
processing from the supraspinal to the motoneuronal levels of the motor pathway. The 
aetiology of central fatigue is task-specific, and can manifest as several of the subsequently 
described phenomena (Todd et al., 2016).  
 
2.3.2.7. Neurobiological Mechanisms 
Neurotransmitters modulate the communication between neurons and broadly speaking, can 
be inhibitory or excitatory in nature. In vivo studies in human populations are difficult to draw 
conclusions from due to the complexity of brain functioning, however, in 1987, Newsholme et 
al proposed a link between the neurotransmitter 5-hydroxitryptamine (serotonin) and central 
fatigue. It was suggested that exercise-induced increases in the concentration of this 
neurochemical led to negative effects on arousal, lethargy, sleepiness, and mood (Newsholme 
et al., 1987). The experimental literature regarding the influence of serotonin and fatigue is 
mixed (see review Roelands & Meeusen, 2010), likely due to the complex interactions 
between different receptors and subsequent functions. Recent evidence does however 
suggest that serotonin might influence CNS adjustments at the spinal level, Kavanagh et al 
(2019) demonstrated that paroxetine administration (a selective serotonin reuptake inhibitor) 
improved VA in an unfatigued state. However, the drug also induced a greater degree of 
motoneuronal excitability depression and exercise-induced VA decrease during fatiguing 
exercise. The authors suggested the latter observation was due to increased extracellular 
concentrations of serotonin activating inhibitory 5-HT1A receptors, resulting in reduced 
motoneuronal activity. Indeed, in vitro work performed in the spinal cord of the adult turtle 
would support this notion (Perrier & Cotel, 2008; Cotel et al., 2013). The available evidence 
suggests that rather than the original notions that serotonin augmented central fatigue at 
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supraspinal sites (Newsholme et al., 1987; Meeusen et al., 2006), this neurotransmitter plays 
a key role in the regulation of spinal motoneuron excitability during exercise. 
 
Other neurobiological mechanisms of central fatigue that have been investigated include 
alterations in the concentrations of catecholamines such as noradrenaline and dopamine 
(Roelands & Meeusen, 2010). Ingestion of a noradrenaline reuptake inhibitor has been 
demonstrated to worsen endurance performance (Piacentini et al., 2002) and in terms of 
neurophysiological responses to exercise, the pharmacological manipulation induces a 
greater decrease in VA following prolonged cycling exercise (Klass et al., 2012, 2016). 
Conversely, dopamine manipulation did not alter endurance performance in normal ambient 
temperatures, only elevated (30°C; Roelands et al., 2008). Furthermore, Swart et al. (2009) 
demonstrated that dopamine reuptake inhibitors enabled participants to work at higher work 
rates, and experience greater cardiorespiratory stress for longer, with identical perceived 
‘exercise stress’ compared to a placebo trial. Despite this, Klass et al. (2012) demonstrated 
no effect on cycling time trial performance or indices of corticospinal excitability and VA. In 
summary, it appears that changes in neurochemistry are implicated in the regulation of central 
fatigue during exercise, with serotonin likely regulating properties of spinal motoneurons. 
However, the supraspinal effects of changing neurochemical concentrations are challenging 
to discern in humans due to the complex interactions between neurotransmitter systems 
(Meeusen & Roelands, 2018). 
 
2.3.2.8. Neural Drive and Excitability 
During sustained maximal contractions, the amplitude of voluntary EMG recorded at the 
muscle is at its greatest, however, progressively decreases as the task progresses due to a 
reduction in the responsiveness of motoneurons (see Section 2.3.2.9), decreased excitatory 
afferent input from Ia neurons, and decreased descending drive due to supraspinal fatigue 
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(Todd et al., 2005; Taylor & Gandevia, 2008). Indeed, multiple studies have demonstrated 
changes in the excitability of cortical and motoneuronal neurons during two-minute MVCs 
(Taylor et al., 1996; Kennedy et al., 2016), which have been thought to account for ~25% of 
the force decreased (Gandevia et al., 1996). However, during submaximal sustained 
contractions, EMG amplitude increases as descending drive increases (Hunter & Enoka, 
2001; Søgaard et al., 2006; Klass et al., 2008). This is thought to be a compensatory 
mechanism for contractile dysfunction in the working muscles, and is commonly observed 
alongside an initial increase in corticospinal excitability (Lévénez et al., 2007; Klass et al., 
2008). This initial increase in corticospinal excitability with fatiguing exercise appears to be 
transient, as studies investigating the pre-post exercise response commonly demonstrate 
reduced or unchanged corticospinal excitability at task-failure (Sidhu et al., 2009, 2017; Klass 
et al., 2012; Girard et al., 2013; Goodall et al., 2014b; Jubeau et al., 2014; Thomas et al., 
2016). Although several studies report an increase (Fernandez-del-Olmo et al., 2013; Temesi 
et al., 2013, 2014b; Jubeau et al., 2017) or a decrease (Sidhu et al., 2014; Thomas et al., 
2014a; Pearcey et al., 2015). The task-specificity of the exercise-induced change in MEP 
amplitude likely explain the discrepancy between results, as well as differences in the 
methodology of testing (Weavil & Amann, 2018). Despite the discrepancies in MEP changes 
following exercise, the literature investigating CMEP changes is more conclusive. Studies in 
both upper (Pearcey et al., 2015) and lower limbs (Weavil et al., 2016; Sidhu et al., 2017; Finn 
et al., 2018) have demonstrated that even in the presence of an unchanged MEP, CMEPs or 
TMEPs decrease with exercise-induced fatigue.  
 
In short, exercise-induced changes in the excitability of the corticospinal tract appear to be 
dependent on the exercise task performed. Changes during single-limb exercise being almost 
completely related to sensory feedback from the exercising muscle or activity-dependent 
changes in the motoneurons (see Sections 2.3.2.9 and 2.3.2.10), whereas, in whole-body 
exercise, the influence of autonomic activity and sensory feedback from cardiovascular 
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systems has been shown to modulate the corticospinal pathway (Buharin et al., 2013). 
Therefore, the generalisability of single-limb findings to whole-body exercise is limited. 
 
2.3.2.9. Motoneuronal Properties and Fatigue 
The decrease in spinal excitability with exercise-induced fatigue is one line of evidence that 
motoneuronal properties are modulated by exercise. Other factors include activity-dependent 
changes with constant input, which manifest as a decrease in firing rate (Kernell & Monster, 
1982; Miles et al., 2005; Brownstone, 2006). Furthermore, through motor unit recordings 
during submaximal contractions, it is evident that the number of active motor units increases, 
implying that to maintain the same output (force), the motoneuron requires greater synaptic 
input (Johnson & Heckman, 2014). Whilst increases in descending drive can compensate for 
some of the impairments in motoneuron excitability (Finn et al., 2018), it would appear that the 
intrinsic properties of low-threshold motoneurons are more negatively affected by exercise-
induced fatigue (McNeil et al., 2011; Finn et al., 2018). This led to the conclusion that the 
intrinsic properties of low-threshold motoneurons are more negatively impaired as they are 
recruited prior to high-threshold counterparts and are more active during fatiguing contractions 
(Carpentier et al., 2001). Therefore, if repetitively active motoneurons are less excitable than 
less active or inactive neurons, it implies that it is the repeated activity inducing the change, 
as altered descending or afferent input would modulate motoneurons regardless of threshold 
(Todd et al., 2016). 
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Figure 2-5: Contributing factors to the reduction in motoneuron firing rate during fatiguing exercise. Taken from 
Taylor et al. (2016). 
 
The change in excitability of a motoneuron likely reflects a combination of changes in the 
intrinsic properties of the motoneuron, as well as the modulation of synaptic input to the 
motoneuron (see Figure 2-5). The firing properties of a motoneuron depends on the integration 
of excitatory input (i.e. descending drive and Ia afferents) as well as inhibitory influences 
(group Ib, III, IV afferents and Renshaw cell input; Enoka 2012). Whilst the role of golgi tendon 
organ (Ib) feedback and Renshaw cells are reduced with fatigue (Gandevia, 2001), group III/IV 
afferent input is increased (Amann & Light, 2015). The aetiology of the inhibitory effects of 
group III/IV afferents is multifactorial and widespread throughout the nervous system, as 
discussed in the subsequent section. 
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2.3.2.10. Group III/IV Afferent Feedback 
Group III/IV afferent neurons are activated in response to mechanical and metabolic stimuli 
(Kaufman et al., 1987; Pollak et al., 2014) and the role of this afferent feedback is purported 
to play a large role in the development of central fatigue (Gandevia et al., 1996; Gandevia, 
2001; Kennedy et al., 2014). Studies employing transient pharmacological blockades of these 
neurons provide evidence that the activation of these neurons increases intracortical inhibition 
(Hilty et al., 2011; Sidhu et al., 2018), and reduces cortical and spinal excitability (Sidhu et al., 
2017). These factors impair the synaptic input to the motoneuron as well as directly affecting 
motoneuron transmission of motor commands, and amalgamate in an impaired ability to 
activate the muscle (Sidhu et al., 2017). Indeed group III/IV neurons have been demonstrated 
to project to spinal and supraspinal sites within the motor pathway (Light et al., 2008; Amann 
& Light, 2015), and while the firing properties of these neuronal populations can only be 
directly assessed using invasive techniques in humans, this link between peripheral and 
central fatigue is thought to be vital in the determination of exercise tolerance (Amann, 2011). 
Gandevia (2001) first proposed that afferent feedback contributed to a sensory limit to 
exercise, at which point a fatiguing task became ‘sufficiently unattractive’ to continue. 
Subsequently, (Amann & Dempsey, 2008) proposed that afferent feedback was a mechanism 
in which the central nervous system limited the exercise performer to a ‘critical threshold’ of 
peripheral disturbance, beyond which the extremely large sensory input would not be 
tolerated. This theory was recently expanded upon, with the suggestion that afferent feedback 
from other physiological systems (e.g. respiratory, cardiac systems) as well as corollary 
discharge from the motor cortex is integrated into a feed-forward mechanism that would 
influence the exercise performer (Hureau et al., 2018). These neurons are also vital for the 
regulation of autonomic control during exercise, reflexively increasing cardiac output, mean 
arterial pressure, and ventilation (Amann, 2011; Amann et al., 2011), enabling the exerciser 
to maintain adequate haemodynamic function to perform the given task. Thus, group III/IV 
feedback cannot be classified as solely negative to the exercise performer, and the intensity 
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of exercise likely mediates the net balance of positive to negative consequences of sensory 
feedback. One counter-argument to this model suggests that perception of effort is the 
predominant limiting factor to high-intensity exercise performance, and that the 
neurophysiological origins of this sensation are not related to group III/IV feedback (Marcora, 
2010). Instead, corollary discharge from motor to sensory areas of the brain is responsible, 
and as greater central motor drive is required to maintain the required exercise task, an equal 
increase in corollary discharge occurs. In constant-load exercise, this increases until 
maximum effort is attained, whereas during self-paced exercise, power output can be reduced, 
to allow full completion of a given time/distance. Critical discussion of the two conflicting 
theories has been previously offered (Perrey et al., 2010), with researchers highlighting a 
multitude of opinions and alternate explanations.  
 
2.4. Fatigue throughout the Exercise Intensity Domains 
Exercise intensity can be categorised into four distinct ‘domains’, and the physiological 
responses to each domain elicit different profiles of neuromuscular fatigue (Burnley & Jones, 
2018). These differing aetiologies of fatigue all eventually elicit task failure during constant-
load exercise via different means, and these can broadly be predicted by the intensity-duration 
relationship. During ramp exercise, the boundaries between intensity domains can begin to 
be established using physiological and performance markers to demarcate the four domains. 
Exercise tolerance in the severe intensity domain in particular becomes predictable if profiled 
correctly (see Section 2.4.3.1). 
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Figure 2-6: Visualisations of the exercise intensity domains. A: the oxygen uptake response to incremental 
exercise. B: the powe-duration relationship during cycling exercise. C: the V̇O2 response to constant load cycling 
in each intensity domain. Taken from Burnley and Jones (2018). 
 
2.4.1. Moderate Intensity Domain 
The lactate threshold is the initial physiological intensity border, beneath which, exercise is 
termed ‘moderate’ intensity. During constant-load trials in the moderate domain, oxygen 
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consumption (̇V̇O2) rises to match the demands of work, then remains constant without further 
increase (see Figure 2-6, Burnley & Jones, 2018). Exercise in this domain is typically observed 
during ultra-endurance events, as this intensity can be sustained for hours without any 
progressive perturbation within the exercising musculature (Black et al., 2016). Rather, 
depletion of muscle glycogen, and subsequent impairment of calcium release,  is a 
contributing factor to peripheral fatigue (Chin & Allen, 1997; Ørtenblad et al., 2013). The 
predominant cause of neuromuscular fatigue in this domain however, is central fatigue; 
following both moderate intensity running (Martin et al., 2010) and cycling (Lepers et al., 2002), 
decreases in VA have been observed. The cause of this central fatigue is likely to be activity-
dependent changes in motoneuron properties (Section 2.3.2.9), as group III/IV afferent 
feedback is minimal due to negligible metabolite accumulation (Black et al., 2016). As 
acknowledged by Burnley & Jones (2018), moderate intensity exercise is commonly 
terminated prior to task failure, therefore it is unclear whether neuromuscular fatigue limits 
performance of these tasks.  
 
2.4.2. Heavy Intensity Domain 
Above the lactate threshold, exercise intensity is deemed ‘heavy’ and the time to task failure 
becomes shorter, typically ~40 minutes to 3 hours (Coyle et al., 1986). During heavy intensity 
exercise, V̇O2 initially rises to match the energy demands of the task, however, a subsequent 
smaller rise is then observed, termed the V̇O2 slow component (Figure 2-6, Burnley & Jones, 
2018). This slow component eventually reaches a steady-state in the heavy intensity domain, 
and is presumed to be a result of additional type II muscle fibre recruitment, possibly as a 
compensatory response to contractile dysfunction, thus increasing the muscle V̇O2 as a result 
(Poole et al., 1991; Whipp, 1994). Indeed, more recent evidence would suggest that exercise 
in the heavy intensity domain results in metabolic perturbation within the exercising muscle, 
however this reaches a steady-state and is therefore unlikely a limiting factor to heavy intensity 
exercise (Jones et al., 2008; Vanhatalo et al., 2010; Black et al., 2016).  
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When neuromuscular responses are compared pre-post exercise in this domain, both central 
and peripheral fatigue are observed (Thomas et al., 2016). It is suggested that peripheral 
fatigue develops in the early phases of heavy intensity exercise because of the 
aforementioned metabolic perturbation (Burnley & Jones, 2018). Later in heavy intensity 
exercise, this peripheral fatigue is potentially exacerbated due to glycogen depletion, with 33-
49% decreases observed following 30 minutes of cycling at 85% of V̇O2max (Ahlquist et al., 
1992). This glycogen depletion could impair excitation-contraction coupling (Chin & Allen, 
1997; Ørtenblad et al., 2013), leading to a reduction in the evoked amplitude of resting muscle 
twitches (Thomas et al., 2016). 
 
Central fatigue during heavy intensity exercise is unlikely a result of exaggerated group III/IV 
feedback, as the metabolic disturbance in the exercising muscle reaches a steady state 
(Jones et al., 2008; Vanhatalo et al., 2016), therefore is unlikely to increase the activity of 
metabo-sensitive afferents. More likely, the extended duration of exercise leads to activity-
dependent changes in the properties of motoneurons (see Section 2.3.2.9), which leads to a 
progressive inability to activate the exercising muscle. As a result, increased central motor 
command is required to maintain the task (Burnley & Jones, 2018). The combination of 
peripheral disturbances and reduced CNS efficacy likely both contribute to the attainment of 
task failure or termination in the heavy intensity domain, with no single mechanism 
responsible. 
 
2.4.3. Severe Intensity Domain 
2.4.3.1. Modelling Severe Intensity Exercise Tolerance 
Above a certain intensity, the metabolic response to exercise becomes unsustainable; this 
threshold is the lower boundary of the severe intensity domain and can be discerned by a 
number of techniques. For example, during a ramp test the lactate turnpoint, onset of blood 
35 
 
lactate accumulation, and respiratory compensation point are all considered to be indicators 
of unsustainable metabolism (Faude et al., 2009; Jones et al., 2019a, 2019b). The limitations 
of these variables are that they represent distinct physiological processes, and might occur at 
contrasting metabolic rates (Jones et al., 2019b). Indeed, controversy exists over the ‘gold-
standard’ for determining the lower boundary of the severe intensity domain, with two 
commonly used methods purported to be the most valid (Jones et al., 2019a). The maximum 
lactate steady state (Beneke & Von Duvillard, 1996; Billat et al., 2003; Faude et al., 2009) is 
determined by performing multiple (usually 4-5) 30 minute exercise bouts, with the work rate 
at which lactate remains constant (< 1mmol.L-1 change in the final 20 minutes) deemed the 
MLSS. Alternatively ‘critical power’ (CP) can be calculated from the hyperbolic relationship 
between exercise intensity (e.g. speed or power) and the time to task failure (Hill, 1925; Monod 
& Scherrer, 1965; Hill & Smith, 1999; Hill et al., 2002; Jones et al., 2010). A comparison and 
critique of both methods has recently been published (Jones et al., 2019a), however the 
authors argue that the evidence demonstrating that CP represents the metabolic boundary 
between sustainable (heavy) and non-sustainable (severe) exercise (Figure 2-7) suggests it 
should be considered the ‘gold standard’ demarcation. 
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Figure 2-7: Mean and SD muscle blood flow (panel A; Copp et al., 2010), muscle metabolic perturbation (pH, panel 
B; lactate, panel C; Blacket al. 2017), and the rates of change in muscle [PCr] (panel D; Black et al. 2017), 
neuromuscular excitability (panel E; Burnley et al. 2012), and pulmonary V̇O2(panel F; Black et al. 2017) following 
moderate-intensity (triangles), heavy-intensity (squares), and severe-intensity (circles)exercise. The dotted vertical 
line indicates CP, and a line of best fit has been drawn for all trials performed below CP (i.e., moderate- and heavy-
intensity exercise; dashed line). Taken from Jones et al (2019)  
 
Critical power is considered to be the greatest exercise intensity that results in ‘wholly 
oxidative’ energy provision (Poole et al., 2016). Therefore energy provision during exercise 
above CP must come from anaerobic sources, which results in an intramuscular disturbance 
(Jones et al., 2010). As mentioned, the non-sustainable nature of exercise tolerance above 
CP results in a hyperbolic relationship between exercise intensity and duration. Typically, this 
relationship is profiled using multiple constant-load trials to task failure, with the most accurate 
estimations discerned from trials between 2-20 minutes (Bishop et al., 1998; Jones et al., 
2010; Mattioni Maturana et al., 2018). The asymptote of the hyperbolic relationship is used as 
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CP, and the curvature constant (W’) the maximum work capacity above CP. As described in 
Chapter 1, W’ can be used to predict time to task failure using the following equation:  
 
Tlim = W’ ÷ (P – CP) 
 
In which Tlim is time to task failure, W’ is the curvature constant parameter, P is the intensity 
of exercise (power) and CP is critical intensity (expressed as power for cycling). Other 
statistical methods of discerning these parameters can be used. For instance plotting work (in 
Joules) versus time to task failure creates a linear relationship, with the intercept of the linear 
regression taken as CP, and the slope as W’ (Moritani et al., 1981). Similarly, the inverse 
linear model can be used when exercise intensity (power) is plotted against the inverse 
(1/time) of the time to task failure, and a linear relationship is observed, again, with the 
intercept of the linear regression taken as CP, and the slope as W’ (Whipp et al., 1982). A 
common approach is to model the power-duration relationship in multiple ways, and use the 
model with the lowest error to determine subsequent exercise intensities (Mitchell et al., 
2018a). 
 
2.4.3.2. Fatigability in the Severe Intensity Domain 
Below critical power (i.e. the heavy intensity domain), metabolic responses reach a steady 
state, as described above, however above CP, the muscle metabolic milieu increases 
progressively, until task failure is reached (Vanhatalo et al., 2010). This physiological response 
to unsustainable exercise is reflected in the V̇O2 response as well, as the V̇O2 slow component 
rises to V̇O2max, at which point task failure is imminent (Figure 2-6; Poole et al., 1988; Burnley 
& Jones, 2007; Murgatroyd et al., 2011). An increase in exercise intensity above CP increases 
the rate of muscle metabolic perturbation and the V̇O2 slow component increases (Vanhatalo 
et al., 2010), however the end-exercise metabolic milieu and consequent contractile 
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dysfunction is remarkably consistent, regardless of work rate (Jones et al., 2008; Vanhatalo 
et al., 2010, 2016; Black et al., 2016; Schäfer et al., 2019). This relationship is also observed 
during single-limb exercise as well as cycling, when the rate of fatigue above critical torque is 
augmented (Burnley et al., 2012).  
 
It is thought that the attainment of V̇O2max and the maximum intramuscular disturbance are 
tightly linked with W’ (Murgatroyd et al., 2011; Vanhatalo et al., 2011). W’ was originally 
considered to be a finite ‘anaerobic work capacity’ (Monod & Scherrer, 1965; Moritani et al., 
1981), however interventions such as hyperoxic breathing (Vanhatalo et al., 2010), and 
endurance exercise training (Gaesser & Wilson, 1988; Vanhatalo et al., 2008) elicit divergent 
effects on CP and W’. Therefore, the parameters cannot be considered solely aerobic or 
anaerobic, and are likely a result of an integrated physiological system that acts to determine 
exercise tolerance in the severe intensity domain. Recent work has suggested that W’ during 
single-limb exercise is closely related to the depletion of intramuscular energy stores and 
accumulation of metabolites (Broxterman et al., 2015b), however it is well established that the 
determinants of exercise tolerance differ between single-limb and whole-body exercise 
(Hureau et al., 2018; Thomas et al., 2018). Indeed Poole et al (2016) suggested that in whole-
body exercise, W’ is likely influenced by cardiopulmonary limiting factors to exercise in addition 
to muscle dysfunction. 
 
The mechanisms underpinning peripheral fatigue in the severe intensity domain are primarily 
related to the uncontrollable muscle metabolic perturbation (Jones et al., 2008; Vanhatalo et 
al., 2010, 2016; Black et al., 2016). Which leads to a necessary recruitment of additional motor 
units as the contractile function of previously recruited units decreases (Burnley et al., 2012). 
The severe intensity domain is also where the role of group III/IV afferent neurons is implicated 
in the development of central fatigue (Section 2.3.2.10), as metabo-sensitive receptors are 
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activated by the presence of metabolic stimuli (e.g. Pi, H+, and K+). The effects of III/IV afferent 
feedback include a decrease in the excitability of various levels of the central nervous system 
(see Section 2.3.2.10), which, when combined with activity-dependent impairments in 
motoneuron properties (Section 2.3.2.9) amalgamates in a reduced capacity to voluntarily 
activate the exercising muscle (Sidhu et al., 2017).  
 
The ultimate limiting mechanism to severe intensity exercise is debated (Amann, 2011; 
Hureau et al., 2018; Thomas et al., 2018), with researchers suggesting that the modest degree 
of central fatigue experienced post-exercise likely does not limit exercise tolerance (Thomas 
et al., 2014a, 2016). The consistent degree of post-exercise peripheral fatigue following trials 
above CP fits with the hyperbolic nature of the power-duration relationship, and consistent 
depletion of W’ at task failure (Poole et al., 2016a; Burnley & Jones, 2018), suggesting that 
contractile dysfunction of the exercising muscle limits performance. Whilst this might hold true 
for single-limb exercise (i.e. Burnley et al., 2012), whole body exercise tolerance is likely a 
result of the integration of cardiovascular, respiratory, and muscular responses to exercise. 
Indeed, as recently acknowledged by Poole et al (2016), a physiological equivalent of W’ has 
not be demonstrated, and is likely task- and population-specific. 
 
2.5. Sex Differences in Neuromuscular Function 
Considering sex as a biological variable has been promoted as an area of importance for 
biomedical research, highlighted by a series of review articles (Cahill, 2006; Beery & Zucker, 
2011; McCarthy et al., 2012; Shansky & Woolley, 2016). These sex differences also extend 
to exercise performance; all exercise requires coupling of the nervous system with skeletal 
muscle(s), therefore sex differences at any stage of the motor pathway have the potential to 
influence exercise performance. Understanding how sex influences the neuromuscular 
system in health and disease will enable practitioners to optimise the prescription of exercise 
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in athletic and clinical populations. This section aims to detail the current scientific knowledge 
of sex differences in neuromuscular function, whilst outlining areas for future research. 
 
2.5.1. A brief history of the scientific study of sex and performance 
The anatomical and physiological differences between males and females have been thought 
to determine the absolute limits to human performance for centuries. The scientific 
understanding of this topic has developed considerably over the past 150 years, mainly due 
to advances in technology. However, in the 19th century, medical literature consisted mainly 
of hypotheses and opinion. For instance, Dr Edward Clark published ‘Sex in Education; or, A 
Fair Chance For Girls’ in 1873, which suggested that if women pushed themselves to compete 
with males, they would experience nervous collapse and sterility. However, similar to other 
essays of that era, the conclusions were not based on empirical data. The first to 
comprehensively study female performance was Dr Mary Putnam-Jacobi, who studied  a 
range of parameters including muscle strength, pulse pressures and daily physical activity 
levels. The data showed that menstruation did not hinder female performance, and her essay 
“The Question of Rest for Women during Menstruation” was awarded Harvard University’s 
esteemed Boylston Prize in 1876. Since the pioneering work of Dr Putnam-Jacobi, 
technological advances have permitted further insight into the how the sex of an individual 
might influence physiological responses to exercise.  
 
2.5.2. Sex differences throughout the motor pathway 
The chain of events that results in muscle contraction outlined in Section 2.3 is susceptible to 
influences that can augment or impair the process. While aspects of the motor pathway can 
be trained and augmented, the characteristics of the exercise performer ultimately define the 
maximal neuromuscular output in a given scenario; it is for this reason why certain individuals 
are capable of athletic feats that others are not. Indeed, the sex of the exerciser influences 
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characteristics of the motor pathway and leads to both subtle and clear differences in 
performance of a wide range of tasks between males and females. 
 
2.5.2.1. Pre-motor processes 
Beginning at the top of the motor pathway, sex differences in brain structure and function are 
prevalent, including greater connectivity between the sensory and motor cortices in males 
(Ritchie et al., 2018). Techniques such as functional and structural magnetic resonance 
imaging, positron emission tomography, and single photon emission computed tomography 
have identified sex differences in cerebral blood flow and neurochemistry (Cosgrove et al., 
2007), indicating that males and females have distinct cerebral features that could contribute 
to sex differences in a wide range of both healthy and pathological states. However, how these 
differences relate to motor function is unclear, and whether these sex differences are 
physiological or related to social factors remain undetermined. Further evidence supports the 
notion that a sex difference in cortical and sub-cortical activation occurs during both simple 
and complex motor tasks (Lissek et al., 2007). Whilst sensorimotor activation, assessed by 
functional MRI (fMRI), has been implicated in the production of force (Cramer et al., 2002), 
and exercise-induced fatigue (Liu et al., 2003), the causal role of interaction between brain 
areas on neuromuscular function during exercise is still unclear (Robertson & Marino, 2016; 
Meeusen et al., 2016). As suggested by Hunter (2014), the present challenge is to determine 
the functional significance of sex differences in brain activity during motor output. 
 
2.5.2.2. Intracortical and corticospinal neurons 
Understanding whether neurotransmitter systems might differ between sexes can aid in 
optimising a wide range of physiological processes, such as adaptation to strength training 
(Weier et al., 2012), and exercise-induced fatigue (Sidhu et al., 2017; Goodall et al., 2018), 
both of which have been suggested to be influenced by sex (Crewther et al., 2006; Hunter, 
42 
 
2009). To date, only  one investigation has addressed the question of sex differences in TMS-
assessed intracortical neurotransmission directly, reporting no sex difference in the resting 
first dorsal interosseous muscle (Cahn et al., 2003). However, as acknowledged by Kalmar 
(2018), excitability of intracortical and corticospinal structures is state, time, and task 
dependent, therefore resting data should not be extrapolated to an active state. On this note, 
cortical representations of different muscle groups also exhibit different input-output properties 
in response to single and paired-pulse TMS (Chen et al., 1998). Thus, a comprehensive 
investigation into the dynamics of intracortical properties in different muscle groups, during 
different tasks is required before conclusions can be made about sex differences in 
neurotransmission in motor regions of the brain. 
 
At rest, the properties of the corticospinal tract in response to single-pulse TMS are known to 
be similar between males and females (Pitcher et al., 2003; Rozand et al., 2019). Similarly, 
both sexes experience changes in corticospinal excitability following fatiguing exercise (Hunter 
et al., 2006a; Senefeld et al., 2018), suggesting that the responsiveness of this descending 
tract is not responsible for any sex differences in aspects of neuromuscular performance. 
However, to fully discern the aetiology of change in corticospinal properties, direct subcortical 
stimulation must be delivered in addition to TMS (Petersen et al., 2002; Martin et al., 2008). 
To date, no studies exist comparing the contribution of cortical and subcortical structures to 
indices of neuromuscular performance in fatigued or non-fatigued states. 
 
2.5.2.3. Motor Unit Properties 
A variety of techniques exist to assess motor unit discharge properties, however, there is a 
lack of literature directly comparing sex differences. Higher discharge rates have been 
observed in males compared to females at low (15%) contraction intensities (Harwood et al., 
2014), possibly due to the fact that males have a lower proportion of low-threshold motor units 
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(Kukulka & Clamann, 1981). These factors, amongst others, are suggested to contribute to a 
sex difference in force steadiness (Jakobi et al., 2018), that appears to be exacerbated by 
exercise-induced fatigue (Ansdell et al., 2018b).  Although Jakobi et al. (2018) concluded that 
despite a clear sex difference in steadiness, the underlying mechanisms are unclear. A recent 
investigation using high-density EMG (Pereira et al., 2019) demonstrated no differences in 
discharge rate, but rather showed that females experienced greater oscillations in the common 
synaptic input to motor units. This greater coefficient of variation (CV) in the common synaptic 
input has been associated with the CV of force during sustained submaximal contractions 
(Farina & Negro, 2015). The present challenge is to assess how the interaction between sex, 
motor unit firing properties, and fatigue interact to affect functional tasks, which as suggested 
by Jakobi et al. (2018) is a challenging task. 
 
2.5.2.4. Skeletal Muscle Physiology 
The morphological differences in skeletal muscle are likely the area of the motor pathway that 
differ the most between sexes when exercise-induced fatigue is of interest (Hunter, 2016a). A 
simple observation is that males possess a greater quantity of skeletal muscle, which leads to 
greater maximum strength (Miller et al., 1993; Lindle et al., 1997; Ivey et al., 2000; Welle et 
al., 2008). This sex difference in maximum strength varies between muscles (Miller et al., 
1993; Senefeld et al., 2013), however, the VA of skeletal muscle does not differ between males 
and females (Hunter et al., 2006a; Yoon et al., 2007b), indicating the properties of muscle are 
the reason for the strength difference. This strength difference can have implications for sex 
differences during certain fatiguing exercises, as detailed in Section 2.6.1. 
 
In terms of muscle metabolism during exercise, females oxidise more fat, but less 
carbohydrate and amino acids compared to males (Tarnopolsky, 2008). This is likely due to 
the fact that males have greater glycolytic capacity (Esbjörnsson et al., 1993), whereas 
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females have greater whole-muscle oxidative capacity (Russ et al., 2005). All of which, are 
likely a result of a difference in the proportional area of type I muscle fibres, which has been 
shown to be consistently greater in females, particularly in the knee extensors (see Figure 2-
8, Simoneau & Bouchard, 1989; Staron et al., 2000; Roepstorff et al., 2006; Welle et al., 2008). 
These differences result in observations such as females exhibiting a smaller decrease in ATP 
concentrations and increases in products of ATP breakdown (Esbjörnsson-Liljedahl et al., 
1999; Esbjornsson-Liljedahl et al., 2002), leading to the suggestion that differences in skeletal 
muscle metabolism contribute to the sex difference in fatigability (Hunter, 2014). 
 
 
Figure 2-8: Type I fibre area (% proportional area of the sample) of skeletal muscle in men and women across 13 
studies. The mean (± SEM) proportional area of type I fibers of all the muscles from the 13 studies is plotted on the 
right side of the figure. Women had greater type I fiber area (%) than men for the 13 studies when pooled (P<0.05). 
Taken from Hunter et al. (2016). 
 
This fibre type difference between sexes contributes to more than just metabolism during 
exercise and has implications for the contractile properties of the skeletal muscle(s). Male 
skeletal muscle exhibits faster relaxation rates than female muscle (Hunter et al., 2006a), 
which agrees with the notion that type I fibres demonstrate slower Ca2+ kinetics, lower power 
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generation, slower shortening and relaxation velocities than type II fibres (Schiaffino & 
Reggiani, 2011). Indeed, evidence from biopsies has shown females have a 24% lower rate 
of maximal sarcoplasmic reticulum Ca2+ATPase activity than males (Harmer et al., 2014). 
Slower Ca2+ ATPase activity and Ca2+ reuptake into the sarcoplasmic reticulum is linked with 
slower rates of relaxation (Gollnick et al., 1991), with a positive relationship observed between 
Ca2+ ATPase and type II fibre proportional area (Madsen et al., 1994). This slower activity 
does not mean a ‘less active’ female muscle, as this parameter is not altered in response to 
resistance training (Hunter et al., 1999), or immobilisation (Thom et al., 2001). However, as 
suggested in Section 2.3.1.3, dysfunction in calcium-related processes can cause peripheral 
fatigue, which has lead Hunter (2014) to suggest that females possess slower, yet more 
fatigue-resistant skeletal muscle properties than males. 
 
Another result of greater type I fibre proportional area is the haemodynamic and perfusion 
properties of the muscle, which has implications for oxygen delivery and the accumulation of 
metabolites during exercise. Vasodilatory responses of the feed arteries to exercising skeletal 
muscles appear to be greater in females, for instance, the femoral artery exhibits greater 
vascular conductance and blood flow during incremental exercise, as a result of greater 
increases in artery diameter compared to males (Parker et al., 2007). This sex difference could 
promote greater muscle perfusion during exercise; however, this would also depend on the 
capillarisation of muscle. Evidence from muscle biopsies also demonstrates a higher density 
of capillaries per unit of skeletal muscle in females compared to males in the vastus lateralis 
(Roepstorff et al., 2006). Collectively, the greater delivery of oxygenated blood and muscle 
capillarity implies that muscle perfusion during exercise would be greater in females compared 
to males. Indeed, a recent study employing near-infrared spectroscopy (NIRS) demonstrated 
that forearm muscle oxygenation decreases to a greater degree during handgrip exercise in 
males (Mantooth et al., 2018). However, this study employed sustained contractions, of which 
pressure-related occlusion might influence the sex difference (see Section 2.6.2). More recent 
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evidence demonstrated a lesser deoxygenation in females during high-intensity intermittent 
contractions (resistance training) compared to males (Marshall et al., 2019). Therefore, it 
remains to be seen whether a similar phenomenon occurs during endurance exercise, and 
whether a potential sex difference in oxygenation affects fatigability. 
 
2.5.2.5. The Influence of the Menstrual Cycle on Neuromuscular Function 
Sex differences cannot be discussed without acknowledging the potent effects of sex 
hormones on neural function. Throughout the female lifespan, women experience changes in 
sex hormone concentrations from menarche to menopause (Brown & Thomas, 2011). These 
sex hormones can modulate activity within the nervous system, which has led researchers to 
refer to them as ‘neurosteroids’ (Paul & Purdy, 1992). The effects of these hormones can be 
simplified into net excitatory or inhibitory, with the amalgamation of all hormonal 
concentrations at a given time point creating a ‘dynamic ecosystem’ within the nervous system 
(Tenan, 2016). Typically, oestrogens have excitatory effects, as they attenuate the release of 
GABA at inhibitory synapses (Schultz et al., 2009), leading to decreased firing thresholds and 
increased discharge frequency of cerebral neurons (Smith et al., 1989; Wong & Moss, 1992). 
On the contrary, progesterone and its metabolites have a net inhibitory effect on the nervous 
system, as the activity and effects of GABA are potentiated, leading to decreased neuronal 
discharge rate (Smith et al., 1989) and in an animal model, increased inhibition of pyramidal 
neurons (Hsu & Smith, 2003). Collectively, this in-vitro evidence suggests human neuronal 
function could be affected; however, in-vivo studies are relatively sparse in comparison. 
 
Research employing TMS to investigate the neurosteroidal effects of these hormones often 
use the menstrual cycle to study changes, due to the predictable cyclical changes in oestrogen 
and progesterone. Smith et al. (1999) first demonstrated the inhibitory effects of these 
hormones by assessing SICI in the resting hand muscles during the follicular (low oestrogen 
47 
 
and low progesterone) and luteal (high oestrogen and high progesterone) phases. The authors 
reported greater inhibition in the luteal phase, which supported the notion that progesterone 
potentiated GABAergic processes (Smith et al., 1989; Hsu & Smith, 2003). The authors then 
built on their findings by demonstrating that in the late follicular phase (high oestrogen, low 
progesterone) oestrogen reduced intracortical inhibition and increased facilitation (Smith et 
al., 2002). These changes have since been suggested to cause changes in motor unit firing 
properties across the menstrual cycle (Tenan et al., 2013); specifically, a lower initial firing 
rate at recruitment was observed in the early follicular phase, when hormone concentrations 
are lowest. Similarly, inhibition in other locations of the nervous system has been shown to be 
modulated by hormones. Using TMS, Hausmann et al. (2006) demonstrated that ipsilateral 
silent period, an index of transcallosal inhibition (Ferbert et al., 1992), was reduced in the late 
follicular phase. Furthermore, lower in the motor pathway, pre-synaptic inhibition of sensory 
Ia axons is reduced concurrently with elevated oestrogen concentrations (Hoffman et al., 
2018b). This theme of inhibitory pathways being modulated by sex hormones is evidently 
common within the nervous system. 
 
The aforementioned neuronal changes throughout the menstrual cycle have been purported 
to elicit functional consequences too, for instance a body of literature suggests that females 
can produce greater maximal force in the late follicular phase, when intracortical inhibition is 
reduced (Sarwar et al., 1996; Birch & Reilly, 2002; Tenan et al., 2016a). Despite this, there 
are a number of studies showing no difference in strength across the menstrual cycle 
(Dibrezzo et al., 1991; Janse De Jonge et al., 2001; Elliott et al., 2003; Kubo et al., 2009). 
During submaximal contractions, force steadiness is decreased in the mid luteal phase (Tenan 
et al., 2016a), with the authors suggesting this could potentially be due to reduced motor unit 
synchronisation, however, this mechanistic index of neuromuscular function is yet to be 
examined across the menstrual cycle. Discrepancies between studies could be caused by 
factors such as the identification and confirmation of menstrual cycle phases (e.g. counting 
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days since menstruation vs. obtaining serum hormone concentrations); time of day (Birch & 
Reilly, 2002); and variability in the cycle phases durations (Fehring et al., 2006). However, 
efforts are now being made to reduce ambiguity in study designs involving females (Elliott-
Sale et al., 2013; Sims & Heather, 2018), which, if followed could aid with reducing 
heterogeneity in study designs and methodologies for menstrual cycle research. 
 
 
2.6. Sex Differences in Fatigability: Current Evidence & Purported 
Mechanisms 
First noted by Petrofsky & Lind (1975) during handgrip exercise, females frequently outlast 
males during open-ended exercise tasks, and the current body of evidence shows a sex 
difference in fatigability occurs during a variety of exercise tasks and muscle groups. However, 
it is not a universal phenomenon, and the aetiology of the sex difference is not consistent 
across tasks (Hunter, 2014). It is well established that the mechanisms of neuromuscular 
fatigue are specific to the task being performed (Enoka & Stuart, 1992), and as suggested by 
Hunter (2009), this specificity can be different between males and females. The following are 
examples of how the mechanisms of fatigue can differ between sexes across various exercise 
tasks. 
 
2.6.1. Sustained Isometric Contractions  
Sustained isometric contractions are a commonly used task to assess performance fatigability, 
with neuromuscular responses compared pre-post a contraction held for a given time period, 
or through the use of open-ended tasks with the time to task failure used as the variable of 
interest. When sex comparisons are performed using these tasks, females typically 
outperform males at submaximal intensities (Hunter & Enoka, 2001; Clark et al., 2005; Hunter 
et al., 2006b). Interestingly, whilst a sex difference is still apparent during maximal contractions 
(Russ & Kent-Braun, 2003; Hunter et al., 2006a), the magnitude becomes lesser as 
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contraction intensity increases (see Figure 2-9 from Hunter, 2014). This relationship helps to 
provide insight into the aetiology of the sex difference in fatigability during sustained 
contractions, as noted by Hunter, (2009). When contraction intensities are matched for relative 
intensity, this is typically done using a percentage of maximum voluntary contraction (% MVC, 
e.g. Hunter & Enoka, 2001; Hunter et al., 2006b). This means that for the same % MVC, males 
will typically produce greater absolute forces than females (Yoon et al., 2007b), which results 
in greater intramuscular pressures and occlusion of blood flow into the contracting muscle(s) 
(Hicks et al., 2001). This negative correlation between maximum strength and time to task 
failure was observed by Hunter & Enoka (2001), who suggested that a lesser reduction in 
muscle blood flow and perfusion permitted a greater time to task failure in females compared 
to males. Indeed, Hunter (2009) later reviewed the literature on sex differences in fatigability 
during sustained contractions, and demonstrated a negative linear relationship (r2 = 0.42) 
between contraction intensity and the percentage difference between sexes. Further 
experimental evidence for this notion includes matching sexes by maximum strength (Hunter 
et al., 2004a), or artificial blood flow occlusion (Clark et al., 2005), both of which result in no 
sex difference in fatigability.  
 
 
Figure 2-9: Sex differences in fatigability during isometric contractions. The solid line demonstrates the relationship 
between intensity of contraction and the magnitude of the sex difference. Taken from Hunter (2014). 
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2.6.2. Intermittent Isometric Contractions 
When research concerning the sex difference in fatigability employs intermittent isometric 
contractions, the sex difference is still evident (Hunter, 2009). A fundamental difference 
between sustained and intermittent contractions is that muscle blood flow is not occluded 
during the latter, provided that an adequate duty cycle is used (Hunter et al., 2009). Indeed, 
when sexes are matched for maximum strength, the sex difference is maintained (Hunter et 
al., 2004b; Ansdell et al., 2018b), implying that a factor other than strength and or occlusion 
is influencing fatigability. As suggested by (Hunter, 2009), the sex difference during this 
contraction modality is likely meditated by the differences in the composition of skeletal muscle 
(e.g. Section 2.5.2.4). For instance, Wüst et al. (2008) demonstrated that female muscle has 
slower relaxation rates following electrical stimulation, an indirect suggestion of a greater 
proportion of type I fibres. This was then suggested by the authors to be related to the 26% 
lesser decline in force following an electrical stimulation fatiguing task in females. Similarly, 
Hunter et al. (2004b) demonstrated the same finding when correlating TMS-evoked twitch 
properties with fatigability following an intermittent isometric voluntary fatiguing task. The sex 
difference observed during this contraction modality also appears to be affected by the 
intensity of the task. As shown by Hunter (2009), a greater difference is shown at lower 
contraction intensities (≤ 50% MVC) compared to higher intensity tasks, this does however 
remain an under-researched area of the sex difference in fatigability. Given the functional 
relevance of intermittent contractions to everyday tasks (Hunter, 2016a), discerning the 
underpinnings of an intensity-dependent sex difference could inform aspects of exercise 
prescription. 
 
2.6.3. Whole Body Exercise 
The majority of the literature pertaining to sex differences in fatigability utilises single-limb 
contraction modalities to explore the underpinning mechanisms, which might not necessarily 
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translate to whole-body exercise. The available data suggest that females exhibit greater 
fatigue-resistance following multiple-sprint cycling (Esbjörnsson et al., 1993; Esbjornsson-
Liljedahl et al., 2002; Billaut & Bishop, 2012) and running (Laurent et al., 2010). Furthermore, 
the ability to reconstitute power in the 20 minutes between 30 s Wingate tests was shown to 
be superior for females (Esbjornsson-Liljedahl et al., 2002), with authors reporting a lesser 
decrease in muscle glycogen content and blood lactate production in females. Despite these 
apparent metabolic differences, when changes in multiple sprint studies are expressed as a 
function of strength, or maximum power output, the sex difference is negated (Esbjornsson-
Liljedahl et al., 2002; Billaut & Smith, 2009; Billaut & Bishop, 2012). As a result, a consequence 
is that whilst males are able to exert greater absolute force, females are able to recover from 
repeated exertions at a faster rate (Laurent et al., 2010). 
 
In terms of sex differences in fatigability following continuous whole-body exercise, the 
literature is relatively sparse in comparison to literature pertaining to single-limb protocols 
(Hunter, 2016a). Following long-duration exercise, evidence suggests that females 
experience less neuromuscular fatigue, as shown by a lesser decrease in MVC following two 
hours of running at ventilatory threshold (Glace et al., 1998). Similarly, the same group then 
demonstrated that a long duration cycling protocol (two hours at ventilatory threshold, 
interspersed with one minute sprints, followed by a three km time trial) elicited peripheral 
fatigue in males only, with no observable decrease in evoked force in females (Glace et al., 
2013). Furthermore, Temesi et al. (2014) showed that following a 110 km ultra-endurance trail 
race, males experienced greater MVC declines in the knee-extensors, and greater peripheral 
fatigue in the plantar flexor muscles. This data fits with the notion that the sex difference in 
competitive race performance is lowest at ultra-endurance distances, and a greater fatigue-
resistance in females could lead to females outperforming males at distances above 66 km 
(Bam et al., 1997). Temesi et al. (2014) also suggested that the sex difference in plantar flexor 
evoked force decrease could be due to a sex difference in muscle stiffness and reduced 
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exercise-induced muscle damage, which could provide a plausible explanation given the 
demands of trail running. 
 
Interestingly, data is equivocal regarding shorter-duration events. Recent evidence showed 
no sex difference in indices of central and peripheral fatigue following a half marathon (21 km, 
~110 minutes, Boccia et al., 2018). Whereas O’Leary et al. (2018) demonstrated a greater 
decrease in MVC for males following a 9.7 km loaded-march (~87 minutes) in military recruits. 
One potential reason for the discrepancies in the aforementioned literature is that the sex 
difference in fatigability following whole-body exercise is typically assessed following self-
paced tasks. Whilst these tasks provide greater ecological validity in the assessment of 
exercise-induced fatigue, self-paced tasks often involve fluctuating exercise intensities (i.e. 
pacing) in an effort to conserve energetic resources for crucial moments of a race (Tucker & 
Noakes, 2009). The consequence of pacing strategies means that often, exercise is performed 
in multiple intensity domains (Hettinga et al., 2006; Thomas et al., 2012), with different fatigue-
characteristics observed in each domain (Burnley & Jones, 2018). As recently demonstrated 
by Azevedo et al. (2019), different phases of an ‘inverted U’ race strategy have different effects 
on neuromuscular fatigue. Specifically, the fast-start and end-spurt can occur in higher 
intensity domains than the even-paced middle portion, with decrements in neuromuscular 
function observed at the elevated work rates. Conceivably, these effects could influence the 
degree of end-exercise neuromuscular function in studies utilising self-paced exercise tasks 
(Glace et al., 2013; Temesi et al., 2015; Boccia et al., 2018; O’Leary et al., 2018). 
 
2.6.4. The Possibility of Sex Differences within Intensity Domains 
The use of self-paced exercise tasks could hinder the mechanistic insight that sex 
comparisons of fatigability can offer, and as highlighted by (Hunter, 2016a), more studies are 
needed to bridge the gap between single-limb and whole-body exercise when considering sex 
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differences. Furthermore, it has been suggested that accounting for exercise intensity 
domains is vital when modelling fatigability (Burnley & Jones, 2018), therefore a 
comprehensive sex comparison of fatigability at metabolically-matched exercise intensities 
could permit the most mechanistic insight to be gained about the sex difference in fatigability.  
 
As outlined in Section 2.4.2, peripheral fatigue in the heavy intensity domain is related to 
depletion of muscle glycogen stores, as well as progressive impairment in excitation-
contraction coupling. Thus, the augmented rate of fat oxidation (Tarnopolsky, 2008), and 
slower calcium handling kinetics (Harmer et al., 2014) in females could contribute to reduced 
peripheral fatigue in this intensity domain. Furthermore, if CP (the boundary between heavy 
and severe domains) is related to the exercise performer’s ability to deliver and utilise oxygen 
to working muscle (Section 2.4.3), a sex difference could also be expected. This rationale is 
based on recent evidence suggesting that CP is positively correlated with the proportional 
area of type I muscle fibres and muscle capillarisation (Vanhatalo et al., 2016; Mitchell et al., 
2018a). As outlined in Section 2.5.2.4, female knee-extensors are consistently observed to 
have a greater percentage area of type I fibres compared to males, therefore it could be 
possible that when CP is expressed relatively (e.g. as a % of maximum ramp test power for 
cycling, or MVC for isometric exercise) females demonstrate greater values.  
 
Exercise in the severe intensity domain is terminated once V̇O2max is reached, and W’ is fully 
utilised (Section 2.4.3). The contributing processes to task-failure depend on the modality of 
exercise (e.g. single-limb versus whole-body, Hureau et al., 2018; Thomas et al., 2018), 
however a critical accumulation of metabolites and depletion of substrates is assumed to play 
a key role in task failure in this domain (Section 2.4.3.1). It could be hypothesised that if 
females are able to maintain perfusion of the muscle, this could augment the delivery of 
oxygenated blood and the clearance of metabolites to attenuate the aforementioned 
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accumulation and depletion processes. During whole-body exercise, the limitations of other 
physiological systems (e.g. cardiovascular, ventilatory, etc) are considered to contribute to the 
attainment of task failure. Evidence suggests females experience a slower rate of 
neuromuscular fatigue in respiratory muscles such as the diaphragm (Guenette et al., 2010; 
Welch et al., 2018), which could reduce the degree of afferent feedback from this physiological 
system, slowing the attainment of the sensory threshold and task failure (Hureau et al., 2018; 
Thomas et al., 2018). 
 
Despite these potential contributors to superior fatigue resistance in females for whole-body 
exercise, it remains to be seen whether these factors are offset by sex differences in 
physiology that might impair female performance in comparison to males. For instance, 
equivalently-trained females have a ~10% lower V̇O2max, relative to body mass (Joyner, 2017), 
likely as a result of differential body composition between sexes. Furthermore, during exercise 
females experience a greater oxygen cost of breathing (Guenette et al., 2007; Dominelli et al., 
2015), have smaller lung volumes (Schwartz et al., 1988), and lower haemoglobin 
concentrations (Cureton et al., 1986) compared to males. These factors contribute to females 
being prone to exercise-induced arterial hypoxemia (Harms et al., 1998). This is thought not 
to affect sub-maximal exercise performance as muscle oxygen extraction can be increased 
as a compensatory mechanism, however, at maximal exercise intensities (i.e. the severe 
intensity domain), no room exists for oxygen extraction increases, leading to reduced arterio-
venous oxygen difference, and impaired performance. Indeed, recent evidence suggests that 
these physiological sex differences could mask any potential sex differences in fatigability of 
locomotor muscles during whole-body exercise (Dominelli et al., 2017). Therefore, it would be 
remiss to suggest that all physiological sex differences would contribute to improved fatigue-
resistance, however, different modalities of exercise (i.e. single-limb versus whole-body) might 
be differentially influenced by sex. Therefore, a comprehensive sex comparison of fatigue-
resistance should take into account different forms of exercise and consider the limiting factors 
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to each when forming mechanistic conclusions about the underpinnings of any sex 
difference(s). 
 
2.7. Investigations, Aims, and Hypotheses 
As this literature review has outlined, neuromuscular fatigue is an unavoidable consequence 
of exercise, and is specific to the task being performed, as well as the exerciser performing 
the task. Biological sex has been shown to influence physiology, which in turn affects the 
underpinnings of neuromuscular fatigue. What is unknown, however, is how sex differences 
in physiology contribute to sex differences in fatigue throughout distinct exercise intensity 
domains, when the metabolic demands of the task are matched between males and females. 
However, before this can be performed, the influence of the menstrual cycle on locomotor 
muscle function and fatigability must be discerned. Following this, endogenous hormones can 
potentially be controlled for, and the sex comparison of fatigability through exercise intensity 
domains in single-limb and whole-body exercise can be conducted. 
 
Chapter 4 – Study 1 
Title:  The effect of the eumenorrheic menstrual cycle on neuromuscular function and 
fatigability. 
Aim:  To investigate the influence that changing endogenous hormone 
concentrations have on neuromuscular parameters at baseline, and following 
an open-ended, intermittent, isometric fatiguing task. 
Hypothesis: The menstrual cycle would induce changes in maximum strength, as well as 
excitability and inhibition within the nervous system. It was also hypothesised 
that fatigue-resistance would be improved in the luteal phase of the menstrual 
cycle. 
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Chapter 5 – Study 2 
Title:  Test-retest reliability of neuromuscular function and fatigability in hormonally-
constant females. 
Aim:  To investigate the repeatability of indices of neuromuscular function and 
fatigability used in Chapters 4, 5, and 7 in a population of monophasic oral 
contraceptive users. 
Hypothesis: Neuromuscular function and fatigability would not differ between two testing 
sessions on separate days, and reliability would be similar to previously 
reported data in males. 
 
Chapter 6 – Study 3 
Title: A sex comparison of fatigability and recovery following exercise normalised to 
the intensity-duration relationship 
Aim: To compare the intermittent isometric intensity-duration relationship between 
sexes, and assess fatigability and recovery following exercise 10% above and 
below the critical intensity. 
Hypothesis: The critical intensity would be greater in females when normalised to MVC. 
However, when exercise intensity was matched relative to the critical intensity, 
no sex difference would be observed. It was also hypothesised that females 
would recover at a faster rate than males. 
 
Chapter 7 – Study 4 
Title:  Methods development: assessing the validity of lumbar electrical stimulation 
for the assessment of subcortical contributions to corticospinal excitability. 
57 
 
Aim: To investigate the interaction between transcranial magnetic stimulation and 
lumbar electrical stimulation at rest and during voluntary muscle contraction. 
Hypothesis: Facilitation and inhibition of the electromyographic response would be 
observed when the two stimuli were delivered at appropriate interstimulus 
intervals. The two stimuli would exhibit similar relationships between voluntary 
contraction intensity and response size. 
 
Chapter 8 – Study 5 
Title: A sex comparison of fatigability following exercise normalised to the power-
duration relationship.  
Aim: To compare the power-duration relationship in both sexes, and assess 
fatigability during exercise 10% above and below critical power. 
Hypothesis: Females would demonstrate a greater critical power when expressed as a 
percentage of peak ramp test power. However, when exercise intensity was 
matched relative to the critical power, no sex difference would be observed. 
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CHAPTER 3 - GENERAL METHODS 
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3.1. Introduction 
The general methods used within the studies included in this thesis are outlined in this chapter. 
Each of these methods were conducted within the British Association of Sport and Exercise 
Science (BASES) accredited exercise physiology laboratories at Northumbria University. 
Specific details pertaining to their application are found in the respective experimental 
chapters. 
 
3.2. Pre-test procedures 
3.2.1. Ethical approval 
Prior to data collection, institutional ethical approval was obtained from the Department of 
Sport, Exercise, and Rehabilitation ethics committee at Northumbria University. All studies 
were completed according to the World Medical Association’s Declaration of Helsinki.  
 
3.2.2. Health and safety 
All experimentation was carried out with in line with Northumbria University standard operating 
procedures. All researchers involved had received departmental ethical and health and safety 
training. Risk assessments were completed and approved for the use of all laboratories, 
exercise modalities, and techniques involved ensuring safety of the participants and 
researchers. The control measures outlined by the risk assessments were enforced during all 
aspects of testing. During each data collection session, a minimum of two researchers were 
always present, and it was explained to female participants that the option of a female 
chaperone was available if they wished. If participants exhibited signs of disproportionate 
discomfort, or symptoms such as chest pain, nausea, vomiting or syncope, experimental 
sessions were terminated prematurely. However, this did not occur in the studies contained in 
this thesis. 
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3.2.3. Confidentiality and Data Protection 
This research was conducted in accordance with the Data Protection Act 1998, and the 
General Data Protection Regulations 2018. The privacy, rights and dignity of participants was 
maintained throughout all aspects of testing. Confidentiality was ensured by assigning an 
alpha-numerical code (i.e. P01) to each participant; all subsequent data pertaining to the 
participant were anonymised and stored using this code. Data stored on institutional 
computers were secured using password access, and subsequently exported to an external 
hard disk and a cloud-based storage service, both requiring passwords to access. Any 
subsequent use of the data (e.g. publication) was, and will, remain anonymous. Hand-written 
data from participant screening questionnaires and informed consent forms were locked in a 
cabinet in the lead investigators office to prevent unauthorised access, these data will be 
stored for ten years, then securely disposed of as confidential waste. The participants were 
informed of these procedures in the information sheets and informed consent forms. If a 
participant completed the screening questionnaire (see Appendix 3) and/or did not meet the 
inclusion and exclusion criteria for the study, the records were securely disposed of 
immediately. 
 
3.2.4. Recruitment of Participants 
Participants were recruited from the student population at Northumbria University, as well as 
the general population (Chapters 4-7) via an introductory email or poster. Recruitment for 
Chapter 8 involved emailing and using social media to contact members of local 
cycling/triathlon clubs, as well as the student-athlete population of Northumbria University. All 
means of advertisement provided a brief outline of the study requirements and the contact 
details of the lead investigator, with no obligation to respond. Potential participants were asked 
to express their interest in the study and/or request further information by emailing the lead 
investigator. Subsequently, the respective information sheet (see Appendix 1 for an example) 
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was sent in a preliminary invitational email, free from coercive or suggestive language. If 
participants indicated they wished to volunteer for the study, a familiarisation visit was 
arranged. 
 
3.2.5. Informed Consent 
Participants were given opportunities via email and in person to discuss the purpose and 
nature of the research, as well as risks and the commitment of taking part prior to any 
experimental sessions. Participants were also provided with the departmental ethics 
coordinator, who was not involved with the study, should they wish to discuss any queries with 
a scientist independent of the research team. Participants were informed that taking part in 
the study was completely voluntary, and that they were free to withdraw at any time. After this 
was clarified, the written informed consent form was signed (see Appendix 2), and the 
familiarisation visit was scheduled. 
 
3.2.6. Familiarisation 
To ensure participants were fully accustomed to the experimental techniques and procedures, 
comprehensive familiarisation visits were performed prior to experimental sessions. Care was 
taken to ensure that participants understood and could perform the neuromuscular protocols 
as well as the exercise task(s) of the study. Data from these visits was not used for subsequent 
analysis. 
 
3.2.7. Experimental Controls 
Prior to any experimental visits in the laboratory, participants were instructed to refrain from 
strenuous physical activity for 48 hours, and refrain from consuming alcohol and caffeine for 
24 hours prior. The importance of refraining from alcohol and caffeine was stressed due to the 
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modulating effects on the motor pathway that the two substances cause (Gandevia & Taylor, 
2006; Kalmar & Cafarelli, 2006; Ziemann, Lönnecker, & Paulus, 1995). Experimental trials 
were conducted at the same time of day (± 1 hour) to account for diurnal effects on 
corticospinal excitability and maximal force production (Tamm et al., 2009), as well as 
endurance performance (Bessot et al., 2006). Trials were separated by a minimum of 48 hours 
in order to ensure full recovery from neuromuscular fatigue between sessions (Carroll et al., 
2016). During experimental sessions participants received standardised encouragement from 
researchers to avoid influencing motivation (Andreacci et al., 2002). 
 
3.3. Apparatus and procedures 
3.3.1. Anthropometry 
The date of birth of each participant was recorded and converted into age (years). Stature was 
measured to the nearest mm using a wall-mounted stadiometer (Seca, Bonn, Germany) using 
the stretch-stature method (Marfell-Jones et al., 2012). Participants stood upright with their 
heels, buttocks, and upper back in contact with the stadiometer and instructed to fully inhale 
and briefly hold the breath while the experimenter adjusted the headboard to make full contact 
with the vertex of the head. Body mass was calculated to the nearest 0.1 kg using a precision 
balance scale (Seca 200, Vogel and Halke, Germany) with participants wearing minimal or 
lightweight clothing and no footwear.  
 
3.3.2. Assessment of Neuromuscular Function 
3.3.2.1. Data Acquisition 
Neuromuscular data were captured using a data acquisition system (Power1401, Cambridge 
Electronic Design, Cambridge, UK). Force and electromyography (EMG) data were pre-
amplified (1902 amplifier, Cambridge Electronic Design, Cambridge, UK). Data were recorded 
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online via Spike2 software (v8, Cambridge Electronic Design, Cambridge, UK), and saved on 
a password secured computer. 
 
3.3.2.2. Isometric force measurement 
All experimental Chapters involved measuring isometric knee extensor force (N) production 
during both voluntary and evoked contractions using a calibrated load cell (MuscleLab force 
sensor 300, Ergotest technology, Norway). The load cell was fixed to a custom-built chair and 
connected to a non-compliant strap around the participants right leg, 2 cm superior to the 
ankle malleoli. The height of the load cell was adjusted so that force was applied in a direct 
line away from the cell. The load cell was calibrated by suspending objects of known masses 
(kg), and using regression analysis to convert raw analogue signals (mV) to force (N). This 
procedure was performed prior to each round of data collection. During knee extensor force 
recordings participants were sat upright with hips and knees at 90˚ flexion, hands were placed 
on handles attached to the chair at waist height.  
 
3.3.2.3. Surface Electromyography 
Surface electromyography was recorded from the right knee extensors (Chapters 4-8) and 
accessory respiratory muscles (Chapter 8 only). Activity of the vastus lateralis (VL), rectus 
femoris (RF), and lateral head of the biceps femoris (BF) muscles were recorded during 
isometric and cycling trials to quantify locomotor muscle activation. These muscles were 
chosen as previous work from our laboratory has demonstrated the optimal transcranial 
magnetic stimulation variables for the assessment of corticospinal and intracortical properties 
in the RF (Brownstein et al., 2018b). Whilst the VL was chosen as it is considered a ‘power 
generator’ during cycling exercise (Ryan & Gregor, 1992). The BF was selected to quantify 
antagonist co-activation in response to TMS during neuromuscular function assessments. 
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To lower impedance and ensure good contact between skin and electrodes, skin was 
prepared by shaving and cleansing the area with an alcohol wipe, before leaving skin to dry 
(Basmajian & DeLuca, 1985). In chapters 4-7, single use Ag/AgCl electrodes (Kendall 
H87PG/F; Covidien, Mansfield, MA, USA) were used in a bipolar arrangement, whereas, in 
Chapter 8, wireless surface EMG electrodes (Trigno Sensors, Delsys, Natick, MA, USA) were 
used as movement during cycling and transitions from ergometer to isometric chair were not 
feasible with wired electrodes. For the locomotor muscles, SENIAM guidelines were used to 
determine muscle belly location (Hermens et al., 2000), then electrode position was adjusted 
during the initial stages of testing sessions to a position eliciting the largest amplitude 
maximum compound action potential (M wave) at a submaximal intensity stimulation. 
Electrode placement was marked with indelible ink to ensure consistent placement between 
trials on separate days. For the wired electrodes (Chapters 4-7) the raw EMG signal was 
amplified (×1000), bandpass filtered (20-2000 Hz), digitised (5 kHz), and analysed offline. The 
wireless electrodes (Chapter 8) were bandpass filtered (20-450 Hz), digitised (2 kHz), and 
analysed offline. 
 
3.3.2.4. Electrical Stimulation of the Femoral Nerve 
In all experimental Chapters, electrical stimuli (0.2 ms duration) were applied to the right 
femoral nerve using a constant-current stimulator (DS7AH, Digitimer Ltd, Welwyn Garden 
City, UK) via adhesive surface electrodes (CF3200, Nidd Valley Medical Ltd, Harrogate, UK). 
The cathode was placed high in the femoral triangle, in the position that elicited the greatest 
the greatest twitch amplitude (Qtw) and M-wave in the RF at rest. The anode was placed 
halfway between the greater trochanter and iliac crest. Single electrical stimuli were delivered 
for the assessment of contractile function and VA (see below), as the number of stimuli 
delivered in a train has not been reported to affect the interpolated twitch technique 
(Bampouras et al., 2006). 
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Before the baseline neuromuscular assessment in each visit to the laboratory, stimulations 
were delivered at an intensity of 20 mA and increased by 20 mA intervals until a plateau in 
evoked Qtw and M wave were observed. To ensure maximal depolarisation of the femoral 
nerve, despite activity-dependent changes in axonal excitability (Burke, 2002), the plateau 
intensity was increased by 30%; the mean ± standard deviation for current used are reported 
in individual Chapters. Stimulation electrodes remained attached and in the same position 
throughout testing visits, and were marked with indelible ink to replicate position between visits 
on separate days.  
 
3.3.2.5. Electrical Stimulation of the Spinal Cord 
Single electrical stimuli (1 ms duration) were delivered with a constant current stimulator 
(DS7AH, Digitimer Ltd, Welwyn Garden City, UK) via self-adhesive electrodes (Nidd Valley 
Medical Ltd, Harrogate, UK). The cathode (5 × 9 cm) was centred over the first lumbar spinous 
process, with the long axis of the electrode aligned to the centre of the vertebral column. The 
anode (3.2 cm diameter) was placed in the midline of the vertebral column, 5 cm above the 
upper edge of the cathode (Ugawa et al., 1995b), corresponding to the level of the eighth 
thoracic spinal process (T8). Specific rationale for using this stimulation setup is contained in 
Chapter 7, and the mean ± standard deviation current used are contained in individual 
Chapters. 
 
3.3.2.6. Transcranial Magnetic Stimulation 
Magnetic stimuli were delivered to the motor cortex via a concave double cone coil (diameter: 
110 mm; maximum output 1.4 Tesla) powered by two linked monopulse magnetic stimulators 
(Magstim 2002 and BiStim, The Magstim Company Ltd, Whitland, UK). A double cone coil 
(Type 9902, The Magstim Company Ltd, Whitland, UK) was chosen instead of a figure of eight 
coil, as the lower limb cortical representation lies close to the midline of the brain, within the 
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depths of the inter-hemispheric fissures (Ugawa et al., 1994). The angulation of the double 
cone coil permits deeper penetration of the induced electrical field into cortical tissue (Deng 
et al., 2013) thus, delivering the most appropriate form of magnetic stimuli for activation of the 
lower limb area of the motor cortex. The coil was held over the left motor cortex to stimulate 
with a postero-anterior intracranial flow. Transcranial magnetic stimulation was used for the 
determination of VATMS, measures of corticospinal excitability, and short-interval intracortical 
inhibition (SICI) in the RF. 
 
A standardised procedure was employed prior to each use of TMS to determine optimal coil 
position. First, the vertex of the cranium was located by measuring the midlines between the 
tragions (a point in the notch above the tragus of the ear), and the inion (prominent projection 
of the occipital bone) to the nasion (a projection superior to the bridge of the nose). These 
distances were measured using an anatomical tape measure, and the midlines were marked 
with indelible ink. Following this, stimulations were delivered during a 10% contraction to find 
the optimal coil position, which was defined as that which elicited the largest motor evoked 
potential (MEP) in the agonist muscle (RF), with a concurrent small MEP in the antagonist 
(BF). These stimulations were delivered at 50% of maximum stimulator output (MSO), or if 
MEPs could not be found at this intensity this was increased as necessary. Optimal coil 
position was measured relative to the vertex (i.e. 1-2 cm lateral and 1-2 cm posterior), and 
marked on the scalp with indelible ink to ensure consistent positioning throughout testing 
sessions. 
 
In Chapters 4-6 and 8, active motor threshold (aMT) was used to normalise stimulus intensities 
for the assessment of corticospinal excitability and SICI pre and post exercise, and was 
defined as the stimulus intensity required to obtain peak-to-peak MEP amplitudes ≥ 0.2 mV in 
three out of five stimulations (Brownstein et al., 2018b). The use of an active motor threshold, 
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and delivery of subsequent stimuli during contraction was chosen rather than performing these 
tasks in relaxed muscle as it was specific to the motor tasks performed during exercise 
(Chapters 4-6), and similar to the state of the motor pathway during exercise (Kalmar, 2018). 
To ascertain aMT, stimuli were delivered while participants performed contractions at 10% of 
maximum voluntary contraction (MVC). These stimuli were first delivered at 50% MSO, and 
increased or decreased by 5% where necessary, then refined by 1% changes in stimulator 
output. Mean ± standard deviation for stimulator intensities are contained within individual 
chapters.  
 
Short-interval intracortical inhibition was used to quantify GABAA related inhibition within the 
motor cortex (Kujirai et al., 1993). The stimulation variables for conditioned MEPs were those 
determined by Brownstein et al. (2018), and were as follows: 2 ms interstimulus interval, 
conditioning pulse intensity 70% aMT, test pulse intensity 120% aMT, contraction intensity 
10% MVC. 
 
Stimulation intensity for VATMS was determined using a step-wise procedure. Participants were 
instructed to maintain a 50% contraction for ~5-6 s whilst single pulse TMS was delivered 
twice (~2 s between stimulations). Participants were given 30 s rest between contractions. 
The size of the superimposed twitches (SITs) was measured and averaged, and the stimulator 
intensity was set at 50% and increased in 5% intervals until SIT amplitude either plateaued or 
decreased. For the knee extensors, as stimulator intensity is increased the agonist MEP 
increases until a plateau is reached and amplitude does not change further, meanwhile the 
agonist MEP increases linearly with no plateau (Temesi et al., 2014, see Figure 3-1). 
Therefore, the largest SIT in this procedure should correspond to the largest agonist MEP, 
with a concurrently small antagonist MEP, in the example Figure 3-1, this would correspond 
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to 60% MSO. Mean ± standard deviations for VATMS stimulation intensities are provided within 
individual chapters.  
 
Figure 3-10: A representative stimulus-response curve during a 50% MVC. Peak to peak MEP amplitudes for 
vastus lateralis (●), rectus femoris (∇), vastus medialis (■) and biceps femoris (◊) are provided in Panel A. The 
corresponding means of four SITs are displayed in Panel B. Taken from Temesi et al (2014). 
 
3.4. Neuromuscular Function Assessments 
3.4.1. Assessment Protocol 
The pre and post exercise neuromuscular assessment protocols used in the experimental 
Chapters of this thesis remained consistent throughout. In Chapter 8, there was a longer delay 
(30 s) between task termination and the start of the assessments due to the need to transfer 
participants from the cycle ergometer to the isometric force chair. Figure 3-2 shows a 
schematic of the order of the assessment. These began with five MVCs, the first two were to 
maximise potentiation of quadriceps twitches (Qtw.pot) from the final three MVCs. Potentiated 
twitched were chosen as they are known to be more sensitive to fatigue-induced changes in 
contractile function (Kufel et al., 2002). Electrical stimulation was delivered at the plateau of 
peak force and 2 s following MVCs to quantify VAMNS, and contractile function of the 
quadriceps (Qtw.pot). Following these, the maximum of the five MVCs (peak instantaneous 
force), was used to set guidelines for the assessment of VATMS. Five guidelines were used 
between 50-100% MVC, and the contractions were performed in two sets (Dekerle et al., 
69 
 
2018). The TMS stimuli were delivered on the plateau of force at the target guideline; care 
was taken to avoid stimulating as force was increasing or decreasing. Following the 
quantification of VATMS, corticospinal excitability and SICI were assessed. Single- and paired-
pulse TMS were delivered alternately in two sets of 10 stimulations; the aforementioned 
variables are discussed in further detail below. 
 
 
3.4.2. Voluntary Activation 
The twitch interpolation technique was used to quantify VA, which can be defined as the level 
of voluntary drive to a muscle, resulting in force generation (Gandevia, 2001). First described 
by Merton (1954), VA relies on the assumption that recruitment of motor neurons by voluntary 
descending drive is sub-maximal (Taylor, 2009), potentially due to excitatory/inhibitory 
influences from other areas of the central nervous system (Rekling et al., 2000). The presence 
of a SIT during an MVC indicates that the electrical stimulation of the motor nerve, and 
subsequent action potential arriving at the muscle fibres, was able to recruit motor units that 
were not firing at maximal rates, resulting in extra force. This SIT is then compared to the 
Qtw.pot which is delivered shortly (2-3 s) following the MVC. The relationship between voluntary 
force and SIT is inversely linear, therefore, the SIT during MVC to be interpolated against 
Figure 3-2: Schematic of the neuromuscular function assessments performed in Chapters 4-6 and 8. 
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Qtw.pot, to account for between individual or conditions (e.g. fatigue) differences, using the 
following equation: 
 
VA = (1 – SIT / Qtw.pot) × 100 
 
When TMS is used for the assessment of VA, the resting twitch must be estimated, due to the 
inability of a TMS pulse to recruit the entire motoneuron pool at rest (Todd et al., 2003). This 
estimated resting twitch (ERT), is a result of regression of SITs and voluntary force between 
50-100% MVC (see figure 2-3), these high forces are required as corticospinal excitability is 
relatively similar, and the SIT – force relationship is linear above 50% MVC in the knee 
extensors (Goodall et al., 2009; Sidhu et al., 2009). The y-intercept of this regression is then 
used as the estimation for the TMS-evoked twitch at rest, and entered into the aforementioned 
equation. 
 
Figure 3-3: The linear relationship between SIT and voluntary force pre and post-exercise in Chapter 5. 
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The conceptual benefit of quantifying VA using TMS is that it provides more detail about the 
site within the motor pathway that causes an increase or decrease in the value compared to 
VAMNS (Nuzzo et al., 2019). Theoretically, if VATMS changes in response to an intervention, 
voluntary drive from the motor cortex is better or less able to recruit the motoneuron pool 
(Todd et al., 2003). Technical challenges exist with VATMS (Todd et al., 2016), however, 
methodological choices can be made to minimise the influence of factors such as antagonist 
activation (see Transcranial Magnetic Stimulation paragraph above), resulting in a more valid 
quantification of VATMS. Throughout this thesis, attempts have been made to maximise validity 
of VATMS by addressing the technical challenges outlined by Todd et al. (2016). Details are 
provided in Table 1. 
 
Table 3-1: Technical challenges of assessing VATMS from Todd et al. (2016). The consequences and 
compromises that were addressed in the present thesis are presented. 
Technical Challenge Result if unaddressed Methodological adjustment 
TMS activates antagonist 
muscle(s). 
Smaller SIT due to 
inadvertent antagonist 
torque generation. Occurs 
particularly at high forces 
(> 75% MVC), resulting in 
an overestimation of ERT. 
TMS intensity chosen to elicit 
the greatest SIT. 
Corresponding to greatest 
agonist MEP and relatively 
small antagonist MEP. See 
Transcranial Magnetic 
Stimulation. 
TMS pulse might not activate 
enough of the motoneuron 
pool.  
Extra motor unit activation 
is submaximal, resulting in 
smaller SITs, and therefore 
an underestimation of 
ERT. 
Agonist activation (MEP) is 
required to be >40% Mmax 
during a 50% contraction. 
The regression for 
estimation of ERT might not 
be linear. 
Invalid estimation of the y-
intercept, resulting in 
under/overestimation of 
ERT. 
If the SIT-force regression was 
not linear (P > 0.05), outliers 
from the 10 regression points 
were identified and removed. 
Intra- and inter-individual 
variability 
Larger measurement error 
associated with ERT might 
limit the observation of 
meaningful changes. 
A 10-point regression is used, 
which has been shown to have 
superior reliability values to 3- 
and 5-point alternatives. 
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Whilst debate exists as to whether ‘full activation’ can be accurately quantified using the 
interpolated twitch technique (de Haan et al., 2009), it is generally established that when 
methodological constraints are controlled for (i.e. stimulation intensity and location, joint angle, 
and dynamometer sensitivity), VA provides a tool for discerning changes in the nervous 
system’s ability to drive muscle (Nuzzo et al., 2019). 
 
3.4.3. Contractile Function 
The Qtw.pot elicited by electrical stimulation of the femoral nerve was used to assess contractile 
function of the knee-extensors pre- and post-exercise. The twitches were potentiated by 
preceding MVCs, which elicited the post-activation potentiation phenomenon (Hodgson et al., 
2006). This is thought to occur via the phosphorylation of myosin regulatory chains, increasing 
the sensitivity of the actomyosin complex to Ca2+, causing the myosin cross bridges to move 
from weak to strong binding states (Allen et al., 2008a). Thus, increasing the size of the evoked 
twitch; the sensitivity of which to a fatiguing task is greater than an unpotentiated equivalent 
(Kufel et al., 2002). The peak-to-peak amplitude of the evoked twitches was used as an index 
of contractile function. 
 
3.4.4. Evoked Electromyographical Responses 
Electrical and magnetic evoked potentials were recorded using EMG and the peak-to-peak 
amplitude was analysed offline. Responses to supramaximal electrical stimulation of the 
femoral nerve (Mmax) were used to assess maximum muscle membrane excitability. When the 
motor cortex was stimulated magnetically (Chapters 4-8), the resultant MEP was used to 
quantify corticospinal excitability, and when the spinal cord was stimulated electrically 
(Chapter 8), the LEP was used to assess spinal excitability. The MEP and LEP were 
expressed as percentages of Mmax to account for any potential day-to-day variation in 
electrode placement (Lefebvre et al., 2004). The peak-to-peak amplitude and area of evoked 
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responses were calculated, with area defined as the integral of the reflected value of the entire 
response. Further detail of EMG analyses can be found within the relevant chapters. 
 
Following an MEP, a period of silence is observed in the ongoing EMG, termed the TMS silent 
period (SP). The duration of the SP is measured in milliseconds (ms) and is believed to reflect 
a combination of both intracortical and spinal mechanisms of inhibition (Škarabot et al., 2019). 
As outlined by Škarabot et al. (2019), several methodological factors can confound the SP, 
with a moderate contraction intensity (40-60% MVC) and moderate stimulus intensity 
(between aMT and ~80% MSO) recommended when delivering TMS. Therefore, studies 
within the present thesis assessed SP during 50% contractions, using the TMS intensity 
chosen for VATMS assessment (typically between 50-70% MSO). 
 
Figure 3-4: The TMS silent period, with options for SP onset and offset marked. Taken from Skarabot et al. 
(2019). 
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When determining SP onset, three options exist: stimulus artefact, MEP onset, and MEP 
offset, with potential confounds existing for all three. As the present studies did not include 
neurologically diseased, or elderly participants, MEP latency was not expected to change. 
Additionally, evoked potential duration can be increased in a fatigued state (Gandevia et al., 
2013), which could confound SP duration if MEP offset was used for SP onset. Therefore, in 
the present thesis, SP duration was calculated from the stimulus artefact to avoid this 
confound. The offset of the SP can be determined visually (Todd et al., 2005; Sidhu et al., 
2009), whilst other researchers have used mathematical modelling (King et al., 2006). An 
alternative method is to use a minimum value (i.e. ± 2 standard deviations of the pre-stimulus 
EMG; Goodall et al., 2010) as the offset point, which also avoids the contamination of SP with 
reflexive low-level ‘bursts’ of EMG activity (Butler et al., 2012). Thus, the present thesis utilised 
this method of SP offset determination. 
 
3.5. Metabolic variables 
3.5.1. Near Infrared Spectroscopy 
The oxygenation status of biological tissues was quantified throughout this thesis using Near 
Infrared Spectroscopy (NIRS; INVOS 5100C, Somanetics, Troy, MI, USA). In Chapters 6 and 
8, the right VL was monitored. Two wavelengths (765 and 855 nm) were used, with the 
intensity of transmitted light continuously monitored at 1 Hz. Based on the absorption and 
scattering coefficients of light at each wavelength, determined by Beer-Lambert law, 
concentrations were estimated for oxy (HbO2), deoxy (HHb), and total haemoglobin (THb). 
Tissue oxygenation (TOI) index was also calculated using the following equation: 
 
TOI = 
[𝑯𝒃𝑶𝟐]
[𝑯𝒃𝑶𝟐]+[𝑯𝑯𝒃] 𝒙 𝟏𝟎𝟎
 
75 
 
For the VL, optodes were placed over the muscle belly 20 cm superior from the fibular head 
(Keane et al., 2018). Data was recorded and stored offline for further analysis, specific details 
of the analyses performed can be found within the respective chapters.  
 
3.5.2. Cardiovascular Measurements 
In Chapters 6 and 8 cardiovascular variables were monitored during exercise via a finger 
plethysmography (Finometer MIDI, TNO Biomedical Instrumentation, Netherlands). This non-
invasive technique uses a finger-clamp method, whereby the diameter of the finger cuff was 
maintained at a constant, while changes in intra-arterial pressure occurred during the cardiac 
cycle. Changes in the diameter of the cuff are measured by an infrared photoplethysmograph 
(wavelength: 950 nm) and sensor within the inflated finger cuff. The cuff then applies the 
required counter (extramural) pressure, to avoid changes in volume (Bogert & Van Lieshout, 
2005). When extramural and intra-arterial pressures are matched (termed set-point) at the 
onset of recording, changes in the latter can be measured. The in-built calibration program 
(Physiocal, Finometer Medical Systems, Netherlands), acts as a calibration tool during 
recording to ensure the set point remains constant (Imholz et al., 1991; Imholz, et al., 2006). 
Systolic, diastolic, and mean arterial pressures (MAP) were obtained from the pressure 
changes within the cardiac cycle. Left ventricular stroke volume (SV) was estimated from the 
integral of the arterial pressure-flow wave, with the aortic cross-section adjusted for age, 
gender, height, and body mass of the participant (Langewouters et al., 1984). Instantaneous 
heart rate (HR) measurements were then multiplied by SV to obtain cardiac output (Q̇).  
 
The reliability of this technique for estimating cardiovascular variables during exercise has 
been established (Waldron et al., 2017a), with low measurement errors reported for estimates 
of blood pressure (1.6-3.2%), heart rate (3.4-3.9%), and cardiac output (3.8-4.8%), however, 
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stroke volume exhibited larger error at rest (7.4%). The validity of the technique has also been 
established during exercise by comparing non-invasive estimates to aortic arch catheterisation 
(Eckert & Horstkotte, 2002). 
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CHAPTER 4 - THE EFFECT OF THE EUMENORRHEIC 
MENSTRUAL CYCLE ON NEUROMUSCULAR FUNCTION 
AND FATIGABILITY 
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4.1. Introduction 
Prior to the comparison of neuromuscular function and fatigability between males and females, 
the effect of cyclical sex hormone changes on these parameters must be discerned. The 
eumenorrheic menstrual cycle presents cyclical changes in concentrations of multiple sex 
hormones, including oestrogen and progesterone (Sherman & Korenman, 1975). These sex 
hormones can act as neurosteroids and affect CNS function due to their ability to cross the 
blood-brain barrier (Stoffel-Wagner, 2001). In vitro models have shown direct evidence for the 
effect of sex hormones on neuronal function. For instance, estradiol (an estrogenic steroid) 
binds to estrogen receptor α (ER-α) sites on GABA-ergic neurons, causing an attenuation in 
GABA synthesis and release, resulting in a net excitatory effect (Wallis & Luttge, 1980; Schultz 
et al., 2009). Additionally, estrogen has been shown to decrease firing thresholds and increase 
discharge frequency of cerebral neurons (Smith, 1989a; Wong & Moss, 1992). On the 
contrary, progesterone has a net inhibitory effect on the nervous system, as the activity and 
effects of GABA are potentiated, leading to decreased neuronal discharge rate (Smith, 1989b) 
and increased inhibition of pyramidal neurons in rats (Hsu & Smith, 2003). These alterations 
have also been established in vivo, with TMS studies showing increased intracortical 
excitability and reduced intra-cortical inhibition mid-cycle, when estradiol concentration is high 
and progesterone low (Smith et al., 1999, 2002), reflecting the alterations seen in the 
aforementioned in vitro studies. 
 
Previous research shows clear changes in human CNS function, however, they were 
conducted in the resting upper limbs, specifically in hand muscles associated with fine motor 
tasks. It is established that properties of intracortical and corticospinal circuits vary between 
upper and lower limb projections (Brouwer & Ashby, 1992; Chen et al., 1998), and the neural 
control of large locomotor muscle groups, such as the KE, are implicated in athletic 
performance, everyday tasks, and rehabilitation from injury. To date, there is relatively little 
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research investigating menstrual cycle induced changes in nervous system function with 
regard to the KE. Some evidence suggests that factors such as motor unit firing rates are 
augmented when oestrogen concentrations are elevated (Tenan et al., 2013), with the authors 
proposing that increased excitability of corticospinal neurons and decreased intracortical 
inhibition could be an explanatory factor (Smith et al., 1999, 2002).  
 
Literature concerning the functional consequences of altered CNS function across the 
menstrual cycle is equivocal. Previous studies investigating motor functions such as MVC are 
unclear. Several studies have shown that females can produce 8-23% more force with the 
KEs mid-cycle compared to early follicular and luteal phases (Sarwar et al., 1996; Birch & 
Reilly, 2002; Tenan et al., 2016b). However, multiple studies report no difference in maximal 
strength of the KEs across the menstrual cycle (Dibrezzo et al., 1991; Janse De Jonge et al., 
2001; Elliott et al., 2003; Kubo et al., 2009). Furthermore, two studies have shown that VA of 
the knee extensors is unaltered by the menstrual cycle (Janse De Jonge et al., 2001; Kubo et 
al., 2009), further contradicting the studies reporting strength changes. Other aspects of motor 
performance, such as performance fatigability (Hunter, 2018), have also been studied 
throughout the menstrual cycle with inconclusive results. Sarwar et al. (1996) showed that the 
knee extensors of eumenorrheic females were less fatigable in the luteal phase, however, this 
is a finding that has not been consistently observed (Dibrezzo et al., 1991; Janse De Jonge et 
al., 2001), potentially due to heterogeneity in contraction type, and the use of open-ended 
versus fixed duration tasks. 
 
The effects of hormonal fluctuations on neuromuscular function and fatigability still remain 
unclear. Conflicting literature exists for the majority of neuromuscular variables in the knee 
extensors, despite a rationale for change. One potential issue is that information about 
potential mechanistic responses (i.e. CNS excitability and inhibition) is typically derived from 
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the resting upper limb. Therefore, the present study aimed to investigate changes in TMS and 
MNS-evoked variables as well as neuromuscular function and fatigability across the 
eumenorrheic menstrual cycle at hormonally-distinct time points in the KE. The findings of this 
Chapter will discern whether endogenous hormone concentrations need to be controlled for 
in subsequent work when females are compared to males. 
 
4.2. Methods 
4.2.1. Participants 
Fifteen eumenorrheic females (EFs; age: 25 ± 4 years; statue: 169 ± 6 cm; mass: 68.3 ± 7.8 
kg; mean cycle duration: 29 ± 3 days, range: 24-34 days) provided written informed consent 
to volunteer for the study. Participants reported having regular menstrual cycles (at least 4 
cycles of 25-35 days duration in the previous 6 months) without using any hormonal 
contraceptives for 6 months. 
 
4.2.2. Experimental Design 
Eumenorrheic females visited the laboratory four times, completing a familiarisation session 
prior to three experimental visits. Participants completed experimental visits on days 2 (early 
follicular phase), 14 (late follicular phase), and 21 (luteal phase) of the menstrual cycle. Testing 
days were counted from the onset of menstruation and fasted blood samples were taken 
between the hours of 06:00 – 09:00 on testing days to analyse serum estradiol and 
progesterone concentration and confirm menstrual cycle phase. The order of visits was 
pseudorandomized and counterbalanced to minimize order effects, with 5 participants 
beginning on each testing day. All testing visits occurred within the same menstrual cycle 
(order: d2, d14, d21), or two consecutive cycles (order d14, d21, d2 or d21, d2, d14). This 
experimental design was based on previous recommendations (Sims & Heather, 2018; Janse 
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de Jonge et al., 2019). Experimental visits consisted of a baseline neuromuscular function, 
performance of intermittent, isometric contractions at 60% MVC until task failure, followed 
immediately by a post-task neuromuscular function assessment. 
 
4.2.3. Experimental Procedures 
Upon arriving between the hours of 06:00 – 09:00, fasted blood samples were taken following 
10 minutes of seated rest. Participants were then instructed to consume a typical breakfast 
and return to the laboratory at their designated testing time. The breakfast and time of testing 
were replicated (± 1 hour) for each experimental visit to control for diurnal variations in 
corticospinal excitability and maximal force production (Tamm et al., 2009). Experimental 
sessions began with participants completing a standardised voluntary isometric contraction 
warm up (two contractions at 25, 50, and 75% perceived maximal effort) followed by a baseline 
neuromuscular assessment (as described in Chapter 3). The fatiguing task involved sets of 
intermittent (3 s contraction, 2 s rest), isometric contractions to task failure. Contractions were 
paced with an audible metronome to ensure the duty cycle was maintained. One set was 
defined as 11 submaximal contractions followed by a MVC with MNS during and after, lasting 
one minute. Task failure was defined as an inability to reach the target force three times. 
Rating of perceived exertion (RPE; Borg, 1982) was recorded following each MVC during the 
fatiguing task. Real-time visual force feedback using guidelines set as percentages of 
maximum force was provided to participants on a computer screen to help maintain a constant 
force level. The post-task neuromuscular assessment began immediately following task 
failure. 
 
4.2.4. Transcranial Magnetic Stimulation 
Active motor threshold was not different on testing visits (43 ± 9, 42 ± 8, and 43 ± 9%, P = 
0.874). Similarly, the mean stimulator intensity was not different between trials (63 ± 10, 63 ± 
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11, and 63 ± 12%, P = 0.984). The stimulator output activated a large proportion of the KE 
motoneuron pool at baseline in each experimental visit, with no difference between trials (61 
± 17; 57 ± 17; 55 ± 14% Mmax; P = 0.788). The TMS pulse also concurrently elicited a small 
MEP in the antagonist muscle group (0.53 ± 0.39, 0.71 ± 0.42 and 0.60 ± 0.34 mV, P = 0.211). 
 
4.2.5. Motor Nerve Stimulation 
The optimum stimulus intensity for MNS was not different between visits (233 ± 72, 244 ± 68, 
and 262 ± 67 mA, P = 0.125). 
 
4.2.6. Blood Sampling and Hormone Analysis 
Venous blood sampling was performed on the morning of each testing session. A 10 mL blood 
sample was drawn from an antecubital vein into a silica coated tube by a trained phlebotomist, 
then left upright for 15 minutes to coagulate before centrifuging. Samples were centrifuged at 
2,500 rpm for 10 minutes at room temperature (Allegra-X22R, Beckman Coulter, USA). Using 
a 500-1000 µl pipette, the supernatant serum was separated into three aliquots (~1000 µl 
each) and stored at −80°C until oestradiol and progesterone analysis were performed. Total 
concentrations of 17-β oestradiol and progesterone were measured in duplicate using 
hormone-specific enzyme-linked immunoassay kits (Cayman Chemical, Ann Arbor, MI). All 
samples were analysed using the ELISA technique with absorbance detection (wavelength 
405 nm). The minimal oestradiol and progesterone detection was 15 pg/ml and 7.5 pg/mL, 
respectively. To calculate 17-β oestradiol and progesterone levels, a standard curve was 
plotted using eight standards against their absorbance. Using the mean absorbance from the 
duplicate of each sample, the concentration of the sample was interpolated directly from the 
standard curve. The coefficients of variation (CV) for the ELISA kits, as provided by the 
manufacturer, were 8-12% for 17-β oestradiol, and 5-8% for progesterone. In one instance, 
the CV of a duplicate sample exceeded the manufacturer’s CV due to an excessively high 
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(non-physiological) reading in one well. Therefore, the lower of the two was used for data 
analysis. Participants’ hormonal profiles were deemed ‘acceptable’ when a peak in 
progesterone concentration was observed during the luteal phase (D21) and an increase in 
17-β oestradiol was observed from D2 to D14. If neither peak was observed, then participants 
were deemed anovulatory and excluded from further analyses. This occurred in two of the 15 
participants. 
 
4.2.7. Data Analysis 
The regression between TMS-evoked SIT amplitudes and voluntary force for estimation of 
resting twitch was not significantly linear (p > 0.05, r2 < 0.85) in four out of 60 cases. As a 
result, outliers were identified (as described in Chapter 3) and six out of 870 (0.7%) SITs were 
excluded. This meant that there were 86 ten-point regressions, three nine point regressions, 
and one eight point regression used to estimate resting twitches. The mean ± SD r2 values 
were 0.92 ± 0.05 pre exercise, and 0.89 ± 0.07 post-exercise. 
 
4.2.8. Statistical Analysis 
Data are presented as mean ± SD within the text and figures. Normal Gaussian distribution of 
data was confirmed using the Kolmogorov–Smirnov test. If a violation was detected, the data 
were logarithmically transformed. The alpha for all statistical tests was set at p ≤ 0.05. One-
way repeated measures ANOVAs were performed for all pre-exercise dependent variables to 
assess MCP changes in neuromuscular function and hormone concentrations. Sphericity was 
assessed using Mauchly’s test and if necessary, controlled using the Greenhouse-Geisser 
correction. Two-way repeated measures ANOVAs were run using pre and post exercise 
variables to obtain both fatigue, and menstrual cycle phase × fatigue interaction effects. To 
explore potential differences in the fatigue profiles of neuromuscular and perceptual variables, 
two-way repeated measures ANOVAs were run including data points from baseline, 25, 50, 
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75, and 100% of TTF. Significant main and interaction effects were explored using Bonferroni-
corrected tests.  
 
4.3. Results 
4.3.1. Hormonal Concentrations 
Thirteen out of 15 participants presented a regular hormonal profile (see Table 4). Two 
participants had no increase in progesterone on D21; given the hypothesis that changing 
hormone concentrations would modulate neuromuscular function, and these participants did 
not exhibit any change in hormone concentrations, they were excluded from further statistical 
analyses. The repeated measures ANOVAs showed an effect of MCP on 17-β oestradiol 
(F1.4,19.5 = 3.55, p = 0.040, ηp2 = 0.18) and progesterone concentration (F=1.0,14.1 = 8.35, p = 
0.012, ηp2 = 0.37). Post hoc tests revealed that 17-β oestradiol concentrations were greater 
on D14 compared to D2 (p = 0.033), and greater on D21 than D2 (p = 0.029). Progesterone 
was greater on D21 than D2 and D14 (p = 0.011, and 0.012, respectively). 
Table 4-1: Group average concentrations for 17-β oestradiol and progesterone across the three tested phases of 
the menstrual cycle. * = greater than d2, # = greater than d14 (all P < 0.05). 
 Day 2 Day 14 Day 21 
17-β Oestradiol 
(pg·ml-1) 
 
248 ± 129 328 ± 160* 341 ± 186* 
 
Progesterone 
(ng·ml-1) 
 
1.27 ± 0.50 1.38 ± 0.69 4.41 ± 4.60* # 
E:P ratio 0.20 ± 0.13 0.28 ± 0.18 0.12 ± 0.10* # 
 
4.3.2. Baseline Neuromuscular Function 
MVC force was unaffected by MCP (Figure 4-1A, F1.4,16.8= 0.15, p = 0.790, ηp2 = 0.01). 
Potentiated twitch force was also unchanged (Figure 4-1B, F2,24 = 0.25, p = 0.782, ηp2 = 0.02); 
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however, the SIT elicited by MNS was affected by MCP (F2,28 = 3.69, p = 0.040, ηp2 = 0.24), 
with greater SITs on D14 compared to D2 (mean difference: 2 N, p = 0.031). The reduced SIT 
on D14 meant that VAMNS was affected by MCP (Figure 4-1C, F2,28 = 9.23, p = 0.001, ηp2 = 
0.44) with post hoc tests showing greater VAMNS on D14 compared to D2 (mean difference: 
1.9%, p = 0.007), however, there was no difference between D14 and D21 (mean difference: 
1.0%, p = 0.059). VATMS was also affected by MCP (Figure 4-1D, F2,28 = 5.89, p = 0.008, ηp2 = 
0.33) with greater values on D14 compared to D21 (mean difference: 3.0%, p = 0.016), 
however, D14 and D2 were not different (mean difference: 2.5%, p = 0.080). Despite the 
change in VATMS, neither of its constituent parts were altered by MCP: ERT (F1.3,15.3 = 0.25, p 
= 0.784, ηp2 = 0.02) and SIT elicited by TMS (F1.3,15.3 = 2.17, p = 0.136, ηp2 = 0.15).  
 
Figure 4-11: Baseline neuromuscular measures across the three time points. Panel A: maximum voluntary 
contraction; Panel B: potentiated twitch force; Panel C: voluntary activation assessed with motor nerve stimulation; 
Panel D: voluntary activation assessed; Panel E: superimposed twitch evoked by motor nerve stimulation; Panel 
F: superimposed twitch evoked by transcranial magnetic stimulation. Individual data are shown with mean data 
overlaid as the filled symbols and connecting line. 
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As shown in Table 3, Mmax was unaffected by MCP (F2,28 = 0.24, p = 0.786, ηp2 = 0.02), nor 
was normalized MEP amplitude (Figure 4-2A, F2,28 = 2.24, p = 0.129, ηp2 = 0.16). However, 
SICI was affected (Table 5 and Figure 4-2B, F1.4, 16.8 = 13.52, p < 0.001, ηp2 = 0.53) with post 
hoc tests showing greater inhibition on D21 compared to D2 (mean difference: −10%, p = 
0.048) and D14 (mean difference: −14%, p = 0.001). The pre-stimulus normalised rmsEMG 
activity was not different between MCPs (D2: 1.16 ± 0.43, D14: 1.07 ± 0.53, D21: 1.20 ± 0.64% 
Mmax, F2,28 = 0.31, p = 0.736, ηp2 = 0.025) and neither was the SP (Figure 4-2C, Table 5, F2,28 
= 0.53, p = 0.594, ηp2 = 0.04). 
 
 
Figure 4-2: Transcranial magnetic stimulation evoked responses across the three testing time points. Panel A: 
corticospinal excitability; Panel B: short interval cortical inhibition; Panel C: TMS evoked silent period. Individual 
data are shown with mean data overlaid as the filled symbols and connecting line. 
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4.2.4. Fatigability 
Time to task failure during the intermittent, isometric, fatiguing task was significantly affected 
by MCP (see Figure 4-3, F1.4, 14.8 = 6.89, p = 0.030, ηp2 = 0.32), with post hoc tests showing 
greater TTF on D21 compared to D2 (mean difference: 187 s, p = 0.025).  However, there 
was no difference between D21 and D14 (mean difference: 135 s, p = 0.103), or D2 and D14 
(p = 0.594). The two-way ANOVA (MCP × time) time effect showed that MVC decreased pre-
post exercise (F1,11 = 80.056, p < 0.001, ηp2 = 0.88), as did Qtw.pot (F1,11 = 123.53, p < 0.001, 
ηp2 = 0.92), VAMNS (F1,11 = 15.219, p = 0.002, ηp2 = 0.58), and VATMS (F1,11 = 13.99, p = 0.003, 
ηp2 = 0.56). SP also increased pre-post exercise (F1,11 = 9.68, p = 0.010, ηp2 = 0.468). The 
MCP × time interaction effects for the aforementioned variables that changed pre-post 
exercise indicated no difference between MCPs (all p ≥ 0.128). The only exception to this was 
VATMS (F2,22 = 3.48, p = 0.049, ηp2 = 0.24), however, post hoc tests revealed that the differences 
were only apparent pre-exercise (as indicated above), and not post-exercise (p ≥ 0.670). 
Despite no time effect (p = 0.578), SICI displayed a MCP × time interaction effect (F1.4, 15.0 = 
5.26, p = 0.028, ηp2 = 0.32), however, the only differences were evident pre-exercise (as 
indicated above), with no post-exercise difference (p ≥ 0.247). 
 
 
Figure 4-3: Time to task failure during the submaximal intermittent isometric fatiguing task at the three testing 
time points. Individual data are shown with mean data overlaid as the filled symbols and connecting line. 
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All variables measured during the fatiguing tasks (see Figure 4-4) demonstrated time effects 
(p ≤ 0.024), however, only some (MVC, Qtw.pot, VAMNS) demonstrated an absence of MCP × 
time interaction effects (p ≥ 0.205). MVC (Figure 4-4A) decreased progressively from baseline 
to 75% TTF (all intervals p ≤ 0.001), however, between 75 and 100% TTF no further decrease 
was observed (p = 0.776). A similar pattern was observed with Qtw.pot (Figure 4-4B), with 
decreases exhibited until 50% TTF (both intervals p ≤ 0.009), however, between 50-100% 
TTF Qtw.pot did not further decrease (p ≥ 0.593). VAMNS (Figure 4-4C) demonstrated the inverse 
time course, with no change from 0 to 50% TTF (p ≥ 0.345), then a progressive decrease from 
50 to 100% TTF (p ≤ 0.034). rmsEMG (Figure 4-4D) and RPE (Figure 4-4E) exhibited phase 
× time interaction effects (p ≤ 0.032). RPE increased progressively throughout all trials (p ≤ 
0.008), however, at 25% TTF RPE was greater on D21 compared to D14 (+2, p = 0.006), at 
50% TTF D21 was greater than D2 (+2, p < 0.001), and at 75% TTF D21 was greater than D2 
(+1, p = 0.005). The only significant increase in rmsEMG was between 25 and 50% TTF (p = 
0.003), and despite the phase × time interaction effect, no post hoc differences between 
phases were apparent (p ≥ 0.205). 
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Figure 4-4: Neuromuscular variables assessed at 25, 50, 75 and 100% TTF throughout the fatiguing tasks in each 
MCP. Panel A: maximum voluntary contraction; B: potentiated quadriceps twitch; C: voluntary activation assessed 
with motor nerve stimulation; D: root-mean- squared EMG; E: rating of perceived exertion. Data are means with 
the standard deviation shown in panels A-D for the final point. Data are displayed as % baseline, although statistical 
analyses were performed on absolute data. Statistical differences (P < 0.05) are depicted by a: significantly 
difference between baseline-25% TTF; b: significant difference between 25-50% TTF; c: significant difference 
between 50-75% TTF; d: significant difference between 75-100% TTF; *: significant difference between D21-D14; 
#: significant difference between D21-D2. 
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Table 4-2: Variables assessed throughout the pre- and post-exercise testing battery across the menstrual cycle. P values from the baseline ANOVA (1 × 3 repeated 
measures), and the pre-post exercise ANOVA (2 × 3 repeated measures) are reported. When a significant effect of exercise was found, the ∆ in a variable from pre-post 
exercise was reported. * =greater than day 2, # = greater than day 14, † = greater than day 21. 
  Day 2  Day 14  Day 21  MCP effect Pre-post exercise MCP × Exercise 
    Pre Post ∆  Pre Post ∆  Pre Post ∆  1×3 ANOVA 2×3 ANOVA 2×3 ANOVA 
MVC (N)  457 ± 79 344 ± 59 −25%  454 ± 78 337 ± 67 −26%  460 ± 87 355 ± 93 −24%  0.790 <0.001 0.236 
                 
SITMNS (N)  9 ± 5
# 11 ± 7 -  7 ± 4 10 ± 8 -  8 ± 4 11 ± 6 -  0.040 0.069 0.452 
                 
Qtw.pot (N)  148 ± 20 95 ± 24 −36%  150 ± 20 91 ± 22 −39%  151 ± 23 94 ± 26 −38%  0.782 <0.001 0.634 
                 
VAMNS (%)  93.4 ± 2.8 88.4 ± 8.8 −6%  95.3 ± 1.9* 87.9 ± 6.9 −8%  94.3 ± 2.2 88.0 ± 5.6 −7%  0.001 0.002 0.303 
                 
SITTMS (N)  6 ± 2 10 ± 8 67%  5 ± 3 9 ± 7 80%  7 ± 6 10 ± 9 43%  0.136 0.028 0.292 
                 
ERT (N)  94 ± 43 74 ± 37 −35%  96 ± 39 64 ± 60 −40%  93 ± 43 70 ± 36 −35%  0.784 0.001 0.128 
                 
VATMS (%)  93.2 ± 2.8 87.5 ± 8.5 −6%  95.7 ± 2.4
† 84.3 ± 9.4 −12%  92.6 ± 3.2 86.7 ± 9.7 −7%  0.008 0.003 0.049 
                 
MEP/Mmax (%) 17 ± 5 17 ± 9 -  22 ± 7 18 ± 9 -  18 ± 10 15 ± 8 -  0.129 0.278 0.485 
                 
SICI (%)  77 ± 11* 84 ± 14 -  82 ± 10* 74 ± 22 -  67 ± 12 75 ± 19 -  0.001 0.578 0.028 
                 
SP (ms)  160 ± 42 176 ± 49 12%  173 ± 70 176 ± 54 2%  174 ± 48 176 ± 49 3%  0.594 0.010 0.360 
                 
Mmax (mV)  4.05 ± 2.19 3.93 ± 2.27 -  4.39 ± 1.88 4.06 ± 2.12 -  4.30 ± 2.50 3.80 ± 2.28 -  0.786 0.087 0.436 
                 
TTF (s)   519 ± 164   571 ± 179   706 ± 262   0.030 - - 
MVC: maximum voluntary contraction, SITMNS: superimposed twitch elicited by motor nerve stimulation; Qtw.pot: potentiated quadriceps twitch; VAMNS: voluntary activation assessed with motor nerve stimulation; SITTMS: 
superimposed twitch elicited by transcranial magnetic stimulation; ERT: estimated resting twitch; VATMS: voluntary activation assessed with TMS; MEP/Mmax: corticospinal excitability; SICI: short-interval cortical inhibition; 
SP: TMS evoked silent period; Mmax: maximum compound muscle action potential; TTF: time to task failure. 
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4.4. Discussion 
The present investigation aimed to assess the influence of modulations in female sex 
hormones across the eumenorrheic menstrual cycle on neuromuscular function and 
fatigability. The data showed that whilst one index of neuromuscular function (MVC) did not 
change, females experienced modulations in CNS control of muscle contraction. Specifically, 
VA was greatest on D14, concurrent with an increase in the concentration of oestrogen. 
Additionally, parallel to an increase in progesterone, SICI was greatest on D21. Time to task 
failure during the open-ended intermittent, isometric protocol was greatest on D21 of the cycle. 
Collectively, the present data suggest that neuromuscular function and fatigability are 
modulated by the eumenorrheic menstrual cycle. 
 
4.4.1 Maximum strength and voluntary activation across the menstrual cycle 
There was no effect of MCP on MVC force. As mentioned, previous data regarding maximum 
voluntary strength across the menstrual cycle is equivocal. In agreement with the present 
study, multiple studies have shown no effect (Janse De Jonge et al., 2001; Elliott et al., 2003; 
Kubo et al., 2009), however, several studies have shown that strength peaks mid-cycle 
(Sarwar et al., 1996; Birch & Reilly, 2002; Tenan et al., 2016b). Previously, discrepancies such 
as the time of day (Birch & Reilly, 2002), or variability in menstrual cycle duration, as well as 
the chosen days of the menstrual cycle for testing (Fehring et al., 2006) have been used as 
explanatory reasons for this discrepancy. The present study controlled both factors by testing 
at the same time of day and confirming participants were in the correct phase by serum 
hormone analysis, yet no effect of MCP was observed.  
 
Interestingly, participants demonstrated changes in VA (assessed by both MNS and TMS) 
despite no change in MVC. VAMNS peaked on D14 and VATMS was greater on D14 compared 
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to D21 (see Figure 4-1). As Qtw.pot and ERT were not affected by MCP, these changes in VA 
were mediated by a decreased SIT amplitude on D14 in response to both motor nerve and 
motor cortical stimulation. This could indicate that there was a decrease in the capacity of the 
CNS to elicit extra force in response to stimulation. The TMS and MNS evoked SITs represent 
the extra force from motor units that the CNS is not able to voluntarily recruit or discharge at 
a sufficient rate (Todd et al., 2003). As acknowledged by Todd et al. (2003), a change in SIT 
force could be caused by changes in the CNS altering activation of the motoneuron, therefore 
changes within the motor cortex could provide an explanation for the change in VA. Previous 
studies that have shown VAMNS not to change have used the central activation ratio equation 
(Janse De Jonge et al., 2001; Kubo et al., 2009), which is less sensitive to change than the 
ITT (Place et al., 2007). It is therefore likely that the magnitude of menstrual cycle effect on 
VAMNS and VATMS is marginally greater than the random error associated with the techniques 
used to assess it, thus based on current evidence, the true effect is unclear. Also of note is 
the MCP × time interaction effect for VATMS, which would indicate that the magnitude of change 
from pre-post exercise was different between MCPs. However, this appears to be driven by 
the increased VATMS pre-exercise on D14, as there were no differences in post-exercise 
values. Therefore, it is unlikely that participants experienced a greater degree of CNS 
adjustment following exercise during the late-follicular phase (D14). 
 
4.4.2. Corticospinal and intracortical function across the menstrual cycle 
As previously mentioned, the increase in both measurements of VA on D14 (VAMNS and VATMS) 
could represent changes in supraspinal properties altering synaptic drive to the motoneuron 
pool across the menstrual cycle (Rekling et al., 2000).  To investigate the state of the 
corticospinal tract and motor cortex, the present study employed single- and paired-pulse 
TMS. No menstrual cycle effect was observed on corticospinal excitability, however, 
intracortical inhibition was increased on D21. Single pulse MEPs in the resting FDI muscle 
have previously been shown to be unaffected by oestrogen concentrations (day 1 vs. day 14 
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of the menstrual cycle, Inghilleri et al., 2004), and the present study extends this conclusion 
to the active knee extensors, whilst demonstrating that the increase of progesterone 
concentrations on D21 is not concurrent with changes in corticospinal excitability. When 
considering paired-pulse responses, however, the increase in progesterone concentrations 
were concomitant with a ~14% increase in SICI, which when considered with previous 
evidence (Smith et al., 1999, 2002) was likely through potentiation of GABAA inhibition. Indeed, 
GABA agonist pharmacological interventions (e.g. baclofen and gabapentin) have shown 
similar changes (Ziemann et al., 1996a). Interestingly, SICI followed a similar pattern to the 
E:P ratio (see Table 4), with the only significant change demonstrated on D21 concurrent to a 
decrease in the E:P ratio. Furthermore, the MCP × time interaction effect for SICI would 
suggest that intracortical inhibition is differentially modulated by exercise throughout the 
menstrual cycle. Whilst this is a concept that has been postulated before (El-Sayes et al., 
2019), and the present data appears to show this phenomenon, the interaction should be 
treated with caution as the post exercise reliability of SICI is unknown, therefore further 
investigation is required to test this hypothesis. 
 
The TMS SP, thought to partly reflect GABAB inhibitory mechanisms (Chen et al., 1999), was 
not affected by MCP, supporting previous data recorded in the FDI muscle (Hausmann et al., 
2006). However, the conclusion that the menstrual cycle affects only GABAA 
neurotransmission cannot be made with the current data, as the SP has a large spinal 
contribution (Yacyshyn et al., 2016; Škarabot et al., 2019). Additionally, glutamatergic ICF was 
not measured in the present study, but has previously been shown to be affected by the 
menstrual cycle, with augmented ICF demonstrated mid-cycle (Smith et al., 1999, 2002). 
Whilst the causal link between intracortical function and voluntary activation is under 
researched, it is possible that the adjustments of intracortical circuitry altered the capacity of 
TMS and MNS to evoke a SIT. For instance, if intracortical excitability was greatest on D14, 
there may have been a ‘ceiling effect’, meaning the stimulations were not able to induce 
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additional excitation in the motor cortex, thus, innervating fewer additive motor units during 
MVCs, and evoking a smaller SIT, and the contrary occurring on D21, when inhibition was 
greatest. The modulation of neurotransmitters has previously shown to affect VA, with 
pharmacological increases in noradrenaline (Klass et al., 2016)  and serotonin (Kavanagh et 
al., 2019) resulting in a ~1-2% increase in VA. Indeed the effects of serotonin has been shown 
to be augmented by oestrogen (Bethea et al., 2002), and inhibited by progesterone 
(Henderson & Bethea, 2008). Therefore, it is possible that the modulation of inhibitory and 
facilitatory intracortical circuitry across the menstrual cycle might collectively contribute to the 
changes in VAMNS and VATMS. 
 
4.4.3. Fatigability across the menstrual cycle 
Fatigability, as measured by the TTF of the open-ended fatiguing protocol, was lowest on D21 
(i.e. greatest TTF), thus supporting the findings of Sarwar et al. (1996), who showed that 
fatigue index was lowest in the luteal phase during a three-minute intermittent involuntary 
contraction protocol. The present data, however, contradicts Janse De Jonge et al. (2001), 
who showed no effect of MCP during voluntary or electrically evoked fatiguing protocols 
performed with the knee extensors. The differences between tasks could explain these 
discrepancies. The voluntary task used by Janse De Jonge et al. (2001) involved both dynamic 
knee extension and flexion, rather than a single muscle group. This anisometric, multi-muscle 
group exercise likely elicits a different pattern of sensory afferent feedback (Gandevia, 2001), 
and was not open-ended like the present study, which could explain the discrepancies in 
fatigability. The same reasons might also apply to why the findings of Dibrezzo et al. (1991) 
are inconsistent with the present study, who similarly demonstrated no menstrual cycle effect 
on fatigue during a set amount of dynamic contractions. Thus, the task employed in the 
present study likely permitted a greater degree of fatigue to develop, allowing the 
aforementioned MCP differences to be discerned. 
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As widely acknowledged, fatigability has both physiological and perceptual components that 
interact to determine exercise tolerance (Enoka & Duchateau, 2016; Hureau et al., 2018; 
Thomas et al., 2018). The fatiguing task in the present study involved high intensity (60% 
MVC) intermittent, isometric contractions, which were assumed to be far greater than the 
critical torque (~30% MVC, Burnley, 2009; Burnley et al., 2012), and limited by decrements in 
neuromuscular adjustments (Amann, 2011; Burnley et al., 2012). With no MCP x time 
interaction effects displayed for neuromuscular variables (MVC, Qtw.pot, and VA), the degree 
of pre-post exercise adjustment was not different between menstrual cycle phases. 
Accordingly, one hypothesis for why TTF was longer on D21 could be the influence of 
neurotransmitter systems on perceptions of fatigue. The present study measured GABAergic 
inhibition and demonstrated a large increase in SICI on D21 (Figure 4-2B), and it has 
previously been shown that GABA can have anti-nociceptive properties (Enna & McCarson, 
2006)  acting as an analgesic (Jasmin et al., 2003). Indeed, it has recently been postulated 
that “luteal analgesia” occurs in eumenorrheic females when progesterone is elevated, where 
the affective response to nociceptive pain is reduced due to alterations in functional 
connectivity in the emotional regulation network (Vincent et al., 2018). Thus, it could be 
possible that the analgesic effects of enhanced GABAergic neurotransmission permitted 
participants to continue exercising for a longer period due to a lower perception of pain. 
However, more evidence is needed to explore the effects of GABAergic inhibition on exercise-
induced fatigue. 
 
4.5. Conclusion 
The present investigation demonstrated that when eumenorrheic females were tested at three 
distinct phases of the menstrual cycle the changing hormonal environment coincided with 
large changes in CNS function, which affected aspects of motor performance of a large 
locomotor muscle group. Specifically, oestrogen had neuro-excitatory effects that were 
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associated with an increase in VA on D14, whereas progesterone’s neuro-inhibitory effects 
was concurrent with an increased intracortical inhibition and decreased VA. Additionally, 
fatigability was modulated by MCP, with the greatest TTF seen on D21, concurrent with an 
increase in progesterone. Thus, the menstrual cycle elicits changes in neuromuscular function 
and fatigability in locomotor muscle of eumenorrheic females, a finding that has implications 
for exercise prescription in female exercisers. Additionally, this evidence highlights a need to 
control for female endogenous hormone concentrations in future comparisons between males 
and females, for instance, the subsequent Chapters of this thesis. 
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CHAPTER 5 – REPEATABILITY OF NEUROMUSCULAR 
FUNCTION AND FATIGABILITY IN A HORMONALLY-
STABLE FEMALE POPULATION 
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5.1. Introduction 
As demonstrated in Chapter 4, neuromuscular function and fatigability of the knee-extensors 
in eumenorrheic females can change substantially across the menstrual cycle. With the 
increasing number of studies investigating sex differences in neuromuscular function and 
fatigability (Temesi et al., 2015; Casamento-Moran et al., 2017; Ansdell et al., 2018b; Senefeld 
et al., 2018), it is clear that in order for the true difference between males and females to be 
elucidated, sex hormones must be controlled for within and between female subjects. One 
opportunity to do so in healthy, young females is to test those using monophasic oral 
contraceptives (mOCP). Whilst it must be acknowledged that the dosage of exogenous sex 
hormones might differ between brands (Elliott-Sale et al., 2013), the mOCP provides a 
consistent hormonal dosage throughout the period of consumption to maintain a nadir in 
circulating endogenous hormone concentrations and preclude ovulation (Frye, 2012). This 
was evidenced previously, where sex hormone concentrations did not vary during two time 
points during consumption of the mOCP (Elliott et al., 2005). 
 
One caveat to this suggestion of testing mOCP users is that, despite multiple studies 
assessing changes in neuromuscular function, the measurement error and repeatability of 
commonly used neurostimulation variables is yet to be elucidated in females. Without such 
information, many aspects of research can be impeded. For instance, sample size calculations 
require estimations of measurement error when determining the minimum number of 
participants required for a study design; furthermore, meaningful changes of a variable in 
response to an intervention also cannot be inferred (Hopkins, Schabort, & Hawley, 2001;  
Hopkins, 2000). This latter point is of particular importance for the field of TMS research, which 
is notorious for variability in evoked responses (Kiers et al., 1993). Indeed, as recently 
highlighted by Furlan & Sterr (2018), including indices of measurement error in 
neurostimulation research is necessary to better elucidate the true effect(s) of an intervention. 
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While these measures have been reported in healthy populations, only one of these studies 
has involved females, and reported the reliability of a combined male and female cohort 
(Temesi et al., 2017a). Additionally, the authors did not control for menstrual cycle phase or 
oral contraceptive usage when testing females on repeated visits 2-14 days apart. As 
emphasised by Sims & Heather (2018), the combination of sexes into one experimental group 
is inappropriate, and controlling for changes in the hormonal milieu is necessary for human 
physiological studies. Sex differences in various aspects of neuromuscular function (Lissek et 
al., 2007; Tenan et al., 2016c; Hoffman et al., 2018a; Peng et al., 2018) mean that it is incorrect 
to assume that previously published reliability data collected in males will also apply to 
females.  
 
The concept of reliability testing to determine measurement error in exercise science relies 
upon the ability to limit confounding variables. In a male population this is relatively simple to 
do, with factors such as prior exercise, nutrition, stimulants and alcohol intake all usually 
controlled for between visits. However, the menstrual cycle and its associated effects on 
neuromuscular function and fatigability (see Chapter 4), means that unless sex hormones are 
the same during each testing session, there is a confounding factor potentially influencing the 
repeatability of measures. As suggested by Sims and Heather (2018), mOCP users can be 
used to examine outcome measures without the influence of fluctuations in endogenous 
hormones. Therefore, to understand the reliability of neuromuscular function tests before and 
after a fatiguing task in females, independent of fluctuations in the hormone levels typically 
observed during a eumenorrheic menstrual cycle, the present study aimed to assess test-
retest reliability in a population of healthy young females taking a monophasic combined oral 
contraceptive pill. It was hypothesised that by controlling for neuroactive hormone 
concentrations, there would be no differences in neuromuscular function between visits, and 
reliability indices would be comparable to previously published data on male participants. 
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5.2. Methods 
5.2.1. Participants 
A total of fifteen healthy young females (mean ± SD age: 23 ± 2 years, stature: 169.7 ± 6.2 
cm, body mass: 70.6 ± 8.5 kg) volunteered to take part in the study. Participants reported 
taking an mOCP for a minimum of six months in the prescribed manner (i.e. a 7 day break 
every 21 days). A full list of the mOCPs taken by the participants is provided below. 
Table 5-1: Monophasic combined oral contraceptive pills taken by the participants. 
OCP brand 
No. 
Participants 
Synthetic 
Estrogen 
Dosage 
(µg) 
Synthetic 
Progestin 
Dosage 
(µg) 
Rigevidon® 6 Ethinylestradiol 30 Levonorgestrel 150 
Cilest® 3 Ethinylestradiol 35 Norgestimate 250 
Yasmin® 2 Ethinylestradiol 30 Drospirenone 300 
Gedarel® 1 Ethinylestradiol 20 Desogestrel 150 
Gedarel® 1 Ethinylestradiol 30 Desogestrel 150 
Microgynon® 1 Ethinylestradiol 30 Levonorgestrel 150 
Levest® 1 Ethinylestradiol 30 Levonorgestrel 150 
 
5.2.3. Procedures 
Participants visited the laboratory three times, completing a familiarisation and two 
experimental visits. Experimental visits were completed during the final 14 days of the pill 
cycle, with a minimum of 48 h between visits to allow recovery (Carroll et al., 2016). The time 
of testing was replicated (±1 hour) for both experimental visits to control for diurnal variations 
in corticospinal excitability and maximal force production (Tamm et al., 2009). Additionally, 
participants consumed their mOCP a constant time prior to experimental sessions in order to 
standardise circulating exogenous oestrogen concentrations between visits. The procedures 
performed in the familiarisation trial replicated those of the experimental visits. 
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5.2.4. Experimental Visits 
Experimental sessions began with participants completing a standardised voluntary isometric 
contraction warm up (2 contractions at 25, 50, and 75% perceived maximal effort) followed by 
a baseline neuromuscular assessment (as described in Chapter 3). The fatiguing task involved 
sets of intermittent isometric contractions (3 s contraction, 2 s rest at 60% MVC) to task failure. 
Contractions were paced with an audible metronome to ensure the duty cycle was maintained. 
One set was defined as 11 submaximal contractions followed by a 3 s MVC with MNS 
delivered at the peak force and 2 s post, lasting one minute. Task failure (TTF) was defined 
as an inability to reach the target force three times at any stage of the protocol. Rating of 
perceived exertion was recorded using a 6-20 scale following each MVC throughout the 
fatiguing task. Real-time visual force feedback using target forces set as percentages of 
maximum force was provided to participants on a computer screen to aid a constant force 
level. The post-task neuromuscular assessment began immediately following task failure. 
 
5.2.5. Transcranial Magnetic Stimulation 
Active motor threshold was not different between experimental visits (40 ± 6 vs. 40 ± 7%, p = 
0.746). Similarly, the stimulation intensity used for the assessment of VATMS was not different 
between visits (67 ± 10 vs. 66 ± 10%, p = 0.737), and activated a large proportion of the 
agonist motoneuron pool (69 ± 35 vs. 68 ± 36% Mmax amplitude, p = 0.916). The TMS pulse 
also concurrently elicited a small MEP in the antagonist muscle group (0.60 ± 0.37 vs. 0.72 ± 
0.53 mV, p = 0.106). 
 
5.2.6. Motor Nerve Stimulation 
The optimum stimulus intensity for motor nerve stimulation was not different between visits 
(230 ± 61 vs. 241 ± 65 mA, p = 0.271). 
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5.2.7. Data Analysis 
The regression between TMS-evoked SIT amplitudes and voluntary force for estimation of 
resting twitch was not significantly linear (p > 0.05, r2 < 0.85) in four out of 60 cases. As a 
result, outliers were identified (as described in Chapter 3) and four out of 300 (1.3%) SITs 
were excluded. This led to four regressions containing nine data points (one pre-exercise, 
three post-exercise), rather than ten. The mean ± SD r2 values were 0.94 ± 0.04 pre- exercise 
vs. 0.94 ± 0.04 post exercise. 
 
5.2.8. Statistical Analysis 
Data are presented as mean ± SD within the text and figures. Normal Gaussian distribution of 
data was confirmed using the Kolmogorov–Smirnov test. If a violation was detected, the data 
was logarithmically transformed. The alpha for all statistical tests was set at p ≤ 0.05. For 
Study A, between session and pre-post exercise differences were explored using two-way (2 
× 2) repeated measures ANOVAs, if assumptions of sphericity were violated, then the 
Greenhouse-Geisser correction was applied. If significant main or interaction effects were 
detected, Bonferroni-corrected post hoc tests were performed.  
 
For between session test-retest reliability multiple indices were calculated (paired samples t-
tests, typical error, intraclass correlation coefficient, Atkinson & Nevill, 1998; Hopkins, 2000) 
between the two time points. Typical error (TE) was calculated as the standard deviation of 
the mean differences divided by the square root of 2. Typical error was expressed as absolute 
raw values and as a percentage of the mean (coefficient of variation, CV). Intraclass 
correlation coefficients (ICC3,1) were calculated according to Bland & Altman (1986). ICC 
values were defined as follows: <0.5 = poor, 0.5-0.75 = moderate, 0.75-0.9 = good, >0.9 = 
excellent (Koo & Li, 2016). Due to the ceiling effect (i.e. all values grouped close to 100%) 
associated with VAMNS and VATMS, the ICCs were not calculated (Todd et al., 2004; Clark et 
al., 2007). 
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5.3. Results 
5.3.1. Exercise performance and pre-post exercise changes 
The TTF was not different between experimental trial 1 and 2 (560 ± 275 s and 603 ± 357 s 
respectively, p = 0.314). When assessing exercise-induced changes in neuromuscular 
function, the two-way ANOVAs detected no between-trial differences in the change values 
(trial × time interactions: p ≥ 0.331), therefore to assess the pre-post exercise change, data 
from both visits was pooled. The MVC decreased pre-post exercise (time effect: 507 ± 95 vs. 
379 ± 85 N; F1,14 = 136.66, p < 0.001, η2 = 0.907). Similarly, indices of contractile function 
(Qtw.pot and ERT) decreased pre-post trial (Qtw.pot: 169 ± 24 vs. 109 ± 21 N; F1,14 = 92.61, p < 
0.001, η2 = 0.869; ERT: 120 ± 36 vs. 93 ± 28 N; F1,14 = 19.07, p = 0.001, η2 = 0.557). Indices 
of voluntary activation also decreased pre-post trial: VAMNS (93.6 ± 3.2 vs. 85.1 ± 6.8%; F1,14 
= 36.60, p < 0.001, η2 = 0.723) and VATMS (94.6 ± 3.1 vs. 83.1 ± 10.6%; F1,14 = 20.82, p < 
0.001, η2 = 0.598). Corticospinal excitability (MEP/Mmax) was not different pre-post exercise (p 
= 0.057). There were no changes in SICI pre-post exercise (p = 0.667), whereas SP duration 
lengthened post-exercise (189 ± 46 vs. 202 ± 50 ms, F1,14 = 5.49, p = 0.034, η2 = 0.282). 
Lastly, Mmax was not different pre-post exercise (p = 0.362). 
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Table 5-2: Reliability data for mechanical variables pre- and post-exercise. Pre-post change (Δ) is presented when 
a significant (P < 0.05) change was observed. 
 
5.3.2. Reliability of NMF measures 
Pre-exercise data from mechanical variables (Table 5-2) showed good (ERT, and TTF) and 
excellent (MVC, and Qtw,pot) reliability. The TE and CV were also low for the majority of 
variables (CV ≤ 12.5%), except TTF (CV = 20.0%). Post-exercise reliability (Table 2) was 
slightly weaker, but was still interpreted as predominantly good (Qtw,pot, ERT) or excellent 
(MVC). These values were all larger post-exercise; however, remained low (CV ≤ 14.9%). The 
relative reliability (ICCs) of the pre-post change was either moderate (MVC, ERT, VAMNS) or 
good (Qtw,pot), however there was a high degree of random error (CV range: 19.7 – 62.7%). 
Measure   Visit 1 Visit 2 P  Bias TE CV (%) ICC (95% CI) 
MVC Pre 502 ± 90 511 ± 103 0.314  −9 23 4.5 0.96 (0.89 - 0.98) 
(N) Post  375 ± 93 383 ± 81 0.356  −8 24 6.2 0.94 (0.82 - 0.98) 
 
Δ −128 ± 43 −128 ± 51 0.972  0 30 23.9 0.62 (0.18 - 0.85) 
 
 
   
 
    
Qtw.pot Pre 168 ± 27 170 ± 22 0.589  −2 9 5.0 0.90 (0.72 - 0.96) 
(N) Post 110 ± 22 110 ±  21 0.942  0 11 10.4 0.75 (0.40 - 0.91) 
 
Δ −58 ± 29 −61 ± 21 0.643  −2 12 19.7 0.81 (0.53 - 0.93) 
     
 
    
ERT Pre 121 ± 38 118 ± 34 0.689  3 15 12.5 0.85 (0.62 - 0.95) 
(N) Post  94 ± 30 91 ± 27 0.605  3 14 14.9 0.79 (0.48 - 0.92) 
 
Δ −27 ± 25 −27 ± 28 0.943  0 17 62.7 0.63 (0.20 - 0.86) 
     
 
    
VATMS Pre 94.3 ± 3.3 94.8 ± 2.9 0.679  −0.5 2.8 3.0 - 
(%) Post  82.3 ± 11.1 83.9 ± 10.4 0.406  −1.6 5.1 6.1 - 
 
Δ −12.0 ±  11.2 -10.9  ±  9.6 0.573  1.1 5.2 45.4 0.78 (0.46 - 0.92) 
     
 
    
VAMNS Pre 93.6 ± 3.0 93.7 ± 3.2 0.834  −0.1 1.6 1.7 - 
(%) Post  84.5 ± 7.2 85.8 ± 6.7 0.942  −1.3 3.6 4.2 - 
 
Δ −9.1 ± 6.0 −7.9 ± 6.1 0.390  1.2 3.7 43.2 0.66 (0.24 - 0.87) 
     
 
    
TTF 
 
560 ± 275 603 ± 357 0.338  −43 117 20.0 0.88 (0.69 - 0.96) 
(s)          
MVC: Maximum voluntary contraction; Qtw.pot: Potentiated quadriceps twitch; ERT: Estimated resting twitch; 
VATMS: Voluntary activation assessed with TMS; VAMNS: Voluntary activation assessed with MNS; TTF: Time to 
task failure  
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Table 5-3: Reliability values for electromyographical data pre- and post-exercise. Pre-post change (Δ) is 
presented when a significant (P < 0.05) change was observed. 
Measure   Visit 1 Visit 2 P Bias TE CV (%) ICC (95% CI) 
VA MEPs Pre 68.9 ± 33.7 66.0 ± 24.6 0.566 2.88 13.4 19.9 0.82 (0.54 - 0.94) 
(%MMAX) Post  68.3 ± 33.9 59.6 ± 26.5 0.079 8.72 12.6 19.7 0.85 (0.61 - 0.95) 
 
Δ 0.6 ± 30.1 6.5 ± 12.9 0.329 -5.9 15.8 447.4 0.59 (0.13 - 0.84) 
         
MEP10% Pre 22.4 ± 12.0 19.8 ± 10.5 0.291 2.6 6.40 30.1 0.71 (0.34 - 0.89) 
(%MMAX) Post  17.8 ± 9.0 16.9 ± 10.1 0.677 0.9 5.4 31.0 0.72 (0.34 - 0.90) 
 
Δ - - - - - - - 
         
SICI  Pre 78.7 ± 15.0 82.9 ± 13.5 0.148 -4.2 7.40 9.2 0.75 (0.42 - 0.91) 
(%)  Post  75.3 ± 13.3 84.3 ± 13.3 0.031 -9.1 10.4 13.0 0.42 (0.00 - 0.75) 
 
Δ - - - - - - - 
         
MMAX Pre 2.96 ± 1.13 3.08 ± 1.28 0.507 -0.12 0.48 15.9 0.86 (0.64 - 0.92) 
(mV) Post  2.74 ± 1.01 2.88 ± 1.03 0.466 -0.14 0.50 17.8 0.79 (0.47 - 0.92) 
 
Δ - - - - - - - 
         
SP Pre 187 ± 45 190 ± 50 0.791 -3 31 16.4 0.60 (0.24 - 0.82) 
(ms) Post  201 ± 56 202 ± 46 0.947 -8 37 19.2 0.63 (0.19 - 0.86) 
  Δ 14 ± 29 12 ± 23 0.815 2 19.8 155.1 0.44 (0.00 - 0.77) 
MEP: Motor evoked potential, MVC: maximum voluntary contraction, SICI: Short interval cortical inhibition, MMAX: maximum 
compound action potential 
 
Surface EMG variables (Table 3) showed moderate (MEP10%, SP) or good (VA MEPs, SICI, 
MMAX) reliability pre-exercise, however, displayed larger CVs than mechanical variables 
(range: 9 – 30%). Post-exercise reliability was similar to pre- for most variables, with ICCs 
either moderate (MEP10%, SP) or good (VA MEPs, MMAX), and comparable CVs (range 13 – 
31%). However, the post-exercise reliability of SICI was poor (ICC = 0.42), this was further 
supported by a significant bias between visits 1 and 2 (−9%, p = 0.031). When the pre-post 
change was significant for a variable, i.e. SP, the relative reliability of change value was 
deemed poor (ICC = 0.44), with a high degree of random error (CV: 155%). 
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Figure 5-12: Agreement of values from visit 1 and 2 including the line of equality for NMF variables. Panel A: MVC, 
Panel B: Qtw,pot, Panel C: VAMNS, Panel D: VATMS. Panel E: MEP/Mmax during a 10% MVC contraction, Panel F: 
SICI, Panel G: SP, Panel H: TTF. Black circles indicate pre-exercise values, whereas grey circles indicate post-
exercise values, apart from panel H, which only contains TTF data. 
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5.4. Discussion 
The present study assessed the test-retest reliability of neuromuscular function assessments 
before and after a fatiguing task in females taking a monophasic oral contraceptive pill. 
Previous studies have quantified the test-retest reliability of these measures in male or mixed 
sex populations; however, it was unclear whether commonly used KE neuromuscular function 
assessment techniques were reproducible in female populations due to the lack of control for 
factors such as neuroactive sex hormones that change across the menstrual cycle. The results 
demonstrate that elements of neuromuscular function can be reliably measured in females 
when hormones are controlled by taking the mOCP and provide a meaningful tool to assess 
changes in future experiments investigating neuromuscular function and/or fatigability, whilst 
contextualising previously reported changes in female populations. 
 
Neuromuscular function was assessed using voluntary contractions and stimulation of 
nervous tissue. When force-derived variables were considered (Table 5-2), pre-exercise 
reliability was good to excellent, and similar to previously reported data in other populations. 
For instance, MVC, VAMNS, VATMS, ERT, and Qtw.pot had CVs ranging from 2 – 13%, and ICCs 
ranging from 0.85 – 0.96. The only previous data in females (Hunter et al., 2000) showed 
MVCs had ICCs of 0.91 and 0.95 in young and older females, respectively. In male populations 
(Place et al., 2007; Thomas et al., 2014b, 2016; Goodall et al., 2017; Ansdell et al., 2018a), 
pre-exercise CVs for the aforementioned force-derived variables ranged from 2 – 14%, and 
ICCs ranging from 0.70 – 0.96. When the same force-derived measures were performed 
immediately following the fatiguing task, the reliability was moderate to excellent for all 
variables (Table 5-2). However, all variables demonstrated poorer reliability than pre-exercise, 
for instance, the post-exercise CV range for force-derived variables was 4 – 15% and ICCs 
0.75 – 0.94. This exercise-induced decrease in reliability is also common in male populations. 
For instance, Goodall et al. (2017) reported CVs of 10 – 18% for MVC, VAMNS, and Qtw.pot at 
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several stages throughout 120 minutes of simulated soccer activity, whilst Place et al. (2007) 
reported increased variability of VAMNS (CV: 3 to 6%) following a 2-minute MVC. In the present 
study, when a significant pre-post exercise change occurred, the reliability of the difference 
(Δ) was measured. All force-derived variables decreased from pre-post exercise, and whilst 
the relative reliability of these Δ was moderate to good (ICC range: 0.62 – 0.81), the random 
error was large (CV range: 20 – 63%). To date, no data exists on the reliability of Δ for common 
neuromuscular function variables. The present data showed that when neuroactive sex 
hormones are controlled, force-derived variables are a reliable method of quantifying 
neuromuscular function (MVC), central nervous system (VAMNS and VATMS) and contractile 
function (Qtw.pot, ERT) in females both pre- and post-fatigue, and the relative reliability (ICC 
values) of the Δ is also acceptable (Koo and Li, 2016). 
 
Electromyographic variables evoked with TMS of the motor cortex or electrical stimulation of 
the motor neuron can be used to understand the integrity of different segments of the 
corticomotor pathway. The present study evoked EMG variables with TMS (MEPs, SICI) and 
MNS (Mmax; Table 5-3; pre-exercise, these variables showed moderate to good ICC values 
(range: 0.60 – 0.86), but large CVs (range: 9.2 – 30.1%). The maximal muscle response to 
MNS (MMAX), was reliable in a non-fatigued state (CV: 16%, ICC: 0.86) and is comparable to 
previous data in male populations (CV range: 25 – 29%   ICC range: 0.70 – 0.86; Thomas et 
al., 2016, 2014). Mmax did not change with exercise, and retained good reliability (CV: 18%, 
ICC: 0.79) post-exercise.  
 
The EMG responses to TMS however, are typically variable due to the fluctuations in the 
corticospinal and motoneuronal excitability (Kiers et al., 1993; Ellaway et al., 1998).  The 
present study showed the reliability of TMS-assessed corticospinal (MEP ICC: 0.71, CV: 30%) 
and intracortical (SICI ICC: 0.75, CV: 9%) properties of the knee-extensors are similar to male 
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and mixed sex populations (ICC range: 0.74 – 0.80, CV range: 11 – 21%; Brownstein et al., 
2018; O’Leary, Morris, Collett, & Howells, 2015; Temesi, Ly, & Millet, 2017). Experimental data 
exists in females for these measures (Smith et al., 1999, 2002), however, these studies were 
conducted in small muscles of the hand, rather than large locomotor muscles such as the 
knee-extensors. Additionally, these previous data assessing the influence of changing 
hormonal state on measures such as SICI, have shown significant effects of sex hormone 
concentrations. Whereas the present study, that controlled for hormone concentrations, saw 
no significant difference between trials. Reliability data regarding paired pulse TMS in the 
knee-extensors is available in male (O’Leary et al., 2015; Brownstein et al., 2018b) and mixed-
sex groups (Temesi et al., 2017a), but to our knowledge, not in a solely female population. 
The present data established that test-retest reliability is good (CV: 9%, ICC: 0.75) when 
attempting to induce SICI in the knee-extensors of healthy females pre-exercise. However, 
whilst the mean SICI did not change following exercise, post-exercise reliability was poor (CV: 
13%, ICC: 0.42), with a significant bias (−9%) between trials. These findings question the 
appropriateness of assessing SICI in the knee-extensors in a fatigued state (Goodall et al., 
2018), and similar investigations should test this in male populations.  
 
Another feature of the MEP is the SP, which might reflect a combination of spinal and 
intracortical GABAB inhibition (Inghilleri et al., 1993; Chen et al., 1999). The present study 
measured SP during a 50% MVC contraction, using the stimulus intensity selected for the 
VATMS protocol. As mentioned in Chapter 3, these parameters were selected because it was 
previously shown that higher contraction intensities (>40% MVC) and stimulus intensities elicit 
a more stable SP duration (Säisänen et al., 2008). In consideration of this, the present study 
showed that SP was moderately reliable pre- and post-exercise (ICCs: 0.60 and 0.63, 
respectively) in healthy females; whereas, the increase in SP (~13 ms) from pre-post exercise 
was not reliable (CV: 155%, ICC: 0.44). Collectively, it would appear that the measurements 
of neural inhibition used here (SICI and SP) were extremely variable when measured in 
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fatigued knee-extensors. However, the use of single- and paired-pulse TMS to ascertain 
cortical and corticospinal excitability in hormonally-constant females taking the mOCP 
appears to be valid and reliable in the non-fatigued muscle, eliminating previously seen 
changes due to fluctuating neuroactive hormones. 
 
The primary measure of performance fatigability used in the present study was the TTF for an 
intermittent, isometric endurance task performed at 60% MVC. The present data showed a 
CV of 20%, which might be considered large, however, this is consistent with previously 
published TTF data (~10-30%, Amann, Hopkins, & Marcora, 2008). Additionally, Amann et al. 
(2008) investigated the differences between open-ended TTF tests compared to fixed-
distance time trial (TT) performance and demonstrated that despite greater measurement 
error, TTFs had similar sensitivity to change as TTs, mainly due to the larger magnitude of 
effect physiological changes have on TTF duration. Therefore, the present data suggests that 
the TTF test used in the present study was reliable, when sex hormones are controlled and 
can be used to assess changes in performance of the knee-extensor muscles in female 
populations. Whilst variability in the TTF during the open-ended fatiguing task could explain 
the poorer reliability seen in the post-exercise NMF measures, the intensity (60% MVC) was 
selected so that it was far greater than a critical intensity (~30% MVC, Burnley, 2009; Burnley, 
Vanhatalo, & Jones, 2012). In theory, and as was demonstrated by the reliable pre-post ∆ 
values (Table 5-2), task failure during constant-load exercise above critical intensity occurs 
once an individual reaches their respective task-specific maximum tolerable neuromuscular 
impairment, theoretically giving a similar degree of post-exercise neuromuscular adjustments. 
 
Several studies have utilised MNS and TMS when assessing the NMF of females. Despite the 
lack of reliability data to assess whether meaningful changes occurred, previous authors have 
made conclusions about changes in NMF. Temesi et al. (2015) compared fatigability of males 
111 
 
and females following an ultra-trail marathon, reporting decreases of 29%, 5%, and 19% for 
MVC, Qtw,pot and VAMNS, respectively, in females. The changes in MVC and VAMNS were greater 
than the CVs (MVC: 5%, VAMNS: 2%) in the present study, however, Qtw.pot was not (5%). Thus, 
the decrease in Qtw.pot in females in must be treated with caution. Data from our own laboratory 
(Ansdell et al., 2018b), showed that females exhibit 15 and 24% decreases in MVC following 
intermittent isometric fatiguing tasks similar to the present study. As these decreases are 
greater than the present CVs, greater confidence can be placed in the results. More recently, 
Senefeld et al. (2018) demonstrated a 56 and 23% decrease in MVC, and ~70% and ~20% 
decrease in Qtw.pot following isometric and dynamic exercise, respectively. These reductions 
are large and meaningful, as they were greater than the CV demonstrated in our data. Finally, 
the present study demonstrated decreases in neuromuscular parameters (MVC, Qtw.pot, VAMNS, 
VATMS, and ERT) that were greater than the CVs for the associated measure (Table 5-2). 
Therefore, it can be concluded that measures of neuromuscular function are sensitive to 
detecting changes induced by exercise-related fatigue in female participants.  
 
The data from the present chapter can also be used to contextualise the findings from Chapter 
4. For instance, the eumenorrheic menstrual cycle associated changes in VAMNS of 1.9% 
between D2 and D14, which is larger than the TE of 1.6% reported here. Similarly, in Chapter 
4 VATMS decreased by 3.1% between D14 and D21, which is also larger than the respective 
TE of 2.8%. Even when more variable measures are considered (i.e. SICI, TE: 7%), the 
significant changes induced by the menstrual cycle were still larger than measurement error. 
For instance, D2 and D14 vs. D21 demonstrated 10 and 15% differences, respectively. 
Likewise, the menstrual cycle associated change in TTF between D2 vs. D21 was 36%, which 
was larger than the measurement error of 20% reported in this Chapter. Thus, using data from 
the hormonally-constant female population in the present Chapter, the hormone-induced 
changes in neuromuscular function exhibited across the menstrual cycle cannot be due to 
measurement error. 
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5.5. Conclusion 
The present study determined reliability of neuromuscular function measures female 
population, by controlling for neuroactive sex hormone concentrations using the mOCP. The 
data showed that the measures investigated were reliable pre- and post-exercise and sensitive 
to exercise-induced change. The force derived variables such as the MVC, Qtw.pot, ERT and 
VA were more reliable than EMG derived variables including MEPs, SICI, SP, and Mmax. The 
data are comparable to previously published data in healthy male and mixed sex populations, 
due to the fact that hormone concentrations were controlled. The findings from the present 
study will be used to inform the forthcoming Chapters in this Thesis and contextualise previous 
findings involving healthy females taking the mOCP.  
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CHAPTER 6 – A SEX COMPARISON OF FATIGABILITY 
AND RECOVERY FOLLOWING EXERCISE NORMALISED 
TO THE INTENSITY-DURATION RELATIONSHIP 
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6.1. Introduction 
As described in Chapter 2, insight into the metabolic demands of a fatiguing task and the 
mechanisms responsible for the attainment of task failure can be gained by determining the 
intensity-duration relationship. This relationship has been frequently reported during dynamic 
tasks (e.g. cycling and knee extension, Jones et al., 2008; Vanhatalo et al., 2010), and a 
similar relationship exists for intermittent, isometric tasks (Burnley, 2009; Burnley et al., 2012). 
However, this has been described primarily in young males (Burnley, 2009; Burnley et al., 
2012). One study included both sexes, but did not conduct a sex comparison of the intensity-
duration relationship (Pethick et al., 2016). It is unknown whether the critical intensity differs 
between males and females for tasks where the sex difference in fatigability is commonly 
reported (e.g. intermittent isometric contractions, Hunter et al., 2004; Ansdell et al., 2018) and 
such an understanding could provide a physiological mechanism to explain previous findings. 
 
A range of reported physiological differences between males and females would suggest the 
critical intensity could differ between sexes for intermittent isometric tasks. Females are 
reported to be less fatigable than males across a range of exercise tasks and muscle groups, 
for contractions performed at the same intensity relative to maximal strength (Hunter, 2009, 
2016a). The sex difference in fatigability is dependent upon the intensity and contraction 
modality of the task (Yoon et al., 2007b; Russ et al., 2008; Hunter, 2016b, 2016a).  During 
intermittent isometric contractions, females demonstrate greater fatigue-resistance compared 
to males, even when strength matched. The magnitude of the sex difference in fatigability 
might also be magnified at lower contraction intensities (Hunter et al., 2004b; Ansdell et al., 
2018b), but it remains unclear whether the relationship between contraction intensity and task 
duration (time to task failure, i.e. fatigability) differs between males and females, and whether 
the underlying neural and contractile mechanisms of fatigue differ. A crucial determinant of 
the intensity-duration relationship is oxygen delivery to the skeletal muscle, with positive 
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correlations between critical intensity and the fraction of inspired oxygen (FIO2; Vanhatalo et 
al., 2010; Dekerle et al., 2012). Critical power (during cycling exercise), for example, is 
positively correlated with type I fibre proportion and muscle capillarity of  knee extensor 
muscles (Vanhatalo et al., 2016; Mitchell et al., 2018a). Typically, females have a greater 
proportion of type I muscle fibres (Simoneau & Bouchard, 1989; Staron et al., 2000; Roepstorff 
et al., 2006), which are less fatigable than type 2 fibres (Schiaffino & Reggiani, 2011). Females 
also exhibit greater capillarisation per unit of VL muscle (Roepstorff et al., 2006), and an 
augmented vasodilatory response of the femoral artery during exercise (Parker et al., 2007). 
Furthermore, females exhibit greater skeletal muscle oxygenation and less deoxygenation 
during upper and lower limb exercise than males when assessed using NIRS (Mantooth et al., 
2018; Marshall et al., 2019). Whether these physiological sex differences could influence the 
critical intensity of the intensity–duration relationship for intermittent isometric contraction 
tasks is unknown.  
 
Finally, recovery of exercise is also influenced by the aforementioned properties of skeletal 
muscle and could therefore differ between males and females; however, the extent of possible 
sex differences and the involved mechanisms of neuromuscular recovery are not understood. 
Limited evidence exists examining the sex difference of recovery for short durations after 
exercise (10-20 minutes), showing that force producing capacity of female knee extensors 
recovers more rapidly than males (Senefeld et al., 2018). Greater capillary density of the 
exercising muscle(s) can increase the rate of recovery from fatigue (Tesch & Wright, 1983; 
Casey et al., 1996), possibly due to an increased rate of metabolite clearance and 
ATP/phosphocreatine re-synthesis post-exercise (Casey et al., 1996; McDonough et al., 
2004), or a reversal in disruptions to calcium handling (Fitts & Balog, 1996). The latter has 
been shown to differ between sexes during exercise (Harmer et al., 2014). However, there is 
a paucity of data relating to sex differences in recovery, and of the neural and contractile 
mechanisms involved following fatiguing exercise.  
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The present Chapter had three primary aims: 1) to compare the relative force (% MVC) at 
which critical intensity is achieved within the intensity-duration relationship for single-limb 
intermittent, isometric tasks in males and females; 2) determine the mechanisms that 
contribute to fatigability during intermittent isometric tasks at intensities of torque above and 
below the critical intensity in males and females; and 3) compare the rate of recovery following 
fatiguing exercise and the underpinning neuromuscular mechanisms. It was hypothesised 
that: 1) due to greater oxygen availability within the muscle, females would demonstrate a 
higher critical intensity than men when expressed relative to MVC. 2) There would be no sex 
difference in TTF when the tasks were compared at the same metabolic intensity of 
contraction, relative to critical intensity. 3) Recovery from fatiguing exercise would be more 
rapid in females than males due to the properties of contractile elements of the muscle.  
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6.2. Methods 
6.2.1. Participants 
Using the effect size for the sex difference in exercise tolerance at 50% MVC from Ansdell et 
al. (2018), a power calculation (alpha = 0.05, power 0.80) determined that a sample size of 16 
participants was required. Therefore, to maximise statistical power, ten males (mean ± SD 
age: 26 ± 5 years, stature: 178 ± 8 cm, mass: 83.4 ± 14.4 kg) and ten females (age: 24 ± 2 
years, stature: 168 ± 9 cm, mass 68.5 ± 7.7 kg) were recruited to take part in the study. The 
females that volunteered were all using monophasic oral contraceptive pills (>6 months), and 
were tested in the 21-day consumption period of the pill cycle in order to negate the effects of 
endogenous hormones on neuromuscular function and fatigability (see Chapter 4). 
 
6.2.2. Experimental Design 
All participants visited the laboratory seven times, completing a familiarisation visit, four 
constant intensity trials to estimate critical intensity, then trials at 10% above and below critical 
torque (see Experimental Protocol). Testing took place over a three to five week period, with 
a minimum of 48 h between visits to permit full recovery of fatigue (Carroll et al., 2016). The 
time of day for each testing session was replicated (± 1 h) to account for diurnal variations in 
maximal force generating capacity and corticospinal excitability (Tamm et al., 2009). 
 
6.2.3. Experimental Protocol 
Visit 1: Familiarisation. Participants were sat in the isometric dynamometer with hip and knee 
angles at 90˚. This set up was replicated for all visits. Electrical nerve stimulation threshold 
was determined, followed by TMS hotspot, aMT and VA stimulator intensity determination 
(described below). Following this, a baseline neuromuscular function assessment was 
performed. After five minutes of passive rest, participants performed the fatiguing task at 60% 
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MVC. An MVC and electrical stimulation was performed, each minute throughout the fatiguing 
task. Immediately following the fatiguing task, participants performed a ‘post-exercise’ 
neuromuscular assessment.  
 
6.2.4. Visits 2-5: Critical Intensity Estimation Trials.  
To establish critical intensity, participants performed four trials to task failure. These involved 
intermittent isometric knee‐extensor contractions at submaximal intensities between 40‐80% 
MVC. The first trial was set at 60% MVC, based on the pre-exercise MVC in the first trial. The 
following three estimation trials were set at intensities that elicit task failure between 2 and 15 
minutes in a randomised order (Burnley, 2009; Burnley et al., 2012). Participants were 
instructed to match a target force displayed using a visual guideline on a computer screen ~1 
m in front of them, and were blinded to the time elapsed in each trial. The contraction regime 
for all trials involved 3 s contractions interspersed with 2 s rest, with an MVC and electrical 
stimulation performed at the end of each minute. This contraction duty cycle has previously 
displayed sex differences independent of strength, and therefore occlusion differences 
between males and females (Ansdell et al., 2017; Hunter et al., 2006). Task failure was 
deemed as a failure to meet the target force three consecutive times despite strong verbal 
encouragement. Participants were informed each time they failed to reach the target force. 
Before the submaximal task, participants performed five 3 s MVCs separated by 30 s, with 
electrical stimulation during and 2 s after the final three contractions. Immediately following 
task failure this was repeated with three MVCs and superimposed electrical stimulations. 
 
6.2.5. Visits 6 and 7: Critical Intensity Trials.  
The supra (+10%) and sub (−10%) critical intensity trials began with electrical nerve 
stimulation and TMS thresholds being determined. Baseline NIRS values were recorded once 
participants were sat in the dynamometer, in the same position as the fatiguing task. NIRS 
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data was captured for the entirety of the trials, and was used to measure changes in muscle 
oxygenation during the fatiguing task.  Cardiac output (Q̇) , heart rate (HR), and mean arterial 
pressure (MAP) were also measured throughout the trial via a fingertip arterial pressure cuff 
(Finometer Midi, Finapres Medical System, Arnhem, The Netherlands). Participants 
completed a standardised isometric warm up (Gruet et al., 2014), before a baseline 
assessment of neuromuscular function. After five minutes of passive rest participants 
completed an intermittent isometric fatiguing task to failure at an intensity relative to their 
critical intensity (+10 or −10%). An MVC with electrical stimulation during and ~2 s following 
was performed and delivered at the end of each minute of the task to assess neuromuscular 
function (see below). The −10% trial was terminated after 45 minutes, as this intensity 
contraction could theoretically be maintained indefinitely without task failure (Burnley et al., 
2012). Therefore, male and female fatigability was compared after an identical ‘dose’ of 
exercise. The intensity for the first critical intensity trial was randomised and counterbalanced. 
Upon task failure or termination, a post‐test neuromuscular function assessment (see below) 
was immediately performed, then repeated at 15, 30 and 45 minutes post-exercise.  
 
6.2.6. Intensity-Duration Relationship  
Critical intensity and curvature constant (W′) were estimated from the force‐impulse 
relationship of the four submaximal trials. A linear regression between force impulse at task 
failure from the four submaximal trials against time to task failure was plotted to determine the 
characteristics of the relationship. The slope of the regression determined critical intensity, 
and the y‐intercept determined W′ (Burnley et al., 2009, 2012). Critical intensity was expressed 
in Newtons, and as %MVC to account for sex differences in absolute force production. 
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6.2.7. Transcranial Magnetic Stimulation 
 The procedure for aMT determination was carried out according to Section 3.3.2.6. Mean 
aMT was not different between males and females (39 ± 7 vs. 43 ± 10%, p = 0.379), or 
between visits (41 ± 9 vs. 41 ± 9%, p = 0.423). Similarly, for VATMS, the mean stimulator 
intensity used was not different between males and females (63 ± 6 vs. 66 ± 11%, p = 0.462) 
or between visits (66 ± 10 vs. 63 ± 7%, p = 0.218). The intensities used activated a large 
proportion of the motoneuron pool for the RF that was not different between trials at baseline 
(53 ± 13 vs. 53 ± 16% MMAX, p = 0.920). The TMS pulse also avoided substantial activation of 
the antagonist (biceps femoris) with small incidental MEPs recorded at baseline (0.68 ± 0.52 
vs. 0.70 ± 0.1 mV, p = 0.902). 
 
6.2.8. Motor Nerve Stimulation 
The procedure for determining optimal stimulus intensity was performed as described in 
Section 3.3.2.4. Mean stimulus intensity was not different between sexes (276 ± 142 vs. 190 
± 75 mA, p = 0.057) or between visits (241 ± 104 vs. 229 ± 107 mA, p = 0.492). 
 
6.2.9. Near Infrared Spectroscopy 
Data was collected according to the procedures outlined in section 3.5.1. 
 
6.2.10. Haemodynamic Monitoring 
Mean arterial blood pressure and heart rate were measured continuously throughout the final 
two testing visits using finger arterial pressure pulse wave analysis (Finometer Midi, Finapres 
Medical System, Arnhem, The Netherlands). This system was also used to estimate Q̇ using 
the Modelfow equation (Wesseling et al., 1993). An appropriately sized cuff was placed 
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between the distal proximal inter-phalangeal joint of the middle finger. To minimise the effect 
of arm and hand movement during the trials, arm position was maintained stationary 
throughout the trial. To account for hydrostatic pressure differences between the level of the 
hand and heart, a height correction unit was used. The Finapres was activated prior to the 
exercise tasks to allow calibration via the Physiocal function within the BeatScope software. 
This technique has previously been validated and shown to be reliable at rest and in exercise 
conditions (Parati et al., 1989; Waldron et al., 2017b). Signals were linearly interpolated and 
resampled at 1 Hz (Faisal et al., 2009), then a 5 s rolling average was used to smooth the 
data (Beltrame et al., 2017), before 30 s time intervals were taken pre-exercise, 25, 50, 75 
and 100% of time to task failure. Pre-exercise, participants remained seated for five minutes 
to establish baseline values, with the final 30 s used as the baseline value. 
 
6.2.11. Data Analysis 
In order to achieve significant linearity (r2 > 0.80, p < 0.05), a total of five out of 850 SITs 
across all trials were excluded (0.6%), which led to five regressions containing 9 data points 
rather than 10 (1 pre-exercise, 4 post-exercise). As a result, mean r2 values for ERTs were 
linear throughout the study (0.93 ± 0.06). The NIRS (O2Hb, HHb, TOI, and cHb) and Finapres 
(HR, Q̇, MAP) data were expressed as a percentage of baseline, and the 30 s epochs 
throughout exercise are presented as ∆%. Despite a linear relationship between TTF and work 
done in the estimation trials (r2 = 0.98), and a physiologically normal value for the critical 
intensity (22.7% MVC), one female participant demonstrated a large 95% confidence interval 
for the estimate of critical intensity (±13% MVC). As a result, there were no signs of fatigability 
(i.e. MVC did not decrease from baseline) during the +10% trial, thus the trial was terminated 
after 90 minutes, and the participant was excluded from further analyses. It was likely the case 
that this participant was exercising below the ‘true’ critical intensity. Similarly, one male was 
excluded due to a large 95% confidence intervals (±12% MVC), which resulted in the intensity-
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duration relationship estimates residing >3 SDs from the mean value for males (critical 
intensity = 31.3% MVC, W′ = 2005 N·s−1), likely caused by premature task failure in the higher 
intensity estimation trial(s). 
 
6.2.12. Statistical Analysis 
Data are presented as mean ± SD within the text and figures. Normal Gaussian distribution of 
data was confirmed using the Kolmogorov–Smirnov test. If a violation was detected, the data 
was logarithmically transformed. This occurred for rmsEMG/Mmax during the fatiguing tasks, 
therefore, statistical tests were run on the transformed data, but in text and figures the non-
transformed data is presented. The alpha for all statistical tests was set at P < 0.05. 
 
For variables assessed pre-, during, and post- exercise (MVC, VAMNS, Qtw.pot, rmsEMG, O2Hb, 
HHb, TOI, HR, Q̇, and MAP) a two-way (2×5) repeated measures ANOVA was used to assess 
differences between sex (male vs. female) and over time (Pre, 25, 50, 75% TTF, and Post). 
For variables that were assessed pre and post-exercise (ERT, VATMS, MMAX, MEP/Mmax, SICI) 
a two-way 2×2 repeated measures ANOVA was used to assess differences between sex 
(male vs. female) and over time (Pre vs. Post). For variables that were assessed during the 
recovery period (MVC, VAMNS, Qtw.pot, ERT, VATMS, MMAX, MEP/M, SICI) a two way (2×4) 
repeated measures ANOVA was used to assess difference between sex (male vs. female) 
and over time (Post, and 15, 30 and 45 min post-exercise). If significant main or interaction 
effects were observed, these were followed up by post-hoc Bonferroni-corrected pairwise 
comparisons. 
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6.3. Results 
6.3.1. Intensity-Duration Relationship 
The trials to estimate the intensity-duration relationship ranged from 1.6 – 16.0 minutes in 
duration (Table 1). In order to match the TTFs between sexes, the trial intensities were 
required to be greater in females than the males (mean difference of 10-11% MVC for the four 
trials, all p < 0.001). Furthermore, the relationship between TTF and impulse across the four 
trials was linear (r2 range: 0.89 – 1.00) for all participants (Figure 6-1A).  
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Figure 6-1: Characteristics of the intensity duration relationship for males and females. Panel A: The linear 
relationships between impulse and time to task failure across the four estimation trials. Panel B: Critical intensities 
expressed as a percentage of MVC. Panel C: W’ in both sexes. 
Maximal voluntary contraction was greater in males compared to females (708 ± 119 vs. 458 
± 59 N, p < 0.001); however, absolute critical intensity was not different (143 ± 26 vs. 123 ± 
26 N, P = 0.109). When normalised to MVC, females had a greater critical intensity compared 
to males (24.7 ± 2.5 vs. 20.8 ± 2.3% MVC, p = 0.003, Figure 6-1B), however, there was no 
difference in W′ (18,206 ± 6,331 vs. 18,765 ± 5,762 N·s, p = 0.850, Figure 6-1C). Males and 
females demonstrated a consistent decline in MVC, Qtw.pot, and VAMNS across the four 
estimation trials (Figure 6-2, Trial × Time interactions p ≥ 0.144). 
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Figure 6-2: Pre-post changes in neuromuscular function across the four estimation trials. A: maximum voluntary 
contraction (MVC); B: potentiated quadriceps twitch force (Qtw.pot); C: voluntary activation (assessed with motor 
nerve stimulation, VAMNS). 
 
Table 6-1: Intensity, times to task failure, impulse for the critical intensity estimation trials, and confidence intervals 
for critical torque. Values are mean ± SD 
 
Males  Females 
Trial % MVC TTF (s) Impulse (N·s-1)  % MVC TTF (s) Impulse (N·s-1) 
1 61 ± 2 217 ± 38 50,188 ± 10,600  71 ± 3* 216 ± 139 52,353 ± 22,164 
2 56 ± 2 335 ± 102 74,185 ± 27,746  66 ± 3* 355 ± 158 70,105 ± 23,355 
3 51 ± 2 427 ± 117 82,614 ± 22,044  61 ± 3* 486 ± 163 94,263 ± 33,207 
4 46 ± 2 647 ± 186 120,318 ± 33,089  57 ± 4* 760 ± 148 141,504 ± 47,839 
        
r2  0.98 ± 0.03    0.99 ± 0.01  
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95% CIs 
(±%MVC)  
5.9 ± 4.3  
 
 6.8 ± 4.2  
95% CIs: 95% confidence intervals for the linear regressions, MVC: maximal voluntary contraction, TTF: time to task 
failure; * = greater than males (P < 0.001) 
 
6.3.2. Intensity-Duration Relationship (Further Considerations) 
The intensity for the subsequent exercise trials was originally set as +10% and −10% from the 
critical intensity noted in the previous section. The intention was to achieve exercise intensities 
in the severe and heavy domains. However, as was noted by Denadai & Greco (2019), the 
calculation for critical intensity in both males and females was underestimated. Specifically, 
the rest period between contractions in the estimation trials was included in the linear 
regression between ‘time to task failure’ and ‘impulse’. This led to an underestimation of the 
critical intensity in both sexes when compared to calculations that only incorporate ‘contraction 
time’ (Figure 6-3). As this was the case in both sexes, the sex difference in critical intensity 
remained when the calculation was adjusted (42.4 ± 4.5 vs. 34.9 ± 3.9% MVC, p = 0.003). 
However, importantly this meant that the trial intensities for subsequent exercise trials were 
both below the re-calculated critical intensity (−12 and −20%, respectively). Nevertheless, as 
described in the subsequent results section, the two trials resulted in ‘unsustainable’ and 
‘steady-state’ work rates and associated physiological responses. For the purpose of clarity in 
the remainder of this results section, the +10% and −10% trials are referred to as the ‘heavy+’ 
and ‘heavy−’ intensity trials, respectively. 
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Figure 6-3: Critical intensities for males (blue) and females (red), re-calculated according to Burnley et al. (2009). 
 
6.3.3. Heavy+ Trial 
6.3.3.1. Fatigability 
Throughout the heavy+ task and at task failure, MVC, Qtw.pot, VAMNS, VATMS, and MEP/Mmax all 
decreased (all time effects p < 0.001, Figures 6-5 and 6-6), whilst rmsEMG/Mmax increased (p 
< 0.001, Table 2). However, SICI (p = 0.232) and Mmax (p = 0.109) did not change. When 
comparing the changes between sexes, MVC (F2.2,34.5 = 4.36, p = 0.017, ηp² = 0.214), and 
Qtw.pot (F4,64 = 2.52, p = 0.049, ηp² = 0.136) decreased more in males compared with the females 
(Figure 6-5, panel A & B), whilst the rmsEMG/Mmax increased more in the males than the 
females (F2.2,34.5 = 7.33, p = 0.002, ηp² = 0.314).  However, the change in VAMNS, VATMS, 
MEP/Mmax, and SICI were not different between the sexes (p ≥ 0.062).  
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Figure 6-4: Time to task failure during intermittent, isometric knee extensor exercise in the heavy+ trial for males 
(blue) and females (red). Individual participants are represented as the dots, and group mean and standard 
deviations are illustrated by the horizontal bars. 
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Figure 6-5: Changes in neuromuscular parameters assessed during the heavy+ exercise task and recovery period. 
Panel A: maximum voluntary contraction (MVC); Panel B: potentiated quadriceps twitch force (Qtw.pot); Panel C: 
voluntary activation assessed with motor nerve stimulation (VAMNS). Filled lines and circles represent the group 
mean values, and the dashed lines represent individual participants. * = different from Pre (P < 0.05), $ =  different 
from Post (P < 0.05), # = different between males and females (P < 0.05). 
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6.3.3.2. Recovery 
In the 45 minute recovery period, MVC, Qtw.pot, VAMNS, VATMS, and MEP/Mmax all demonstrated 
a return towards baseline (recovery effects all p < 0.001, Figures 6-5 and 6-6). Females 
however, demonstrated a faster recovery for Qtw.pot (F3,48 = 3.13, p  = 0.034, ηp² = 0.164), and 
VATMS (F1.8,25.4 = 3.63, p = 0.045, ηp² = 0.206), with no difference in recovery for MVC, VAMNS, 
or MEP/Mmax (p ≥ 0.096).  
 
 
Figure 6-6: Neuromuscular changes across the heavy+ fatiguing task and the recovery period. A: voluntary 
activation (transcranial magnetic stimulation, VATMS); B: motor evoked potentials (normalised to Mmax, MEP/Mmax), 
C: short interval intracortical inhibition (SICI). * = different from Pre (P < 0.05), $ = significantly different from Post 
(P < 0.05), # = different between males and females (P < 0.05). 
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6.3.3.3. Oxygenation and Haemodynamics 
Muscle oxygenation was altered during the heavy+ fatiguing task (Figure 6-7), with O2Hb 
(F1.4,22.5 = 7.00, p = 0.009, ηp² = 0.304), HHb (F1.4,22.5 = 11.53, p = 0.003, ηp² = 0.419), and TOI 
(F1.1,18.3 = 7.12, p = 0.004, ηp² = 0.393) all demonstrating changes from baseline. For O2Hb, 
females demonstrated an increase from baseline, whilst males decreased (F1.4,22.5 = 8.05, p = 
0.005, ηp² = 0.335, Figure 6-7A). Females demonstrated a lesser increase in HHb (F1.4,22.5 = 
8.96, p = 0.007, ηp² = 0.359), and decrease in TOI (F1.2,18.3 = 7.12, p = 0.013, ηp² = 0.308) than 
males (Figure 6-7B and C).  
 
Figure 6-7: Near Infrared Spectroscopy variables throughout the fatiguing task (heavy+). A: Oxyhaemoglobin 
(O2Hb), B: Deoxyhaemoglobin (HHb), C: Tissue oxygenation index (TOI). # = significantly different between males 
and females (P < 0.05), * = significantly different from Pre (P < 0.05). 
The heavy+ fatiguing task induced changes in cardiovascular function (Table 6.2) with HR 
(F4,64 = 47.39, p < 0.001, ηp² = 0.748), Q̇ (F4,64 = 19.70, p < 0.001, ηp² = 0.552), and MAP (F4,64 
= 12.24, p < 0.001, ηp² = 0.433) all increasing. Females demonstrated a lesser increase in HR 
(F4,64 = 8.99, p < 0.001, ηp² = 0.360) and Q̇ (F4,64 = 4.02, p = 0.006, ηp² = 0.201), but not MAP 
(p = 0.175). 
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Table 6-2: Neuromuscular and cardiovascular function throughout the fatigue and recovery periods in both the higher and lower intensity trials. 
    Heavy+     Heavy− 
 
 
                                                                                                       Neuromuscular Function 
  Pre Post Post 15 Post 30 Post 45   Pre Post Post15 Post30 Post 45 
ERT (N) Males 167 ± 66 130 ± 67* 135 ± 60# 133 ± 66 132 ± 63 
  
167 ± 63 124 ± 52* 122 ± 47 120 ± 44 110 ± 39 
 
Females 151 ± 43 101 ± 23* 134 ± 27# 127 ± 23 129 ± 45 
  
149 ± 33 131 ± 37* 123 ± 37 135 ± 39 132 ± 30 
              
MMAX (mV) Males 6.55 ± 2.57 5.89 ± 2.54 5.86 ± 2.28 5.95 ± 2.51 6.41 ± 2.56 
  
6.33 ± 2.44 5.52 ± 2.58* 5.61 ± 2.39 5.75 ± 2.48 5.19 ± 2.32 
 
Females 5.18 ± 2.95 4.75 ± 2.28 4.36 ± 2.32 4.47 ± 2.07 4.59 ± 2.80 
  
4.98 ± 2.40 4.39 ± 1.66 4.43 ± 1.57 4.27 ± 1.63 4.2 ± 1.52 
              
Pre-Stimulus 
rmsEMG (% 
MMAX) 
Males 0.62 ± 0.27 0.65 ± 0.28 0.67 ± 0.28 0.70 ± 0.29 0.66 ± 0.30 
  
0.64 ± 0.23 0.84 ± 0.34 0.80 ± 0.33 0.81 ± 0.32 0.90 ± 0.36 
 Females 0.75 ± 0.34 0.8 ± 0.77 0.82 ± 0.56 0.87 ± 0.49 0.87 ± 0.64 
  
0.73 ± 0.39 0.85 ± 0.53 0.79 ± 0.54 0.79 ± 0.46 0.77 ± 0.46 
  1st Set 25% TTF 50% TTF 75% TTF 100% TTF   1st Set 25% TTF 50% TTF 75% TTF 100% TTF 
rmsEMG during 
task (% MMAX) 
Males 16 ± 8 22 ± 13* 24 ± 12* 25 ± 10*$ 27 ± 11*$   8 ± 3 8 ± 3 8 ± 3 8 ± 4 8 ± 3 
 Females 16 ± 5 19 ± 8 17 ± 5 17 ± 4 17± 4   8 ± 4 9 ± 3 9 ± 4 8 ± 4 9 ± 4 
 
Cardiovascular Function 
  Pre 25% TTF 50% TTF 75% TTF 100% TTF    Pre 25% TTF 50% TTF 75% TTF 100% TTF 
Heart Rate (bpm) Males 78 ± 5 95 ± 12* 99 ± 10* 108 ± 16* 116 ± 16*$   71 ± 11* 88 ± 20* 92 ± 18* 91 ± 19* 91 ± 17* 
 Females 80 ± 13 91 ± 18* 94 ± 21* 94 ± 21* 96 ± 19*   81 ± 14 86 ± 13 87 ± 13 87 ± 12 87 ± 12 
Cardiac Output 
(L·min-1) 
Males 8.1 ± 2.2*$ 10.0 ± 2.3*$ 10.3 ± 2.0*$ 10.6 ± 2.2*$ 10.4 ± 2.2*$   6.8 ± 1.6 7.4 ± 1.8 7.5 ± 1.7* 7.6 ± 1.8* 7.6 ± 1.7* 
 Females 6.0 ± 1.8 7.2 ± 1.9* 7.0 ± 1.6* 6.9 ± 1.6 6.8 ± 1.5   6.0 ± 1.3 6.2 ± 1.3 6.3 ± 1.4 6.3 ± 1.4 6.3 ± 1.2 
Mean Arterial 
Pressure 
(mmHg) 
Males 90 ± 13 98± 13 100 ± 15 104 ± 18* 107 ± 15*   94 ± 8 94 ± 10 95 ± 13 97 ± 10 101 ± 13 
 Females 93 ± 11 104 ± 12* 104 ± 12 101 ± 12 105 ± 11*   93 ± 14 98 ± 15 99 ± 13 100 ± 13 100 ± 15 
* = significantly different from Pre (P < 0.05), # = significantly different from Post (P < 0.05), $ = significantly greater than Females. ERT: estimated resting twitch; Mmax: maximal compound action potential; rmsEMG: root mean squared 
EMG; TTF: time to task failure. 
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6.3.4. Heavy− Trial 
6.3.4.1. Fatigability 
All participants successfully completed the 45 minutes of exercise at the lower intensity and 
did not reach task failure. MVC, Qtw.pot, Mmax, VAMNS, and VATMS all decreased (time effects: p 
≤ 0.016) throughout the intermittent isometric task, whereas rmsEMG/Mmax (p = 0.020), and 
MEP/Mmax (P = 0.017) increased. Short interval intracortical inhibition did not change (p = 
0.061). Of these variables, a sex × time interaction was demonstrated for Q tw.pot (F1.97,31.49 = 
5.31, p = 0.011, ηp² = 0.249) indicating a lesser decrease in females over the course of the 
intermittent isometric task. Post-hoc differences are displayed in Figure 6-8 and Table 6-2. 
 
6.3.4.2. Recovery 
In the 45 minute recovery period the MVC, Qtw.pot , VAMNS, and VATMS increased (recovery 
effects: p ≤ 0.032). Conversely, Mmax (p = 0.267), MEP/Mmax (p = 0.080), and SICI (p = 0.085) 
demonstrated no recovery effects. Of the variables demonstrating recovery effects, VATMS 
demonstrated a sex × time interaction (F1.45,20.26 = 4.57, p = 0.033, ηp² = 0.246), indicating a 
faster recovery in females compared with males. No other variables (MVC, Qtw.pot,  and VAMNS) 
demonstrated this sex by time interaction (p ≥ 0.069). 
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Figure 6-8: Neuromuscular changes throughout the heavy- task and the recovery period. A: maximal voluntary 
contraction (MVC), B: voluntary activation measured using transcranial magnetic stimulation (VATMS), C: 
potentiated twitch force (Qtw.pot), D: motor evoked potential amplitude normalised to MMAX, E: voluntary activation 
measured using motor nerve stimulation (VAMNS), F: short interval intracortical inhibition (SICI). * = significantly 
different from Pre (P < 0.05), $ = significantly different from Post (P < 0.05). 
 
6.3.4.3. Oxygenation and Haemodynamics 
Muscle oxygenation was altered during the intermittent isometric task (Figure 6-9). Whilst 
O2Hb (F1.6,26.5 = 10.27, p = 0.001, ηp² = 0.391) increased, HHb did not change (p = 0.945), and 
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TOI decreased (F1.36,21.71 = 4.98, p = 0.027, ηp² = 0.237). Of these variables, O2Hb 
demonstrated a sex × time interaction (F1.64,26.25 = 3.77, p = 0.044, ηp² = 0.191), indicating a 
greater increase in females compared with males. 
 
 
Figure 6-9: Near Infrared Spectroscopy variables throughout the lower intensity task. A: Oxyhaemoglobin, B: 
Deoxyhaemoglobin, C: Tissue oxygenation index. # = significantly different between males and females (P < 0.05). 
 
Heart rate (F2.6,41.5 = 18.42, p < 0.001, ηp² = 0.535), Q̇ (F2.83,45.23 = 4.06, p = 0.014, ηp² = 0.380) 
and MAP (F1.96,31.37 = 6.72, p = 0.004, ηp² = 0.296) all increased throughout the intermittent 
isometric task (Table 6.2), with a sex × time interaction for HR (F2.59,41.49 = 5.59, p = 0.004, ηp² 
= 0.259), indicating a greater increase in HR in males than females.  
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6.4. Discussion 
The present study aimed to compare the intensity-duration relationship between males and 
females during intermittent, isometric knee extensor exercise, and assess whether a sex 
difference in fatigability and recovery existed when exercise was normalised to the critical 
intensity. Our data show that females demonstrated a greater relative critical intensity during 
intermittent isometric knee extensor exercise compared with males. Contrary to our 
hypothesis however, females lasted approximately twice as long than males for open-ended 
exercise normalised to this threshold. During two exercise trials at higher and lower relative 
intensities, females demonstrated less contractile impairment, and a faster rate of recovery 
following the higher intensity trial. Furthermore, these factors are likely related to the fact that 
females demonstrated lesser deoxygenation during exercise, which provides a plausible 
explanation for the observed sex differences in exercise tolerance and fatigability.  
 
6.4.1. Intensity-Duration Relationship 
Of the two parameters of the intensity-duration relationship, a sex difference was observed for 
critical intensity, but not W′. Females had a critical threshold ~7% MVC greater than males, 
due to a steeper slope in the TTF-impulse relationship (Figure 6-1A) and smaller absolute 
MVC. Critical intensity notes the maximal sustainable metabolic rate during exercise, at which 
oxidative energy provision is sufficient and reaches a steady state (Poole et al., 2016a). 
Increasing the FIO2 during exercise increases critical intensity (Vanhatalo et al., 2010), 
whereas decreasing FIO2 reduces the maximal sustainable intensity (Dekerle et al., 2012). 
Similarly, complete blood flow occlusion reduces critical power to less than zero (Broxterman 
et al., 2015a). Differences in skeletal muscle properties between males and females could 
explain the difference in critical intensity. It is well established that in the VL, females possess 
a greater relative proportion of type I muscle fibres (Simoneau & Bouchard, 1989; Staron et 
al., 2000; Roepstorff et al., 2006) and greater capillary density (Roepstorff et al., 2006) than 
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males. When combined with a greater vasodilatory response of the femoral artery to exercise 
in females (Parker et al., 2007), it is likely that these factors permit greater delivery of 
oxygenated blood to the muscle tissues of the knee-extensors, contributing to an ability to 
sustain greater relative rates of oxidative metabolism (i.e. critical intensity) than males. These 
observations could explain why females were able to attain a higher relative critical intensity 
than males in the present study. Indeed, recent evidence suggests that type I fibre % and 
muscle capillarisation are positively correlated with critical power during cycling exercise 
(Vanhatalo et al., 2016; Mitchell et al., 2018a). Mitchell et al. (2018) suggested that greater 
capillary supply likely leads to greater oxygen supply and extraction during exercise. To 
support this, during the higher intensity trial in the present study, a sex difference was 
observed for HHb, with females demonstrating lesser increases in deoxygenation (Figures 6-
6 and 6-8). Therefore, the present data suggest that females are able to maintain elevated 
delivery of oxygen to the knee-extensors, leading to a greater relative rate of maximal 
sustainable oxidative metabolism.  
 
The curvature constant of the intensity-duration relationship (W′), was not different between 
sexes. Whilst less is known about the origins and determinants of W′ (Poole et al., 2016a), 
evidence suggests that there is no relationship between it and skeletal muscle properties 
(Vanhatalo et al., 2016; Mitchell et al., 2018a). More likely, W′ is related to the depletion of 
intramuscular energy stores (e.g. phosphocreatine, PCr) and accumulation of metabolites 
(e.g. Pi, H+, ADP; Vanhatalo et al., 2010). This notion has been suggested to oversimplify 
such a concept, with the possibility of a different source in W′ between whole-body and single-
muscle exercise (Poole et al., 2016a). However, in single-muscle exercise, Broxterman et al. 
(2015b) suggested that W′ might be related to the maximum tolerable degree of 
neuromuscular dysfunction. Considering there was no difference in the ∆% in MVC, Qtw.pot, 
and VAMNS between males and females at task-failure in the estimation trials (Figure 6-5), this 
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notion could explain why W′ was not different between sexes in the intermittent, isometric 
model used in the present study. 
 
6.4.2. Sex Differences in Fatigability and Recovery  
Despite normalising exercise to the intensity-duration relationship, which is a key step when 
modelling fatigability (Burnley & Jones, 2018), females outlasted males during the open-ended 
isometric intermittent contraction task (Figure 6-4). In both trials below critical intensity, 
females experienced a slower rate of decline in MVC, Qtw.pot, and VAMNS (Figures 6-5 and 6-
8). A similar study in males (Burnley et al., 2012) speculated that the origins of contractile 
dysfunction below this threshold might be related to the effects glycogen depletion had on 
calcium transients in skeletal muscle (Ørtenblad et al., 2013). During whole-body exercise, 
females oxidise relatively more fat than carbohydrate compared to males (Roepstorff et al., 
2002, 2006); when combined with the more fatigue-resistant calcium properties in female 
muscle (Harmer et al., 2014), this could explain why the post-exercise ∆% in Qtw.pot was less 
(Figure 6-8C). Furthermore, females were better able to maintain oxygen availability within the 
working muscles (Figure 6-7A), however, this is not thought to be a limiting factor to exercise 
performance below critical intensity (Poole et al., 2016a), as oxidative metabolism is not at 
maximal rates.  
 
This sex difference in fatigability observed in the present study helps to explain previous 
findings that showed females outlasting males during intermittent isometric exercise (Ansdell 
et al. 2017). For example, in the 50% MVC task in Ansdell et al. (2018), it is likely the case 
that females were working at ~117% of critical intensity, whereas males were working at 
~143%. This greater magnitude of exercise intensity above critical intensity could explicate 
why females lasted over twice as long as males. Furthermore, during the 30% MVC task in 
Ansdell et al. (2018), females were likely exercising at a lower relative exercise intensity, as 
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well as developing both peripheral and central fatigue at slower rate within the heavy intensity 
domain, as the present study demonstrates. Collectively, these factors would explain why after 
60 minutes at 30% MVC in Ansdell et al. (2018), females demonstrated less than half the 
reduction in MVC as males. 
 
Following the higher intensity trial, females demonstrated a faster rate of recovery for Q tw.pot 
(Figure 6-4B), which supports the conclusions of Senefeld et al. (2018), who demonstrated a 
similar pattern following a fixed-duration dynamic fatiguing task. Rapid recovery of contractile 
function is likely related to the removal of potassium ions from the T-tubules, permitting 
repolarisation (Allen et al., 2008a). Whereas further recovery of contractile function following 
long-duration isometric exercise is related predominantly to restoration of intracellular calcium 
handling/sensitivity, rather than metabolite clearance (Carroll et al., 2016). Female skeletal 
muscle demonstrates a 24% lower maximal rate of Ca2+ATPase activity (Harmer et al., 2014), 
which has previously been suggested to lead to lower calcium-related impairments during 
exercise, and create a more fatigue-resistant muscle compared to males (Hunter, 2014). Thus, 
it could be the case that differences in calcium handling in female skeletal muscle translated 
to better post-exercise recovery kinetics. Although somewhat speculative, calcium handling 
has been studied in vitro to support the sex difference in fatigability (Harmer et al., 2014), but 
no similar data in vivo exists to assess recovery of calcium handling between males and 
females after exercise. Therefore, calcium-related properties of skeletal muscle could help 
explain why female contractile function recovered quicker in the present study, but further 
research to support this proposition is warranted. 
 
6.4.3. Further Considerations 
Despite both exercise trials being below critical intensity, differential profiles of neuromuscular 
fatigue were observed. Whilst the higher intensity trial was not in the intended ‘severe’ intensity 
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domain, it did induce an unsustainable work rate, evidenced by progressive declines in MVC, 
potentiated twitch amplitude (Qtw.pot), and voluntary activation (VAMNS), along with increased 
EMG activity. Considering these responses, and the exercise time of this trial (~30 mins in the 
male group), it is likely that participants were exercising in the heavy exercise domain (Brickley 
et al., 2002; Thomas et al., 2016). In contrast, the neuromuscular responses to the lower 
intensity trial indicate a sustainable exercise intensity consistent with the moderate exercise 
domain, where indices of neuromuscular function reached a far smaller nadir in comparison 
(Figure 6-8). Thus, our data demonstrate that females are more fatigue-resistant during 
distinct, metabolically matched exercise at sustainable and unsustainable intensities in the 
heavy and moderate exercise domains. When these data are considered in the context of the 
re-calculated critical intensity, the decline in neuromuscular function exhibited in the original 
“−10%” trial is similar to the CT−20% trial in Burnley et al. (2012). Another similarity between 
the two data sets is that when below critical intensity, neuromuscular function does indeed 
progressively decline, with both central and peripheral contributing factors. However, this 
decline occurs at a slower rate than exercise performed above critical intensity, indicating that 
task failure can indeed occur below this metabolic threshold. 
 
One method to assess fatigability in the ‘severe’ intensity domain from the present study is to 
consider the data collected during the estimation trials when determining the critical intensity. 
By sex-matching the percentage of critical intensity post-hoc, we can identify trials at which 
males (n=8) and females (n=5) were exercising at ~160% critical intensity (Table 6.3). Using 
this approach, it is clear that when exercise is metabolically matched above critical intensity 
in the severe domain, females remain more fatigue resistant than males; not only was the time 
to task failure longer, the rate of decline in Qtw,pot was lower.  
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Table 6.3: Intensity-matched data demonstrating a sex difference in fatigability at 160% of critical intensity. 
Post-hoc matched severe trials 
% critical intensity TTF (s) Qtw.pot change (%) Rate of change (%·min−1) 
Male Female Male Female Male Female Male Female 
158 ± 4 159 ± 2  328 ± 142 624 ± 255 −47 ± 17 −31 ± 5 −9 ± 4 −3 ± 1 
        
P value: 0.732  0.020  0.066  0.009 
TTF: time to task failure; Qtw.pot = potentiated quadriceps twitch 
 
To further support the notion that females possess more fatigue-resistant knee extensors, the 
rise in rmsEMG/Mmax was smaller compared to males during the higher intensity task (Table 
6.2). Despite the known limitations (Farina et al., 2014; Enoka & Duchateau, 2015) associated 
with surface EMG, increases are suggested to reflect additional neural drive and recruitment 
of further motor units, as the contractile apparatus become fatigued (Gandevia, 2001). 
Therefore, the smaller increase in rmsEMG/Mmax could suggest that female musculature was 
able to sustain the required intensity with a reduced need for additional neural drive and motor 
unit activation. This could also explain the smaller decrease in Qtw.pot experienced during the 
tasks, further supporting the notion that the sex differences in skeletal muscle properties 
influence fatigability during intermittent isometric exercise. Further research could employ the 
use of high density EMG, which is capable of discerning motor unit properties (Merletti et al., 
2008), without the limitations associated with bipolar surface EMG (Farina et al., 2014; Enoka 
& Duchateau, 2015). 
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6.5. Conclusions 
The present study is the first to demonstrate that females can sustain a greater relative work 
intensity compared with males during single limb exercise, as shown by the greater critical 
intensity. Importantly, when exercise intensity was normalised to this threshold, females out-
performed males during the open-ended task, and showed reduced fatigability following 
exercise performance at a fixed workload. These sex differences in the intensity-duration 
relationship and fatigue resistance, are likely related to a greater ability to preserve oxygen 
availability within the knee-extensors during exercise, as demonstrated by the NIRS data. 
Following exercise, a faster rate of recovery was observed for contractile function in females, 
suggesting that, in addition to possessing more fatigue-resistant skeletal muscle, females are 
able to resolve exercise-induced dysfunction at a faster rate. These data explain previous 
findings related to sex differences in fatigability tasks, whilst providing the first sex-comparison 
of fatigability during work normalised to a metabolic threshold. Furthermore, the difference 
between sexes highlights the importance of individualising exercise and recovery prescription 
to males and females, rather than generalising from previously generated male-only data 
within the literature. The final experimental chapter of this thesis (Chapter 8) will employ a 
similar study design, but with cycling as the modality of exercise, in an attempt to see if the 
present conclusions translate to whole-body exercise. 
 
 
 
 
 
 
 
143 
 
CHAPTER 7 – METHODS DEVELOPMENT: ELECTRICAL 
STIMULATION OF CORTICOSPINAL AXONS AT THE 
LUMBAR SPINAL SEGMENTS 
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7.1. Introduction 
As outlined in Chapter 2, investigating the responsiveness of the CNS is of interest to 
researchers wishing to discern the central contributions to fatigue. Indeed, as used in previous 
Chapters of this Thesis (Chapters 4-6), TMS is commonly employed to assess the behaviour 
of the corticospinal pathway, with changes in the size of the evoked MEP used to form 
conclusions about exercise-induced changes within the motor pathway. However, any change 
in MEP size might be due to changes in the excitation or inhibition of cortical neurons or spinal 
motoneurons (Rossini et al., 2015). Being able to discern the influence of the spinal 
motoneurons permits researchers to draw conclusions about the ‘final common path’ of the 
nervous system (Sherrington, 1906), and differentiate cortical and subcortical modulations of 
evoked responses.  
 
Typically, subcortical stimulation is performed at the cervicomedullary or thoracic levels of the 
spinal column, but this can be painful and responses can be difficult to ascertain, particularly 
when the lower limbs are targeted (McNeil et al., 2013). Indeed, stimulation over the thoracic 
spinous processes has been shown to evoke responses in quiescent lower limb muscles, but 
not in all muscles and all participants (Martin et al., 2008). Furthermore, even if responses are 
evoked, they tend to be small (≤10% of Mmax; Martin et al., 2008). Notably, stimulation of the 
descending tracts at the mastoid or thoracic level also stimulates motoneurons associated 
with control of upper limb and trunk musculature (Nathan & Smith, 1982; Nathan et al., 1996a) 
therefore the current applied is likely shared between the motoneuron pool of multiple muscle 
groups (Kendall et al., 2005). Excitable tissues such as muscle and upper limb nerve roots 
likely also become depolarised by the large current applied (Taylor, 2006), resulting in 
contraction of back, neck, shoulder and arm muscles (Martin et al., 2008). These reasons 
could potentially explain the relative lack of studies investigating changes in spinal cord 
properties during or following locomotor exercise. Thus, an alternative paradigm that mitigates 
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the aforementioned technical challenges would be advantageous for investigation of 
corticospinal behaviour in lower limb muscles. 
 
One alternative technique to discern spinal contributions is the stimulation of peripheral Ia 
afferent neurons (H-reflex, Nielsen et al., 1999). However, the H-reflex is known to be 
influenced by pre-synaptic inhibition (Zehr, 2002), which means changes in this variable might 
not necessarily be due to changes in corticospinal properties. For this reason, direct 
stimulation of the spinal cord is considered a more appropriate method for assessment of the 
spinal contribution to the overall corticospinal response. This is reinforced by the fact that the 
action potentials descending from the motor cortex are attenuated by antidromic collision of 
those originating from spinal stimulation, indicating activation of some of the same 
corticospinal axons (Ugawa et al., 1991; Maertens De Noordhout et al., 1992; Taylor et al., 
2002; Martin et al., 2008). 
 
A potential solution to the methodological challenge of subcortical stimulation of the 
corticospinal axons when lower limb muscles are targeted could be stimulation of the lower 
spinal column. At the lumbar level, the descending tracts contain a greater relative density of 
motoneurons projecting to lower limb muscles (Sayenko et al., 2015a). Stimulation applied 
closer to these projections will likely result in a higher current density in the motoneuron pool 
of the lower limbs when compared to mastoid or thoracic stimulation. Indeed, Kuck et al. 
(2017) and Fernandes et al. (2018) have shown, via modelling techniques, that when the 
cathode and anode are placed over the lower thoracic and lumbar spinous processes (T8 – 
L2), respectively, the highest density of electrical field is concentrated around the spinal cord 
segments associated with lower limb projections. Furthermore, these modelling studies also 
indicated that electric field magnitude is likely to be higher in the lateral spinal cord white matter 
where the lateral corticospinal tract is located. Thus, when targeting the lower limb muscles, 
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stimuli delivered lower on the spinal tract might provide an alternative methodological 
paradigm to activate the descending corticospinal axons. 
 
One further consideration for assessing lower limb corticospinal excitability is that responses 
are commonly evoked during muscle contraction (Sidhu et al., 2011; Brownstein et al., 2018a). 
This is recommended when responses during or following locomotion are of interest (Gruet et 
al., 2013; Kalmar, 2018b; Weavil & Amann, 2018). Thus, it is important to discern how 
responses to lumbar stimulation behave during different levels or neural drive (i.e. contraction 
intensity). Similar to MEPs, if lumbar evoked responses (LEPs) change with increasing 
contraction intensity (Sidhu et al., 2015), it would indicate that the response is primarily 
mediated by activation of corticospinal tract, and is an appropriate index of excitability during 
locomotor muscle contraction. When considered within the context of exercise-induced 
fatigue, excitability of the spinal cord appears to play a role in the development of lower-limb 
central fatigue (Finn et al., 2018). Therefore, ascertaining the locus of CNS dysfunction 
following locomotor exercise can provide novel insight into the mechanisms of central fatigue 
in different populations and/or exercise modalities. 
 
Therefore, this study aimed to explore whether a single electrical stimulus over the first 
lumbar spinous process (LS) activates descending corticospinal axons innervating lower 
limb muscles by pairing LS with TMS of the motor cortex at appropriately timed ISIs. It was 
hypothesised that when the stimuli are paired at intervals shorter than the difference in 
latencies of each stimulus alone, there will be an occlusion of the response to paired 
stimulation relative to the response to TMS alone. This technique has been employed 
previously with cervical and thoracic stimulation to explore similar hypotheses (Taylor et al., 
2002; Martin et al., 2008). The responses to TMS and LS alone were also compared during 
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different contraction intensities. It was hypothesised that the size of responses would be 
similar with increasing contraction intensities. 
7.2. Methods 
7.2.1. Participants 
Ten healthy, young volunteers (24 ± 4 years, 179 ± 8 cm, 77 ± 12 kg; seven males) participated 
in the study. As the study was not a repeated measures design, menstrual cycle phase or 
contraceptive usage was not controlled for in the three female participants. 
 
7.2.2. Experimental Design 
Participants visited the laboratory on two separate occasions: a familiarisation visit, then an 
experimental visit. These trials were separated by a minimum of 24 hours. Participants 
avoided the consumption of caffeine and performance of intense exercise for 24 h prior to the 
experimental visit. 
 
7.2.3. Experimental Visit 
In the first part of the experiment, with the muscle at rest, TMS and LS were either delivered 
separately, or paired with different ISIs. Initially, the responses to individual TMS and LS were 
standardised to elicit a response that was ~10%–15% of the resting Mmax, and the stimulus 
intensities required to produce these outputs were then applied during paired stimulation. 
Paired TMS and LS were delivered either with TMS preceding LS (ISIs from −16 to −2 ms, 
every 2 ms), both stimuli occurring at the same time (ISI of 0 ms), LS preceding TMS (ISIs 
from 2 to 14 ms, every 2 ms) or LS and TMS delivered independently of each other (Figure 7-
1). Therefore, there were a total of 18 different stimuli, delivered separately in 10 sets, totalling 
180 stimulations. The order of each set of stimuli was randomised, with pulses within each set 
delivered every 5–10 s.  
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Figure 7-1: A, Experimental approach involved two parts, the first part being comprised of paired stimulation 
(transcranial magnetic stimulation and lumbar electrical stimulation) at rest at 16 different interstimulus intervals, 
and the second part consisting of single pulse magnetic and electrical stimulations at 10. 25. 50. 75 and 100% 
maximal voluntary contraction. B, Lumbar electrical stimulation was performed with cathode centred over L1 and 
anode placed over T8 spinous process. Based on modelling literature, this configuration is likely to produce the 
greatest electric field around the area of T10-T12 spinal segments. MEP, motor evoked potential; LEP, lumbar 
evoked potential.  
 
In the second part of the experiment, participants performed two MVCs, of which the greatest 
instantaneous force was used to set guidelines for subsequent contractions. TMS and LS were 
then delivered separately at 10, 25, 50, 75 and 100% MVC (Figure 7-1A). The order of the 
type of stimulation and the contraction strength was randomised. Five stimuli were performed 
at each contraction intensity for each type of stimulation, to avoid the influence of decreases 
in muscle function at higher contraction intensities. Stimulations were delivered once the force 
had plateaued at the target line. At least 60 s rest was given between each contraction. Initially, 
149 
 
the responses to individual TMS and LS were standardised to ~50% Mmax during a contraction 
at 50% MVC, and the stimulus intensities required to produce these outputs remained constant 
for all contraction intensities. Standardising evoked responses during contraction to a higher 
percentage of Mmax than that used when evoking responses at rest was chosen to distinguish 
the evoked response from background EMG activity, and because this size response is known 
to be sensitive to change with contraction strength (Sidhu et al., 2015). 
 
7.2.4. Motor Nerve Stimulation 
The femoral nerve was stimulated according to the methods outlined in Chapter 3; the 
optimum stimulus intensity for the experimental visit was 249 ± 88 mA. 
 
7.2.5. Transcranial Magnetic Stimulation 
Single-pulse TMS was delivered according to the methods outlined in Chapter 3. In the first 
part of the experiment, stimuli were delivered during rest at the intensity eliciting a MEP of 10-
15% Mmax (53 ± 19% MSO). In the second part of the experiment, stimuli were delivered at a 
50% contraction at the intensity eliciting a MEP of 50% Mmax (55 ± 10% MSO). 
 
7.2.6. Electrical Stimulation of the Lumbar Spinous Process 
Lumbar-evoked potentials were elicited with a constant current stimulator (1 ms pulse 
duration; Digitimer DS7AH, Hertfordshire, UK) via self-adhesive electrodes (Nidd Valley 
Medical Ltd., Bordon, UK). The cathode electrode (5 × 9 cm) was centred over the first lumbar 
(L1) spinous process, with the long axis of the electrode aligned to the centre of the vertebral 
column (Figure 7-1B). The surface area of the cathode covered two spinous processes above 
and below the centre point (T11–L3). A cathode of large area was chosen as it produces less 
discomfort and greater tolerance by participants (Ugawa et al., 1995b; Kuhn et al., 2010). The 
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bottom of the anode (circular shape; 3.2 cm diameter) was placed in the midline of the 
vertebral column 5 cm above the upper edge of the cathode (Ugawa et al., 1995b), 
corresponding to the level of the eighth thoracic spinous process (T8). Based on modelling 
studies (Kuck et al., 2017, Fernandes et al., 2017), this electrode configuration was chosen 
as it is likely to induce the greatest electric field magnitude between T10 and T12 spinous 
processes due to electric field being highest between the stimulating electrodes (Kuck et al., 
2017). As such, the site of greatest spinal cord activation is likely to occur between the L1–L5 
spinal segments, corresponding to the motoneuron pools of the rectus femoris (Sharrard, 
1964; Sayenko et al., 2015b). Similar to TMS, the intensity of stimulation was standardised to 
~10%–15% Mmax evoked in the resting position (168 ± 69 mA) and to ~50% Mmax during a 
contraction at 50% MVC (145 ± 58 mA).  
 
To ensure ventral roots were not stimulated, responses were monitored for a lack of an abrupt 
decrease in latency and increase in response size with voluntary contraction (Taylor, 2006). 
Paired LS was also performed at the target stimulus intensity at an ISI of 50 ms before the 
start of the main recording session, with the lack of depression of the second response 
excluding the possibility of stimulation of dorsal roots (Roy et al., 2012; Danner et al., 2016). 
 
7.2.7. Data Analysis 
In the experiment assessing the interaction of LS and TMS, the data analysis was similar to 
that described previously by Taylor et al. (2002). Briefly, using a customised script in Spike2 
(v8, CED, UK), the waveforms of individual responses to LS alone, TMS alone and paired 
stimulation were averaged. These are depicted in the example responses (Figure 7-2) during 
selected ISIs from one individual in the top three rows. The averaged response waveform to 
LS alone was then temporally aligned to the LS stimulus time point of the averaged response 
waveform to paired stimulation and graphically subtracted from the latter (Paired—LEP; Figure 
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7-2, bottom row). After that, the peak-to-peak amplitude of the paired—LEP waveform was 
calculated and compared to the amplitude of the averaged response to TMS alone ([paired—
LEP]/MEP). It has previously been suggested that the subtraction might reveal an inverted 
potential resulting in negative values, such as in the cases when response to LS is larger than 
the response to paired stimulation (Taylor et al., 2002), however, this was never the case in 
the present study.  
 
7.2.8. Statistical Analysis 
Paired sample T-tests were used for assessing the statistical significance of the differences in 
the paired—LEP amplitude relative to the MEP alone amplitude. It should be noted that 
individuals of different height and thus, different lengths of neural pathways along with reported 
differences in conduction velocity between individuals (Andreassen & Arendt-Nielsen, 1987; 
Sadoyama et al., 1988) could confound the interpretation of the interaction of LS and TMS. 
For that reason, additional analyses were performed to account for this potential disparity. 
Firstly, the difference in MEP and LEP latency was calculated estimating the time required for 
the first volley elicited by TMS to reach the segmental level activated by LS. This time (rounded 
to the nearest 2 ms) was referred to as normalised ISI of 0 ms. Subsequently, the positive and 
negative normalised ISI values are indicative of the first volley evoked by TMS not having 
arrived at or having passed the site of descending axon activation by LS respectively (Martin 
et al., 2008). Due to incomplete number of samples (n < 10), statistical analysis using paired 
sample T-test was not performed for this part of the analyses at normalised ISIs of –6, –4 , 26 
and 28 ms.  
 
The variability of individual responses to TMS and LS was assessed by calculating a 
coefficient of variation for each series of 5 evoked potentials (MEPs or LEPs) for each 
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individual (CV = standard deviation of 5 evoked potentials ÷ mean of 5 evoked potentials × 
100%).  
 
In the experiment assessing the responses with increased contraction strength, peak-to-peak 
amplitudes of the single pulse evoked responses were calculated, averaged and normalised 
to Mmax. Background rmsEMG activity was quantified as the 100-ms epoch prior to stimulus 
and normalised to MVC rmsEMG. A 2 × 5 repeated measures ANOVA was performed to 
determine whether contraction strength-response curves and background EMG activity were 
different. The effect of contraction strength on MEP and LEP latencies was assessed via a 
one-way repeated-measures ANOVA. If F-values were found to be statistically significant, 
analysis was continued using pairwise comparison with Bonferroni correction. All statistical 
analyses were performed in SPSS (v20, SPSS Inc., Chicago, IL, USA).  
 
All data are reported as means ± standard deviations. Significance was set at alpha level of 
0.05. To allow for a more nuanced interpretation of the data, Cohen’s dz were calculated as 
an effect size measure for statistical procedures involving paired sample T-tests. Cohen’s dz 
was calculated as the ratio of mean difference and standard deviation of differences, which 
slightly differs from traditional Cohen’s d calculation in that it is better suited for within-subject, 
rather than traditional between-subject differences (Becker, 1988; Smith & Beretvas, 2009). 
Partial eta squared (ηp2) were calculated as a measure of effect size for statistical procedures 
involving ANOVA. 
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7.3. Results 
7.3.1. Latencies and Variability of Responses 
Latencies of MEPs and LEPs at rest and across contraction intensities remained unchanged 
(p = 0.081; Table 7-1). The response variability was greater for MEP compared to LEPs and 
was reduced in an active muscle compared to rest for both evoked responses (Table 7-1). 
 
Table 7-1: Latencies of evoked potentials in milliseconds, and variability of evoked potentials expressed as 
coefficients of variations (mean ± SD). 
 
 
 
 
 Latencies (ms) 
 LEP  MEP 
Rest 9.5 ± 1.1 22.1 ± 1.9 
10% MVC 9.0 ± 1.0 20.8 ± 1.9 
25% MVC 9.2 ± 1.2 20.4 ± 1.7 
50% MVC 9.1 ± 0.9 20.4 ± 1.7 
75% MVC 9.3 ± 0.8 20.8 ± 2.0 
MVC 9.5 ± 1.2 20.4 ± 1.5 
 Variability (%) 
 LEP MEP 
Rest 31 ± 22 38 ± 11 
10% MVC 13 ± 8 20 ± 13 
25% MVC 13 ± 9 30 ± 15 
50% MVC 13 ± 6 24 ± 16 
75% MVC 16 ± 10 20 ± 13 
MVC 17 ± 4 22 ± 7 
MVC = maximal voluntary contraction, LEP = lumbar evoked potential, MEP = motor 
evoked potential. 
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7.3.2. Interaction of LS and TMS 
Representative traces recorded from one individual assessing the interaction of LS and TMS 
are shown in Figure 7-2. Similar individual behaviour was observed across all participants. 
 
 
Transcranial magnetic stimulation alone evoked responses of 15.3 ± 5.8% Mmax, and LS alone 
evoked responses of 13.3 ± 3.3% Mmax. The interaction of TMS and LS resulted in occlusion 
of responses between ISIs of −8 and 14 ms (p value range = 0.001 – 0.049, dz range = 0.5 – 
1.4; Figure 7-3A) and facilitation at ISIs of −16 and −14 ms (p = 0.031 & 0.011; dz = 0.5 & 0.7). 
At ISIs of −12 ms, no facilitation was observed at the group level (p = 0.119, dz = 0.5); however, 
on an individual level, 6 participants exhibited facilitation ([Paired – LEP]/MEP > 1.0). 
Figure 7-2: Individual traces from a participant best representing the sample mean. Evoked responses to electrical stimulation of 
the first lumbar spinous process alone (LEP), magnetic stimulation of the cortex alone (MEP), paired stimuli (Paired), and a 
subtracted response (Paired – LEP) for ISIs of −14, −8, −2, 2 and 8 ms are shown. Each trace is an average waveform of 10 
responses. Shaded grey area is drawn for better visualisation of differences. 
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Figure 7-3: Temporal relationship of the interaction between transcranial magnetic stimulation and electrical 
stimulation over the first lumbar spinous process. Means and standard deviations are shown for the differences in 
peak-to-peak amplitudes of evoked responses between paired stimulation and electrical stimulus alone and 
expressed relative to the response to magnetic stimulation for 16 different interstimulus intervals ranging from −16 
to 14 ms every 2 ms (Panel A) and normalised interstimulus intervals (Panel B) when lumbar stimulation was 
delivered before (positive interstimulus intervals), at (0 ms) or after (negative interstimulus intervals) the first volley 
evoked by transcranial magnetic stimulation was expected to arrive at the lumbar level. Horizontal dashed line 
represents the size of the response that would be expected if there was no physiological interaction. The black 
filled circles indicate the response is significantly different from the MEP alone (p < 0.05). For interstimulus intervals 
denoted by the grey filled circles statistical analyses was not performed due to incomplete number of samples (n < 
10).  
 
7.3.4. The effect of timing of stimuli on interaction of LS and TMS 
The responses to paired stimulation were occluded at >2 ms before the expected arrival of the 
first descending volley evoked by TMS to the segmental level of LS (p value range = 0.001 – 
0.012, dz range = 0.6 – 1.2; Figure 7-3B). The paired responses were also facilitated when 
the first descending volley evoked by TMS was at the same level as LS (0 ms, p = 0.010; dz 
= 0.7), and when LS was delivered 2 ms after the expected arrival of the first descending volley 
evoked by TMS (−2 ms, p = 0.038, dz = 0.6). 
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Figure 7-4: Root-mean-square EMG activity during 100-ms epoch prior to stimulus normalised to root-mean-square 
EMG activity during maximal voluntary contraction (A and B) and the amplitude of responses to motor (filled circles) 
and lumbar (open circles) evoked potentials at different contraction strengths (C and D). 
 
 
7.3.5. Responses with increases in contraction strength 
Background muscle activity increased progressively from 10 – 100% MVC (F2.1, 18.9 = 318.4, p 
< 0.001, ηp2 = 0.97; Figure 7-4A). There was also a contraction intensity effect on MEPs and 
LEPs (F1.6, 7.8 = 11.9, p = 0.001, ηp2 = 0.57) insofar as the responses peaked at 50% MVC 
(Figure 7-4B). There was no interaction between contraction strength and type of stimulus 
(F1.2, 5.8 = 1.9, p = 0.125, ηp2 = 0.18). 
 
 
7.4. Discussion 
The results of this experiment show that the response to paired magnetic cortical and electrical 
stimulation of the lumbar spinal segments is occluded at appropriate interstimulus intervals 
and that responses to TMS and LS similarly increase with increases in contraction strength 
with no change in onset latency. This behaviour suggests that LS and TMS activate some of 
the same corticospinal axons and that responses to LS are evoked transsynaptically with a 
monosynaptic component. Thus, this stimulation technique has applicability as an alternative 
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paradigm for investigating the contribution of spinal motoneuron excitability to the overall 
corticospinal response when lower limb muscles are targeted. 
 
7.4.1. Evidence for stimulation of descending tracts 
The occlusion observed with TMS being delivered before LS at intervals shorter than the 
difference in latencies of each stimulus alone corroborates previous findings when electrical 
stimulation was performed over the mastoids with arm and hand muscles targeted (Ugawa et 
al., 1991; Taylor et al., 2002). Similarly, when LS preceded TMS, the responses were occluded 
to the same degree, again confirming the findings seen when electrical stimulation was 
performed over the mastoids and targeting the muscles of the arm (Taylor et al., 2002). This 
occlusion corresponded to the timing of the stimuli when LS was delivered more than 2 ms 
before the expected arrival of the first descending volley evoked by TMS (Martin et al., 2008), 
which is consistent with collision of the descending cortical volleys of TMS with antidromic 
volley originating from LS. These findings indicate that LS activates some of the same axons 
as TMS, likely the pyramidal cells in the corticospinal tract (Ugawa et al., 1991; Taylor et al., 
2002). Whilst the occluded response could have emerged due to disynaptic inhibition 
originating from LS-induced activation of inhibitory interneurons via cutaneous receptors of 
the lumbosacral region (Frigon et al., 2012), this is unlikely given the facilitation that was 
observed at longer ISIs when TMS preceded LS (Taylor et al., 2002). Facilitation 
corresponded to the first descending volley evoked by TMS having passed the segmental 
level of LS by more than 2 ms. This facilitation, which has been consistently shown for the 
aforementioned timing (Ugawa et al., 1991; Taylor et al., 2002; Martin et al., 2008), is the result 
of the descending volley evoked by LS arriving at the motoneuron pool that is already excited 
by TMS descending volleys (Martin et al., 2008). 
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In theory, it was expected that when LS was delivered prior to TMS at ISIs longer than the 
difference in latencies of individual stimuli, the antidromic volley would reach the cortex prior 
to its excitation by the magnetic stimulus, resulting in a response similar to a single- pulse 
TMS. However, we found that at longer ISIs (LS preceding TMS), responses remained 
occluded in both muscles. This behaviour is in agreement with Taylor et al. (2002), but differs 
to that of Ugawa et al. (1991). However, the latter employed electrical stimulation of the cortex, 
whilst the former stimulated the cortex with TMS, similar to the present study, suggesting that 
the origin of the observed depression at these longer ISIs is cortical, possibly through inhibition 
via collaterals of corticospinal axons (Krnjević et al., 1966; Ghosh & Porter, 1988). 
 
There are certain factors that complicate the interpretation of the interaction between electrical 
stimulation of the spinal tracts and responses evoked by TMS, even if it is assumed that the 
pathway is purely monosynaptic (Petersen et al., 2002). Firstly, magnetic and electrical 
stimulation differ in their mechanism of activation of neurons, such that TMS evokes multiple 
descending volleys, whereas LS only elicits a single descending volley (Nakamura et al., 1996; 
Houlden et al., 1999; Terao et al., 2000). This makes it likely that only the first volley of TMS 
is affected by the collision originating from LS. Consequently, comparison of responses to 
paired stimulation to a single TMS response actually underestimates the occlusion as a result 
of collision (Martin et al., 2008). However, despite the interaction of the stimuli being complex, 
our data, in conjunction with previous work in the area (Taylor et al., 2002; Martin et al., 2008), 
suggests that the single volley produced by LS can occlude the response to TMS. Secondly, 
the observed occlusion could be a result of descending action potentials being in a refractory 
state. However, this is an unlikely contributor given the observed facilitation of responses when 
the first descending volley evoked by TMS had passed the segmental level of LS and since 
occlusion occurred at ISIs far longer than the refractory period of motoneurons (>3 ms; Day 
et al., 1989). Lastly, if the motoneurons are not activated monosynaptically, the paired 
response could be influenced by excitatory and inhibitory interneurons. However, had there 
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been multiple synapses involved in the present study, increased excitability of motoneurons 
with increased contraction strength would have likely shortened the activation time of each 
postsynaptic cell and thus reduced the onset latency of evoked potentials (Petersen et al., 
2002). This was not the case as responses to individual TMS and LS increased similarly with 
increased contraction strength with no change in onset latency.  
 
The increase in response amplitude with increased contraction strength is an indicator that 
the responses were evoked transsynaptically as opposed to distal to the cell bodies (Martin et 
al., 2008). It is also worth noting that both LEPs and MEPs increased at a similar rate as shown 
previously (Maertens De Noordhout et al., 1992; Sidhu et al., 2015) and peaked at 50% 
consistent with the relationship between motor unit recruitment and firing frequency of the 
muscles investigated (Gelli et al., 2007), which determines the probability of an evoked 
response (Brouwer et al., 1989; Bawa & Lemon, 1993; Jones & Bawa, 1999). Similar 
behaviour of LEPs and MEPs with increased contraction strength is a good indicator that 
segmental responses can be assessed during a voluntary contraction which is of importance 
for the lower limbs, where exercise-induced alterations in corticospinal excitability are of 
interest (Lévénez et al., 2007; Finn et al., 2018). 
 
7.4.2. The possibility of stimulation of other neural structures 
Whilst the present data provide evidence that LS and TMS activate similar axons, i.e. the 
pyramidal cells in the corticospinal tract, there remains the possibility that other descending 
tracts might also be excited and hence be contributing to the observed effects (Ugawa et al., 
1991). Of particular consideration would be those tracts located in the lateral white matter, 
such as rubrospinal and reticulospinal tracts (Nathan & Smith, 1982; Nathan et al., 1996b), as 
modelling studies indicate that electric field magnitude, due to LS, is likely higher at the lateral 
aspects of the spinal cord where these tracts are located (Fernandes et al., 2018). Any 
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potential effects from the rubrospinal tract can be discounted as this tract does not project 
below the cervical region in humans (Nathan & Smith, 1982). The reticulospinal tract does 
project down to the lumbar region, however, its contribution to the effects observed is likely 
small due to lower density of the axons compared to corticospinal tract (Nathan et al., 1996b). 
Thus, it appears unlikely that descending tracts other than corticospinal tract were stimulated 
with LS. 
 
Though the aforementioned observations relating to a lack of changes in onset latency with 
increased contraction strength provide support for the monosynaptic nature of the pathway, 
the data from the present experiment does not completely exclude the influence of non- 
monosynaptic pathways. Indeed, a large propriospinal system has been shown to exist in 
humans that might influence corticospinal responses (Pierrot-Deseilligny, 2002). It is important 
to note that the corticospinal pathway as a whole encompasses not only cortical circuitry and 
the motoneuron pool, but also any spinal interneuronal connections (Devanne et al., 1997). 
TMS might activate inhibitory interneurons due to their lower threshold for activation in some 
muscles (Nielsen et al., 1993), reducing the excitability at the level of the motoneuron pool 
leading to reduced temporal summation of the responses. Though supra- additive facilitation 
observed in the present experiment makes this possibility less likely, it should be noted that 
the lower limb muscles investigated in these experiments have been demonstrated to have 
di- and polysynaptic pathways (Nielsen et al., 1993; Simonetta-Moreau et al., 1999). Thus, 
further work is required to elucidate whether responses to LS are evoked purely 
monosynaptically, or whether they involve an interneuronal component. 
 
When LS is performed, there is always the possibility that nerve roots are stimulated in addition 
to the spinal tract. Ventral roots were unlikely to have been activated in the present 
experiments due to the fact that when dorsal roots are stimulated, the occlusion of responses 
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to paired TMS and dorsal root is absent, and responses to dorsal root stimulation are not 
facilitated by voluntary muscle contraction (Roy et al., 2014), the opposite of which was 
observed in the present experiments. Thus, the possibility of having activated ventral or dorsal 
roots with electrical stimulation is minimal. 
 
7.4.3. Variability of responses 
The present data show that the CVs for LEPs at rest and during contraction are lower than 
MEPs (see Table 7-1). As is well established, MEPs are inherently variable due to the 
fluctuating nature of corticospinal and motoneuronal excitability (Kiers et al., 1993; Ellaway et 
al., 1998), randomness in the firing of pyramidal tract neurons and spinal motoneurons (Pitcher 
et al., 2003) as well as desynchronization of action potentials (Magistris et al., 1998). The 
variability of cortically-evoked responses observed in the present study is comparable to that 
reported previously when similar numbers of pulses were employed (Brownstein et al., 2018b). 
A greater variability in MEPs compared to LEPs can perhaps be explained by differences in 
the complexity of the responses to TMS as opposed to LS as discussed above. In addition to 
moment-to-moment fluctuations in motor cortex excitability (Ellaway et al., 1998), some of the 
multiple volleys evoked by TMS, particularly the later, indirect waves, can fire multiple times 
(Edgley et al., 1997), which might contribute to the greater variability. Furthermore, greater 
variability of MEPs might also stem from interference signals from other cortical networks. The 
variability of evoked responses can be reduced by eliciting responses during a contraction 
(Darling et al., 2006), which is shown in the present data for both MEPs and LEPs. Due to the 
inherent variability of evoked responses a large quantity of evoked responses are 
recommended to ascertain a stable index of corticospinal excitability (Brownstein et al., 
2018b). The present data suggests that when using LS to evoke LEPs, fewer responses might 
be required compared to TMS evoked MEPs. However, further work is needed to elucidate 
the optimal number of LS stimuli to obtain a reliable average response, and whether the 
inherent lower variability of LEPs relative to MEPs results in greater repeatability of responses. 
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7.5. Conclusions 
Based on the occlusion of responses when the first descending volley evoked by TMS had 
not arrived at the segmental level, it can be concluded that electrical stimulation of the first 
lumbar spinous process activates some of the same corticospinal axons projecting to lower 
limb muscles as transcranial magnetic stimulation of the motor cortex. These responses at 
rest were standardised to 10-15% Mmax and were elicited with ease in all participants. 
Furthermore, responses to LS grew similarly to TMS with increasing contraction strength, 
suggesting transsynaptic activation. All participants found stimulations to be tolerable and 
whilst muscle activity of upper body muscles was not measured, the experimenters did not 
observe shoulder and arm movements in response to stimulation during the trials. Thus, 
electrical stimulation over the first lumbar spinous process can be used as an alternative 
method to assess corticospinal excitability at the segmental level and might be better suited 
when targeting lower limb muscles due to the proximity of the motoneuronal projections to the 
stimulating site and the ability to evoke responses in leg musculature at rest. Therefore, the 
subsequent Chapter will utilise this technique to discern segmental changes in corticospinal 
excitability following whole-body exercise. 
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CHAPTER 8 – A SEX COMPARISON OF FATIGABILITY 
FOLLOWING EXERCISE NORMALISED TO THE POWER-
DURATION RELATIONSHIP   
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8.1. Introduction 
As established in Chapter 6, the intensity-duration relationship differs between males and 
females for intermittent, isometric exercise. The underpinning mechanism for this is likely 
related to a better ability to maintain oxygenation of the knee-extensors during exercise in 
females. Whilst these data provide mechanistic insight into the sex difference in fatigability 
during single-limb exercise, a phenomenon previously described (Hunter et al., 2006a; Yoon 
et al., 2007b; Russ et al., 2008; Ansdell et al., 2018b), it does not fully explain why a similar 
sex difference is demonstrated during whole-body exercise (Glace et al., 2013; Temesi et al., 
2015). To date, it remains unclear whether the power-duration relationship is different between 
sexes, and whether a sex difference in fatigability exists if exercise to exhaustion is performed 
relative to a critical intensity for whole body exercise. 
 
The underpinning mechanisms of fatigability differ for whole-body and single-limb exercise 
(Hureau et al., 2018; Thomas et al., 2018). Indeed, Poole et al. (2016) suggest that parameters 
of the intensity-duration relationship, such as W’, are likely influenced by different factors in 
the two modalities of exercise. For example, termination of exercise above critical power 
(whole-body exercise) coincides with the attainment of maximum oxygen consumption and 
cardiopulmonary responses (e.g. Vanhatalo et al., 2010; Murgatroyd et al., 2011), whereas for 
single-limb exercise, equivalent variables do not reach maximal values (e.g. Chapter 6). As 
described by Hureau et al. (2018) and Thomas et al. (2018), during whole-body exercise 
afferent feedback from other physiological systems (e.g. respiratory) contributes to the 
attainment of a ‘sensory tolerance limit’, in addition to accumulation of intramuscular 
metabolites and depletion of energy stores (Broxterman et al., 2015b). Therefore conclusions 
based on data from single-limb exercise are not appropriate to explain exercise limitation in a 
whole-body model. 
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The question of sex differences in the whole-body power duration relationship differs from that 
of single-limb exercise. As demonstrated in Chapter 6, females have more fatigue-resistant 
locomotor muscles, and additionally females demonstrate more fatigue resistant respiratory 
musculature (Guenette et al., 2010; Welch et al., 2018). These factors alone might suggest 
that females would be able to sustain a greater relative exercise intensity compared to males, 
however, morphological sex differences within the respiratory system have the potential to 
reduce high-intensity exercise tolerance. For example, even when height-matched, females 
have smaller lung volumes and airway size, weaker respiratory muscles, and smaller alveolar 
surface area for gas exchange compared to males (Mead, 1980; Crapo et al., 1982; Martin et 
al., 1987; Sheel et al., 2009). In response to exercise, these factors amalgamate into a greater 
expiratory flow limitation in females at near-maximal ventilatory capacity (Guenette et al., 
2007). Furthermore, females demonstrate a greater work of breathing (Wb) than males (Witt 
et al., 2007), and at peak exercise, the oxygen cost of breathing (expressed at a fraction of 
whole-body V̇O2), is greater in females compared to males (14 vs. 9%, Dominelli et al., 2015). 
These potentially deleterious factors could counter the greater fatigue-resistance of locomotor 
and respiratory muscle, and negate the sex difference observed in Chapter 6, when a similar 
research design is implemented in whole-body exercise. 
 
Accordingly, the present Chapter had two primary aims: 1) to compare the power-duration 
relationship between males and females; 2) determine whether a sex difference in fatigability 
exists when exercise intensity is normalised to the power-duration relationship. It was 
hypothesised that: 1) no sex difference in the power-duration relationship would exist when 
expressed relative to maximum exercise performance, and 2) females would exhibit greater 
fatigue resistance of the knee-extensors compared to males in both heavy and severe intensity 
domains. 
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8.2. Methods 
8.2.1 Participants 
Using the effect size from Ansdell et al. (2018) for the sex difference in fatigability, a power 
calculation (alpha = 0.05, power = 0.80) determined that a sample size of 20 participants was 
required. Ten males (mean ± SD age: 25 ± 5 years, stature: 178 ± 9 cm, mass: 67.0 ± 8.8 kg) 
and eight females (age: 25 ± 6, stature: 169 ± 9 cm, mass: 63.3 ± 7.2 kg) gave written informed 
consent to participate. The females that volunteered were all using monophasic hormonal 
contraceptives (>6 months), and those using contraceptive pills were tested in the 21-day 
consumption period of the pill cycle in order to negate the effects of endogenous hormones 
on neuromuscular function and fatigability (see Chapter 4). To ensure homogeneity in the 
training status of participants, minimum criteria were set for relative V̇O2max and maximal ramp 
test power (Pmax) attained in the first visit (see section 8.2.3.1). These values were based upon 
recommendations by De Pauw et al. (2013) for males, and Decroix et al. (2016) for females 
and were as follows: minimum V̇O2max of 55 and 48 mL·kg−1·min−1, and Pmax of 4.6 and 3.8 
W·kg−1 for males and females, respectively. Participants had to achieve one of the 
aforementioned criteria in order to proceed to the subsequent experimental visits. In total, 18 
males and 16 females were screened to achieve the resultant sample size. 
 
8.2.2. Experimental Design 
All participants visited the laboratory six or seven times, completing a familiarisation visit, three 
or four constant intensity trials to estimate critical intensity, then trials 10% above and below 
critical power (see Section 8.2.3.1 for more detail). Testing took place over a three to five week 
period, with a minimum of 48 h between visits to permit recovery (Carroll et al., 2016). The 
time of day for each testing session was replicated (± 1 h) to account for diurnal variations in 
maximal force generating capacity and corticospinal excitability (Tamm et al., 2009). For all 
visits, environmental conditions remained constant (20°C, 40% relative humidity). 
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8.2.3. Experimental Protocol 
8.2.3.1. Familiarisation and Incremental Exercise Test 
Upon giving informed consent, participants performed a 5-minute warm up (80-100 W) on a 
cycle ergometer (Velotron Pro, RacerMate Inc, Seattle, Washington, USA) at a self-selected 
cadence (60-100 rpm). Participants were then provided 2 minutes of rest, during which they 
remained stationary on the cycle ergometer, before an incremental exercise test was initiated. 
For both sexes, the test began at 100 W, then for males the intensity increased gradually by 
25 W·min−1 (0.416͘ W·sec−1), and for females by 20 W·min−1 (0.333 W·sec−1). The different rate 
of intensity increase was intended to produce ramp tests of similar duration in both sexes, due 
to lower absolute power outputs demonstrated in females (Sundberg et al., 2016), in an 
attempt to negate the effects of test duration on cardiopulmonary outcomes (Yoon et al., 
2007a). Mean ramp test duration was not different between males and females (males: 10.5 
± 1.2 vs. females: 9.1 ± 2.1 mins, p = 0.103). The test was terminated once the participant’s 
self-selected cadence decreased by 10 rpm despite strong verbal encouragement. During the 
test, expired gas was analysed breath-by-breath using an online system (Vyntus CPX, Jaeger, 
CareFusion, Germany). The outcome variables from the ramp test were V̇O2max and maximal 
ramp test power (Pmax). 
 
Following the incremental exercise test, participants rested for 15 minutes, before a 
neuromuscular familiarisation was performed. For this, participants were sat in the isometric 
dynamometer with hip and knee angles at 90˚. This set up was replicated for all visits. 
Electrical nerve stimulation threshold was determined, followed by TMS hotspot, aMT, and 
VATMS stimulator intensity determination (as described in Chapter 3). Following this, a baseline 
neuromuscular function assessment was performed. 
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8.2.3.2. Critical Power Estimation Trials 
To estimate critical power, participants completed a minimum of three constant-load exercise 
trials to task failure. The intensities for the initial three trials were set at 110, 90, and 80% of 
Pmax and were performed in a randomised order, designed to elicit task failure within 2-15 
minutes (Poole et al., 1988). Time to task failure, recorded in seconds, was taken as the first 
time at which participants’ cadence fell by 10rpm. No feedback was provided to participants 
regarding power output and time elapsed during the trials. A criterion of an end-exercise V̇O2 
of >95% V̇O2max was set, and all trials used for estimation achieved this. 
 
The parameters of the power-duration relationship (CP and W’) were estimated using the 
inverse linear model (equation 9.1), the linear work-time model (equation. 9.2), and the 
hyperbolic model (equation 9.3). The equation with the highest r2 and lowest SE was selected 
for each individual and used for all further analysis (Mitchell et al., 2018a):  
 
9.1.   𝑃 = 𝑊′ ∙ (
1
t
) + 𝐶𝑃 
9.2.   𝑊 = 𝐶𝑃 ∙ 𝑡 + 𝑊′ 
9.3.    𝑡 = 𝑊′/(𝑃 − 𝐶𝑃) 
 
Where t is time to task failure, P is power output, and W is total work done. If three estimation 
trials did result in a large SE for CP (>%5 of the mean) and W’ (>10%), a fourth trial was 
performed (Mitchell et al., 2018a). This occurred for three out of the 18 participants (two males, 
one female). 
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8.2.3.3. Severe and Heavy Intensity Trials 
Once CP and W’ were estimated, severe (110% CP) and heavy (90% CP) intensity trials were 
performed in a randomised order. These visits began with electrical nerve stimulation and 
TMS thresholds being determined. Participants then completed a standardised isometric 
warm up (Gruet et al., 2014), before a baseline assessment of neuromuscular function. 
Following this, the NIRS optodes were attached to the VL and baseline measures were 
recorded for five minutes on the cycle ergometer with the right leg relaxed in the fully extended 
position (crank angle 180° from top dead centre). Resting measures of gas exchange were 
also recorded in this period, then both NIRS and gas exchange were continuously sampled 
until task failure. Participants completed a five-minute warm up (80-100 W), followed by one 
minute of seated rest on the ergometer. In the 5-10 s prior to the trial, participants were 
instructed to obtain their self-selected cadence against no resistance, then when achieved, 
the resistance was applied in a square wave fashion. Time to task failure was recorded for the 
severe intensity trial, whereas for the heavy intensity trial participants cycled to task failure, or 
for 60 minutes, whichever occurred sooner. Immediately upon task failure (<20 s) participants 
transitioned from the ergometer to the dynamometer and commenced a neuromuscular 
assessment which was completed within 2.5 min post-exercise.  
 
8.2.4. Pulmonary Gas Exchange 
Breath-by-breath pulmonary gas exchange and ventilation were measured continuously 
during all exercise tests. Prior to each visit, the Vyntus CPX was calibrated for oxygen (O2) 
and carbon dioxide (CO2) with gas of known concentration (16% O2 and 4.97% CO2) using an 
electrochemical fuel cell and non-dispersive infrared cell, respectively. Ventilatory volumes 
were calibrated using a digital turbine transducer at high (2 L·s−1) and low (0.2 L·s−1) flow rates. 
The associated measurement errors provided by the manufacturer are as follows: O2 = 0.2%, 
CO2 = 1%, volume = 2%, and flow = 3%.  
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8.2.5. Transcranial Magnetic Stimulation 
Mean aMT was not different between males and females (43 ± 6 vs. 40 ± 5%, P = 0.392), or 
between visits (42 ± 5 vs. 43 ± 7%, P = 0.245). Similarly, for VATMS, mean stimulator intensity 
was not different between males and females (65 ± 6 vs. 64 ± 5% MSO, p = 0.791) or between 
visits (66 ± 6 vs. 64 ± 6% MSO, p = 0.100). The intensities used activated a large proportion 
of the motoneuron pool for the RF that was not different between trials at baseline (51 ± 15 
vs. 53 ± 11% MMAX, p = 0.314). The TMS pulse also avoided substantial activation of the 
antagonist (BF) with small incidental MEPs recorded at baseline (0.44 ± 0.23 vs. 0.47 ± 0.23 
mV, p = 0.476). 
 
8.2.6. Lumbar Electrical Stimulation 
Lumbar stimulation was performed as described in Chapter 7, with the pre-exercise LEP 
standardised to 15-25% of MMAX. Lumbar stimulation was performed during a 10% MVC 
contraction alone (unconditioned), and 100 ms into a 200 ms SP (conditioned). The mean 
stimulus intensity for unconditioned LEPs was 172 ± 47 mA for males and 166 ± 24 mA for 
females, (p = 0.732). For conditioned LEPs (SP-LEPs), the TMS intensity to produce a SP of 
200 ms was not different between males and females (49 ± 8 vs. 51 ± 6% MSO, p = 0.605), 
likewise the intensity of subsequent lumbar stimulation was not different between males and 
females (176 ± 46 vs. 172 ± 22 mA, p = 0.747). 
 
8.2.7. Motor Nerve Stimulation 
Mean stimulus intensity was not different between sexes (189 ± 62 vs. 210 ± 57 mA, p = 0.438) 
or between visits (194 ± 61 vs. 202 ± 61 mA, p = 0.620). 
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8.2.8. Near Infrared Spectroscopy 
Data was collected according to the procedures outlined in section 3.5.1. 
 
8.2.9. Data Analysis 
In order to achieve significant linearity (r2 > 0.80, p < 0.05), a total of three out of 720 SITs 
across all trials were excluded (0.4%), which led to three regressions containing 9 data points 
rather than 10 (all post-exercise). As a result, mean r2 values for ERTs were linear throughout 
the study (0.92 ± 0.07). 
 
The NIRS (O2Hb, HHb, and TOI) and gas exchange (V̇O2, V̇CO2, V̇E, and RER) data were 
expressed as a percentage of baseline, and the 30 s epochs throughout exercise are 
presented as ∆%. Gas exchange data was also expressed as a % of final ramp test values, to 
facilitate comparisons between sexes. 
 
Data are presented as mean ± SD within the text and figures. Normal Gaussian distribution of 
data was confirmed using the Kolmogorov–Smirnov test. If a violation was detected, the data 
was logarithmically transformed. The alpha for all statistical tests was set at P < 0.05. For 
variables assessed prior to and during exercise (NIRS and gas exchange) a two-way (2×5) 
repeated measures ANOVA was used to assess differences between sex (male vs. female) 
and over time (Pre, 25, 50, 75, and 100% TTF). For variables assessed only during exercise 
(rmsEMG) a two-way (2×5) repeated measures ANOVA was used to assess differences 
between sex (male vs. female) and over time (Start, 25, 50, 75, and 100% TTF). For variables 
that were assessed pre and post-exercise (neuromuscular function) a two-way 2×2 repeated 
measures ANOVA was used to assess differences between sex (male vs. female) and over 
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time (Pre vs. Post). If significant main or interaction effects were observed, these were 
followed up by post-hoc Bonferroni-corrected pairwise comparisons. 
 
8.3. Results 
8.3.1 Incremental Ramp Test 
The variables recorded during the ramp test are displayed in Table 8.1. As shown, males 
recorded greater values for V̇O2max, and Pmax when expressed in absolute units and also 
when normalised to body mass (all p < 0.001). 
 
Table 8-1: Comparison of the results from the incremental exercise test, and power-duration relationship modelling 
in males and females. 
 Males Females P value 
Incremental Test 
V̇O2max (L·min−1) 4.02 ± 0.47 2.85 ± 0.51 < 0.001 
V̇O2max (mL·kg−1·min−1) 60.5 ± 8.2 45.1 ± 6.3 < 0.001 
Pmax (W) 362 ± 29 241 ± 42 < 0.001 
Pmax (W·kg−1) 5.5 ± 0.6 3.8 ± 0.5 < 0.001 
Power-Duration Relationship 
CP (W) 260 ± 28 179 ± 32 < 0.001 
CP (% Pmax) 72 ± 5 74 ± 2 0.210 
W’ (J) 18,515 ± 4,831 12,684 ± 3,155 0.009 
W’ (J·Pmax−1) 51 ± 11 52 ± 10 0.733 
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8.3.2. Power-Duration Relationship 
The parameter estimates for the power-duration relationship are presented in Table 9.1. The 
range of times to task failure for the shortest estimation trial was 105-185 s, while the range 
for the longest trial was 568-1192 s. Once more, when data were expressed in absolute units, 
males demonstrated greater values than females (p ≤ 0.009), however, when CP and W’ were 
normalised to Pmax, no difference was observed (p ≥ 0.210). 
 
8.3.4 Severe Intensity Exercise 
8.3.4.1. Fatigability 
There was no difference in time to task failure between sexes during the trial at 110% CP 
(males: 752 ± 329 s, females: 681 ± 277 s, p = 0.645).  
 
Figure 8-1: Pre-post exercise changes in neuromuscular function following exercise at 110% CP. Panel A: MVC, 
Panel B: Qtw.pot, Panel C: VAMNS, Panel D: VATMS. * = a greater decrease in males (P < 0.05).Male data is presented 
in blue, and female data in red. Dashed lines indicate individual participants, and the solid lines indicate the group 
mean. 
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The change in neuromuscular variables is displayed in Figure 8-1. As demonstrated, MVC, 
Qtw.pot, VAMNS, and VATMS decreased pre-post the exercise trial at 110% CP (p ≤ 0.002), and 
this decrease was less in females compared to males for Qtw.pot (−36 ± 17 vs. −15 ± 10%, F1,16 
= 8.4, p = 0.010, ηp² = 0.344). The amplitude of MEPs, LEPs, and SP-LEPs did not change 
from pre-post exercise (p ≥ 0.094, Table 8.2). Maximum inspiratory and expiratory pressures 
decreased from pre-post exercise (p ≤ 0.005), with no sex difference in the magnitude of 
decrease (p ≥ 0.565, Table 8.2). 
 
Figure 8-2: The change in indices of neural excitability following exercise at 110% CP. Panel A: MEP, Panel B: 
LEP, Panel C: SP-LEP, Panel D: SICI 
 
8.3.4.2. Oxygenation 
Both O2Hb and TOI decreased throughout exercise (Figure 8-2, time effects P < 0.001), whilst 
HHb increased (P < 0.001). A lesser decrease in O2Hb (F1.2, 20.6 = 8.8, P = 0.005, ηp² = 0.355) 
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and TOI (F1.3, 21.1 = 36.2, P < 0.001, ηp² = 0.656) was observed for females, as well as a 
reduced increase in HHb (F1.7, 26.5 = 10.1, P = 0.001, ηp² = 0.387). 
4
 
Figure 8-3: Changes in indices of muscle oxygenation throughout exercise at 110% CP. Panel A: O2Hb, Panel B: 
HHb, Panel C: TOI. * = greater in males than females (P < 0.05). 
 
8.3.4.3. Respiratory and Locomotor Muscle Electromyography 
The rmsEMG signal from the VL, sternocleidomastoid (SCM), and external intercostal (IC) all 
increased throughout the task (Figure 8-3, all time effects P < 0.001). Females demonstrated 
a lesser increase in rmsEMG for the VL (F4,64 = 2.7, P = 0.041, ηp² = 0.142), but not the SCM 
(P = 0.079), or IC (P = 0.255). 
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8.3.4.4. Pulmonary Gas Exchange 
Oxygen consumption, V̇CO2, and V̇E, all demonstrated increases while RER decreased 
throughout the task (Table 8-2, P < 0.001). The sex effect for VE was not significant (P = 
0.052), and no other sex differences were observed (P ≥ 0.114). End-exercise V̇O2 was not 
significantly different from the V̇O2max measured during the incremental test (P = 0.442). 
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Table 8-2: Changes throughout exercise above critical power for pulmonary gas exchange, EMG, and pulmonary function variables. * = significantly different from pre-exercise 
(P < 0.05). $ = significantly different from females. 
    Severe Intensity 
  
Heavy Intensity 
      
Time to Task Failure/Termination Males 752 ± 329  3073 ± 835  
(s) Females 681 ± 277  2937 ± 964  
             
  Pulmonary Gas Exchange 
  Pre-Exercise 25% TTF 50% TTF 75% TTF 100% TTF  Pre-Exercise 25% TTF 50% TTF 75% TTF 100% TTF 
V̇O2 Males 19 ± 4 87 ± 6* 93 ± 5* 95 ± 7* 98 ± 4*  17 ± 3 76 ± 6* 78 ± 6* 78 ± 5* 81 ± 5* 
(%V̇O2max) Females 18 ± 3 82 ± 6* 87 ± 5* 93 ± 6* 98 ± 4*  18 ± 3 76 ± 7* 79 ± 7* 81 ± 7* 84 ± 6* 
             
V̇CO2 Males 15 ± 2 76 ± 12* 78 ± 12* 79 ± 12* 81 ± 12*  15 ± 2* 64 ± 9* 63 ± 9* 64 ± 9* 65 ± 9* 
(%V̇O2max ) Females 16 ± 2 77 ± 6* 82 ± 6* 84 ± 7* 86 ± 6*  16 ± 4* 63 ± 8* 63 ± 6* 66 ± 6* 68 ± 6* 
             
V̇E Males 15 ± 3 76 ± 12* 78 ± 12* 79 ± 12* 81 ± 12*  14 ± 3 52 ± 8* 56 ± 8* 59 ± 7* 64 ± 10* 
(%V̇O2max) Females 16 ± 2 77 ± 6* 82 ± 6* 84 ± 7* 86 ± 6*  20 ± 2 66 ± 5* 68 ± 8* 72 ± 7* 77 ± 7* 
             
RER Males 0.92 ± 0.04 1.01 ± 0.11 0.98 ± 0.09 0.95 ± 0.06 0.95 ± 0.07  1.00 ± 0.10 0.96 ± 0.05
$ 0.94 ± 0.07 0.95 ± 0.07 0.93 ± 0.05$ 
(V̇CO2 / V̇O2 Females 0.95 ± 0.06 1.02 ± 0.06 1.00 ± 0.05 0.97 ± 0.06 0.94 ± 0.05  0.97 ± 0.14 0.90 ± 0.05 0.88 ± 0.06 0.89 ± 0.05 0.88 ± 0.05 
             
  Muscle Activation 
  Start-Exercise 25% TTF 50% TTF 75% TTF 100% TTF  Start-Exercise 25% TTF 50% TTF 75% TTF 100% TTF 
Vastus Lateralis Males  3.3 ± 1.6 4.2 ± 2.0* 4.5 ± 2.2* 5.2 ± 2.0* 5.7 ± 1.9*  4.3 ± 3.8 4.7 ± 3.8 4.6 ± 3.3 5.3 ± 4.2* 5.1 ± 3.7* 
(rmsEMG·Mmax−1) Females 3.7 ± 1.4 4.5 ± 1.6* 5.0 ± 1.6* 5.0 ± 1.7* 5.2 ± 1.9*  2.9 ± 1.1 3.2 ± 1.2 3.4 ± 1.2 3.4 ± 1.5 3.4 ± 1.4 
             
Sternocleidomastoid Males 11.6 ± 8.8 18.4 ± 9.4 26.2 ± 14.1 33.3 ± 16.0 44.5 ± 22.2  10.6 ± 8.0 11.6 ± 8.2 11.9 ± 8.8 15.1 ± 13.6 15.1 ± 11.1 
(% rmsMIP) Females 16.9 ± 10.5 23.4 ± 12.3 24.9 ± 10.0 28.4 ± 11.7 36.2 ± 11.7  12.9 ± 5.0 19.9 ± 12.8 19.9 ± 12.3 17.9 ± 9.4 19.5 ± 10.8 
             
External Intercostal Males 19.5 ± 9.9 27.9 ± 13.4 34.4 ± 16.3 37.1 ± 17.9 49.6 ± 26.1  10.3 ± 6.5 12.6 ± 13.5 13.5 ± 6.5 13.6 ± 7.8 15.2 ± 7.1 
(% rmsMEP) Females 38.5 ± 18.4 55.5 ± 38.9 54.9 ± 38.9 62.15 ± 38.6 61.0 ± 34.7  24.9 ± 8.3 31.0 ± 11.7 30.2 ± 12.5 29.5 ± 14.2 33.9 ± 17.6 
             
  Maximal Pulmonary Pressures 
  Pre-Exercise  Post-Exercise  Pre-Exercise  Post-Exercise 
Maximum Expiratory Pressure Males 197 ± 52  171 ± 48*  174 ± 39  157 ± 31 
(mmHg) Females 143 ± 37  129 ± 38*  138 ± 34  136 ± 40 
             
Maximum Inspiratory Pressure Males 130 ± 37  118 ± 33*  140 ± 53  135 ± 50* 
(mmHg) Females 113 ± 29   104 ± 25*   138 ± 34   136 ± 40 
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8.3.5. Heavy Intensity  
8.3.5.1. Fatigability 
Three males and three females reached task failure prior to the 60 min cut-off (mean duration: 
3073 ± 835 vs. 2937 ± 964 s, p = 0.758).  
 
Figure 8-4: Neuromuscular changes from pre-post exercise at 90% CP. Panel A: MVC, Panel B: Qtw.pot, Panel C: 
VAMNS, Panel D: VATMS. * = a greater decrease in males (P < 0.05). 
 
From pre-post exercise, decreases in MVC, Qtw.pot, VAMNS, VATMS, MEP, and SP-LEP were 
observed (p ≤ 0.039, Figure 8-4). Females demonstrated less of a decrease in Qtw.pot (−24 ± 
11 vs. −10 ± 11%, F1,16 = 31.8, p = 0.020, ηp² = 0.655) and VAMNS (−9 ± 6 vs. −4 ± 3%, F1,16 = 
5.2, p = 0.036, ηp² = 0.246), but no sex difference was demonstrated for VATMS, MEP, and SP-
LEP (p ≥ 0.051) Maximum inspiratory pressure decreased from pre-post exercise (p = 0.001), 
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whereas maximum expiratory pressure did not (p = 0.063; see Table 8-2). No sex difference 
in the magnitude of decrease for the former was observed (p = 1.000). 
 
Figure 8-5: The change in indices of neural excitability from pre-post exercise at 90% CP. Panel A: MEP, Panel B: 
LEP, Panel C: SP-LEP, Panel D: SICI 
 
8.3.5.2. Oxygenation 
Decreases in O2Hb (p < 0.001) and TOI (p < 0.001) were observed during exercise, with 
females demonstrating less  of a decrease for both (O2HB: F1.8,30.0 = 7.4, p = 0.003, ηp² = 
0.315; TOI: F1.7,26.9 = 29.7, p < 0.001, ηp² = 0.650). An increase in HHb was observed for both 
sexes (p < 0.001), with females demonstrating less of an increase (Figure 8-6, F1.4,22.8 = 33.7, 
p < 0.001, ηp² = 0.678). 
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Figure 8-6: Changes in muscle oxygenation throughout exercise at 90% CP. Panel A: O2Hb, Panel B: HHb, Panel 
C: TOI. * = greater in males than females (P < 0.05) 
 
8.3.5.3. Respiratory and Locomotor Muscle Electromyography 
The rmsEMG signal from the VL, SCM, and IC all increased throughout the task (Table 8-2, 
all time effects p ≤ 0.033). However, there were no sex differences in the rate of increase for 
any muscle (p ≥ 0.063). 
 
8.3.5.4. Pulmonary Gas Exchange 
Oxygen consumption, V̇CO2, and V̇E all increased throughout the task (p < 0.001) while RER 
decreased (p = 0.001). A sex effect was not observed for V̇E (p = 0.052), but was for RER 
(F1,16 = 5.08, p = 0.039, ηp² = 0.241; see Table 8-2). Post-hoc tests indicated that females had 
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a lower RER (−0.05) throughout the trial and end-exercise V̇O2 was 19% lower than V̇O2max (p 
< 0.001). 
 
8.4. Discussion 
The present study aimed to investigate the sex difference in fatigability during locomotor 
exercise by comparing the power-duration relationship, then assessing oxygenation and 
neuromuscular responses to metabolically-matched exercise intensities. In absolute terms, 
males demonstrated a greater critical power and W’, however, when these parameters were 
normalised to Pmax no sex difference was observed. In both severe and heavy intensity 
domains, females demonstrated smaller reductions in knee-extensor muscle function post-
exercise. These sex differences are likely related to the fact that females demonstrated greater 
VL oxygenation during exercise in both intensity domains. The change in corticospinal 
excitability appeared to be domain- but not sex-specific, with a decrease in MEP and SP-LEP 
amplitude observed below CP only. Together, these data present an integrative profile of the 
sex difference in fatigability and suggest that the mechanism(s) for greater neuromuscular 
fatigue-resistance in females reside within the musculature. 
 
8.4.1. Incremental Test & Power-Duration Relationship 
As expected, males were capable of producing greater absolute power outputs for variables 
such as Pmax and CP. Similar to Sundberg et al. (2016), who demonstrated that female Pmax 
was 68% of male equivalents, the present study observed that female Pmax was 66% of male 
values. This sex difference was still evident when Pmax was normalised to body mass (W·kg−1), 
which is likely a result of differences in body composition (Pate & O’Neill, 2007). A similar sex 
difference was observed for V̇O2max, with males having greater absolute and relative values 
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(Pate & O’Neill, 2007). However, as discussed by Joyner (2017), allometric scaling of V̇O2max 
to fat-free mass eliminates this sex difference. 
 
As cycling power output is associated with body mass, the normalisation of CP with Pmax 
presents a method of making inter-individual comparisons of the power-duration relationship. 
Indeed, when relative CP (% Pmax) was compared, no sex difference was demonstrated. The 
present study is the first to directly compare males and females in this way, and conflicts data 
obtained in an isometric exercise setting where females had a ~7% greater critical intensity 
compared to males (Chapter 6). This discrepancy is likely explained by the modality of 
exercise; single-limb intermittent isometric exercise is not limited by blood flow to the 
exercising limb (Duner 1959), whereas leg blood flow during two-leg exercise is associated 
with a plateau at high intensities (Calbet, 2000). Critical power is considered to be limited by 
oxygen delivery to the working muscle (Vanhatalo et al., 2010; Dekerle et al., 2012; 
Broxterman et al., 2015a), therefore, during single-limb exercise, where blood flow is not a 
limiting factor (i.e. Chapter 6), the sex difference in critical intensity could be a result of greater 
diffusive capacity of the muscle. For example, it is well established that females have greater 
capilliarisation and type I fibre proportional area of the knee-extensors (Roepstorff et al., 
2006), which could permit a greater rate of oxygen extraction, and a greater relative critical 
intensity. Whereas in the present study, knee-extensor blood flow is limited due to the modality 
of exercise, therefore, this becomes the primary determinant of CP, rather than diffusive 
capacity of the muscle, leading to the lack of sex difference. Other contributing factors to the 
lack of sex difference in CP could be that haemoglobin concentrations are typically ~12% 
lower (Murphy, 2014), and lung volumes are smaller (Schwartz et al., 1988) in females. The 
negative consequence of these factors is that females are more prone to exercise-induced 
arterial hypoxemia (Harms et al., 1998), meaning that when cardiac output is at its maximum 
(i.e. the severe intensity domain), there is no possibility for increased oxygen extraction. This 
leads to a reduced arterio-venous oxygen difference, which has recently been suggested to 
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negate the sex difference in muscle fatigability (Dominelli et al., 2017) and could conceivably 
oppose the positive aspects of greater type I muscle fibre proportion on CP (Mitchell et al., 
2018a), leading to a lack of sex difference. 
 
8.4.2. Severe Intensity Exercise 
The power-duration relationship successfully predicted time to task failure in the exercise trial 
at 110% CP (Table 8-2), and the V̇O2 response to exercise confirmed that exercise was indeed 
in the severe intensity domain. The end-exercise V̇O2 was >95% V̇O2max and demonstrated a 
gradual increase throughout exercise, indicating the presence of a considerable slow 
component, that drove oxygen consumption to V̇O2max at task failure. Fatigability within the 
severe intensity domain is typically associated with depletion of high-energy phosphates and 
an accumulation of deleterious metabolites within the exercising musculature (Jones et al., 
2008; Black et al., 2016; Vanhatalo et al., 2016), which consequently reduce the contractile 
capacity of exercised musculature until the attainment of a limiting degree of disruption 
(Amann, 2011; Burnley & Jones, 2018). In the present study this can be demonstrated by the 
large decrease in Qtw.pot post-exercise (Figure 8-2B), of which the male data (−36%) is 
comparable to previous studies assessing contractile impairment following severe intensity 
cycling (~30-40%, Amann & Dempsey, 2008; Amann et al., 2011; Thomas et al., 2016). 
Although central fatigue occurred during this trial, excitability of the corticospinal tract was 
unaltered at the cortical and spinal levels, suggesting that responsiveness descending 
neurons did not change post-exercise (Weavil & Amann, 2018). This central fatigue might 
have been a result of impaired neural drive, or synaptic input into the corticospinal tract 
(Amann, 2011). Regardless, central fatigue is not considered to be the limiting factor to 
exercise within the severe intensity domain (Burnley & Jones, 2018). One caveat of this 
Chapter, and other locomotor neuromuscular fatigue studies is that responses were assessed 
pre-post exercise in an isometric setting. Responses evoked during exercise could elucidate 
further details about the time-course and magnitude of change. 
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In contrast to our hypothesis, when exercise intensity was metabolically-matched, females 
demonstrated greater fatigue-resistance of the knee-extensors compared to males (−15% 
Qtw.pot decline). There are multiple factors that could explain this occurrence from the present 
study and previous data. For example, as previously mentioned, females typically have a 
greater proportional area of type I muscle fibres (Staron et al., 2000; Roepstorff et al., 2006), 
and whilst in the context of this study it might not contribute to differences in the power-duration 
relationship, it could provide females with the capacity to tolerate deleterious metabolites when 
exercising above CP. Indeed, previous studies using 31P-MRS have shown lower decreases 
in muscle pH, PCr, and attenuated increases in ADP (Russ et al., 2005; Willcocks et al., 2010) 
at high exercise intensities. Furthermore, slower calcium handling kinetics in females (Harmer 
et al., 2014) could produce more fatigue-resistant contractile apparatus. Additionally, females 
demonstrate a lesser increase in rmsEMG during the severe intensity task, and whilst a limited 
measure of neural activity (Farina et al., 2014), could represent less of a compensatory 
increase in motor unit recruitment as a result of less peripheral fatigue within the already-
recruited motor units. Indeed, this finding mirrors that shown in Chapter 6, and exists when 
rmsEMG is normalised to Mmax to negate the influence of subcutaneous fat on 
electromyographic signal.  
 
Another potential contributing factor to the sex difference in fatigability could be the greater 
oxygenation within the VL for females during exercise (Figure 8-3). In both Chapter 6 and the 
present study, this manifested predominantly as a lesser rise in HHb concentration for females 
during exercise, which could be a result of the fibre type difference between males and 
females. Specifically, the greater HHb increase in males could be a result of greater oxygen 
extraction (Grassi et al., 2003), which could be related to a greater oxygen cost within the 
muscle (mV̇O2) compared to females. Indeed, when assessed at a pulmonary level, 
individuals with greater type I fibre proportion of the VL demonstrate a lower V̇O2 for a given 
exercise intensity (Coyle et al., 1992). This is speculative, although potentially fertile ground 
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for future research as mV̇O2 can be non-invasively quantified with a combination of NIRS and 
muscle occlusion (Ryan et al., 2012). One might expect pulmonary V̇O2 to reflect a potential 
sex difference in mV̇O2, however, females experienced a similar V̇E to males during severe 
intensity cycling, which is linked with a greater oxygen cost of breathing in females (Witt et al., 
2007). When measured at the pulmonary level, the V̇O2 response to exercise is an 
amalgamation of all physiological systems, therefore the elevated Wb might have 
counterbalanced reduced mV̇O2. 
 
Together, the aforementioned data present compelling evidence that whilst exercise 
performance (time to task failure) in the severe intensity domain is not affected by sex, the 
integrative response differs between males and females. Females experience less peripheral 
fatigue, potentially as a result of intramuscular differences in muscle oxygenation and 
contractile differences, however, likely have a greater Wb at a metabolically-matched exercise 
intensity. Therefore implying that the mechanisms of task failure might differ between the two 
sexes. 
 
8.4.3. Heavy Intensity Domain 
The V̇O2 response to exercise at 90% CP was typical of heavy intensity exercise. The V̇O2 
response exhibited a slow component, however only reached ~83% V̇O2max at task 
termination, indicating that energy provision from aerobic sources was not maximal (i.e. 
exercise intensity was less than critical power). 
 
In terms of the pre-post exercise change in neuromuscular function, the fatigue observed was 
not due to an accumulation of disruptive metabolites, or an exhaustion of high-energy 
phosphates as substrate-level phosphorylation reaches a steady-state (Black et al., 2016; 
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Vanhatalo et al., 2016). Rather, neuromuscular fatigue in the heavy intensity domain is a result 
of both central and peripheral contributions, with the latter occurring in response to depletion 
of intramuscular glycogen concentration and the negative consequences for excitation-
contraction coupling (Ørtenblad et al., 2013). Furthermore, reactive oxygen species 
generation, and extracellular accumulation of K+ might also impair contractile function (Allen 
et al., 2008a). The net result in the present study is a decrease in Qtw.pot (Figure 8-4), that was 
less profound in females. Given that the mechanisms of peripheral fatigue differ above and 
below CP, this fatigue-resistance of female knee-extensors below CP must be a result of 
different physiological processes as well. One explanation could be that, given RER was lower 
in females during the 90% CP trial, the rate of fatty acid utilisation was greater, eliciting a 
glycogen-sparing effect. This notion is supported by previous evidence demonstrating that 
males utilise ~25% more muscle glycogen at exercise intensities matched below CP 
(Tarnopolsky et al., 1990; Roepstorff et al., 2002, 2006). Similarly to 110% CP, the decrease 
in muscle oxygenation was less in females at 90% CP, again, potentially reflecting a lower 
oxygen cost of contraction as a result of greater type I muscle fibre proportion.  
 
The central fatigue occurring below CP is thought not to be a result of group III/IV afferent 
feedback, as there is no progressive metabolite accumulation beneath CP. Instead, repetitive 
activation of descending fibres can alter their intrinsic properties, rendering them less 
responsive to activation (Carpentier et al., 2001). This phenomenon is reflected in the present 
study as a decrease in VAMNS and VATMS, with a greater decline in VAMNS only for males. This 
discrepancy might indirectly suggest that the aetiology of the sex difference in central fatigue 
would be located at a sub-cortical level. Indeed, a decrease in MEP and SP-LEP was observed 
(Figure 8-5), and is likely a result of reduced strength of persistent inward currents (Heckman 
et al., 2008). However, the sex × time interaction for these evoked variables was not different 
(p≥ 0.132). Multiple studies have provided evidence to show reduced motoneuronal excitability 
with fatigue in single-limb (Kennedy et al., 2016; Finn et al., 2018) and whole-body exercise 
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modalities (Weavil et al., 2016; Sidhu et al., 2017), however the present study is the first to 
match exercise intensity to critical power and assess the neural response. Interestingly, the 
decrease in LEP was only evident during the SP, with no change in unconditioned LEP (Figure 
8-5). Finn et al. (2018) demonstrated a similar phenomenon in an isometric modality and 
suggested that SP-LEPs were more sensitive to intrinsic changes in motoneuronal properties, 
as inhibiting descending drive from the motor cortex removes a confound of excitatory synaptic 
input to the motoneuron. The unconditioned LEPs do not change, as neural drive is capable 
of increasing (seen in Table 8-2 of the present study) and maintaining net motoneuronal 
output. Therefore, as only SP-LEPs changed, the central fatigue observed at 90% CP in the 
present study is likely a result of a change in intrinsic properties of motoneurons, rendering 
them less responsive to synaptic input. As mentioned, this occurred independently of sex, with 
no sex × time interaction observed for any evoked potential. It is possible that due to far smaller 
measurement error for VAMNS compared to evoked potentials (Chapters 4 and 8), a sex 
difference in motoneuronal excitability was not able to be discerned due to statistical under 
powering. 
 
Collectively, these data suggest that the neuromuscular response to cycling at 90% CP is 
underpinned by decreases in central nervous system function and contractile impairment. 
Similar to severe intensity exercise, performance was not altered, but the neuromuscular 
adjustments were different between males and females. 
 
8.4.4. Further Considerations 
Fatigability of both inspiratory and expiratory muscles was demonstrated above CP, which 
was not sex-dependent. This contrasts previous evidence suggesting that the diaphragm is a 
more fatigue-resistant muscle in females (Guenette et al., 2010; Welch et al., 2018), however, 
the assessment modality employed in the present study was less precise, and could not 
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discern individual muscle fatigability. The rise in rmsEMG for respiratory musculature was 
similar between sexes in both trials, which also contradicts previous findings suggesting 
females activate ‘accessory’ respiratory muscle such as the SCM to reduce the diaphragmatic 
load (Mitchell et al., 2018b). Whilst no sex difference in respiratory muscle fatigability or gas 
exchange were observed, the similar VE during both severe and heavy intensity cycling likely 
led to females experiencing a greater work of breathing during both trials (Dominelli et al., 
2015), which could contribute to greater exertional dyspnea (Schaeffer et al., 2014; Cory et 
al., 2015). When taken into consideration with the reduced peripheral fatigue in locomotor 
muscles, it could conceivably be suggested that the ‘sensory tolerance limit’ consists of 
different magnitudes of afferent feedback from different physiological systems in males and 
females (Hureau et al., 2018, Thomas et al., 2019). Such that the locomotor muscle 
component is lesser, but the respiratory component is greater in females.  
 
To compare fatigability in different populations, it is necessary to match both the intensity of 
exercise and the training status of the populations. The former was addressed in the present 
study by normalising exercise intensity to CP. Attempts were made to recruit populations of 
males and females of equivalent training status (De Pauw et al., 2013; Decroix et al., 2016), 
which resulted in similar average performance levels between groups. However, the sex 
difference in relative V̇O2max was ~25%. This is larger than the sex difference suggested for 
sexes of equivalent training status (~10%, Joyner 2017), although this was based off a mixture 
of studies and a small sample of n = 8 male and 15 female elite distance runners (Pate & 
O’Neill, 2007). Other sources have previously described larger magnitudes in this sex 
difference (e.g. 17%, Froberg & Pedersen, 1984), although similarly rely on small sample sizes 
(n = 6 females and n = 7 males). Indeed, a meta-analysis of 440 male and 381 female 
participants that demonstrated an average sex difference of 28% in V̇O2max when expressed 
relative to body mass; this difference remained in trained vs. untrained populations when body 
composition was accounted for (Sparling, 1980). Nevertheless, there appears to be a 
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discrepancy in what researchers deem to be an appropriate magnitude for the sex difference 
in V̇O2max. The present study used a minimum performance level (De Pauw et al., 2013; 
Decroix et al., 2016) to account for V̇O2max, relative Pmax, as well as training history 
(hours·week-1), and the sex differences demonstrated are therefore assumed to be 
independent of training status. However, as is well established, training status influences 
aerobic fitness, therefore this discrepancy in the appropriate magnitude of sex difference in 
V̇O2max highlights a potential limitation in the present study, if the differences in indices of 
aerobic fitness are considered to be of too great a magnitude. The precise measurement of, 
and normalisation of values to fat-free mass could be an area for future research in order to 
uncouple the effects of sex and muscle mass in the field of integrative exercise physiology. 
 
 
8.5. Conclusions 
This study demonstrated that the power-duration relationship for cycling did not differ between 
males and females when expressed relative to Pmax. Subsequent exercise performance in the 
severe and heavy intensity domains was not different, however the integrative response of 
cardiopulmonary, respiratory, and neuromuscular systems differed between males and 
females. Specifically, muscle oxygenation was greater and locomotor muscle fatigue was less 
in females during both tasks, additionally, the decline in CNS function was attenuated for 
females in the heavy intensity domain. Conversely, females experienced a greater ventilatory 
rate during both trials. Collectively, the present data suggests that the underpinning 
mechanisms of the sensory tolerance limit differ between males and females, which has 
important implications for acute and chronic exercise prescription. These considerations are 
discussed in Chapter 9. 
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CHAPTER 9 – GENERAL DISCUSSION 
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9.1. Experimental Recap 
The overall aim of this Thesis was to investigate the sex difference in fatigability in healthy 
young adults. The focus was placed on the knee extensor muscles, due to their particular 
importance for athletic and locomotor activities. Chapter 4 aimed to investigate how the 
changing hormonal environment across the eumenorrheic menstrual cycle affects 
neuromuscular function and fatigability. Non-invasive neurostimulation was performed before 
and after an open-ended intermittent, isometric exercise task to discern the mechanisms 
behind hormonally-induced and exercise-induced changes, and the interaction between the 
two factors. A reliability study was also conducted (Chapter 5) in a hormonally-constant group 
of females using the monophasic oral contraceptive pill; the tasks performed were identical to 
the eumenorrheic group, which permitted the degree of measurement error of the tasks and 
techniques to be discerned. Chapter 6 then studied the intensity-duration relationship during 
intermittent, isometric exercise in males and females, whilst assessing fatigability and 
recovery during and after two subsequent exercise tasks to failure normalised to the critical 
intensity. Chapter 7 developed a novel method of non-invasive electrical stimulation for the 
assessment of the spinal component of the corticospinal tract. Collision experiments with TMS 
were conducted to study the interaction between the two forms of stimulation, and the size of 
responses was monitored with increasing contraction intensity. Finally, Chapter 8 employed a 
similar design as Chapter 6, but utilised cycling as the modality of exercise. The power-
duration relationship was profiled in both sexes, and then exercise trials in the severe and 
heavy intensity domains, normalised to critical power, were performed to task failure.  
 
9.2. Summary of Main Findings 
In Chapter 4, it was shown that the menstrual cycle induces changes in neuromuscular 
function and fatigability. Specifically, pre-exercise voluntary activation was greatest in the late 
follicular phase, when oestrogen concentrations were greatest and progesterone lowest. 
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Based upon the absence of change in corticospinal excitability, but reduced intra-cortical 
inhibition at this time point, the aetiology of this change was inferred to be related to GABA-
ergic neurotransmission within the motor cortex. Thereafter, during exercise a similar profile 
of neuromuscular fatigue was demonstrated between all three phases, however, in the luteal 
phase, females were able to exercise for longer upon reaching a nadir in neuromuscular 
function, leading to a ~30% longer time to task failure. Thus, the rise in progesterone 
concentration in the luteal phase seemed to positively affect fatigability. The aforementioned 
changes in neuromuscular function and fatigability led to the conclusion that if females were 
to be compared to males, hormonal concentrations would need to be controlled. Chapter 5 
therefore assessed the repeatability of neuromuscular function and fatigability in a hormonally-
constant population of healthy, young females – monophasic combined oral contraceptive 
users. It was demonstrated that the measures and tasks were repeatable, with similar 
reliability indices to previously reported male data. Thus, consequent studies in this thesis only 
recruited females using monophasic hormonal contraceptives. 
 
Chapter 6 then demonstrated that in an intermittent, isometric exercise modality, females are 
capable of sustaining a greater relative exercise intensity (termed the critical intensity). 
Subsequently, during open-ended exercise at intensities normalised to critical intensity, 
females had a greater time to task failure than males. This was accompanied by slower 
declines in neuromuscular function, including central and peripheral components. During 
these normalised exercise trials, muscle oxygenation was monitored and demonstrated to be 
greater in females during both tasks, which likely contributed to the differences in fatigability. 
Following exercise, the rate of recovery for peripheral fatigue was greater for females, which, 
similar to the slower rate of fatigue, is likely a result of differences within the contractile 
apparatus. 
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Chapter 7 served to develop a novel assessment of corticospinal excitability at the spinal level. 
Delivering electrical stimulation to the lumbar spinal cord segments was shown to attenuate 
descending action potentials from the motor cortex, one line of evidence to suggest that it 
activated corticospinal neurons. Additionally, the lumbar evoked responses demonstrated a 
change in amplitude with contraction intensities. This method of spinal cord activation did not 
require high stimulus intensities to evoke responses at rest or during contraction, therefore 
could be considered an alternative to techniques such as CMEPs and TMEPs, which require 
much higher intensities. Thereafter, this technique was used to explore the spinal contribution 
to CNS adjustments following whole-body exercise in Chapter 8. 
 
The final experimental section (Chapter 8) used a similar experimental design to Chapter 6, 
in that the maximum sustainable exercise intensity and subsequent exercise performance was 
assessed in males and females. In this instance, the exercise modality was cycling, which 
presented different limiting factors than the isometric study. In Chapter 8, no sex difference 
was observed for critical power or subsequent exercise performance, however, the 
mechanisms owing to task-failure were different between males and females. Specifically, 
females exhibited less peripheral fatigue of the knee-extensors, as well as greater muscle 
oxygenation. It is speculated that this greater fatigue-resistance of the locomotor muscles 
counteracts known central limitations of oxygen delivery and ventilation for females, leading 
to comparable exercise performance. The explanations for the aforementioned findings are 
presented below in greater detail, and considerations for acute and chronic exercise 
prescription in males and females are discussed. 
 
9.3. The difference between single-limb and whole-body exercise 
Chapter 6 demonstrated a sex difference in the intensity-duration relationship during 
intermittent, isometric exercise, whereas Chapter 8 did not observe a sex difference in the 
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power-duration relationship during cycling. This discrepancy can more than likely be explained 
by the limiting factors of both modalities of exercise. As has been established in fatigue-related 
literature for decades, the mechanisms of fatigue are specific to the exercise task, the 
performer, and the external conditions. This thesis has manipulated the first two, in order to 
explore the interaction between exercise task and performer on fatigability.  
 
Critical power is the greatest metabolic rate that results in wholly-oxidative metabolism, and 
as a result is sensitive to oxygen-related interventions such as manipulation of inspired oxygen 
concentration (Vanhatalo et al., 2010; Dekerle et al., 2012). During whole-body exercise, two 
elements influence the use of oxygen within working musculature: 1) convective factors, such 
as ventilation, cardiac output, haemoglobin concentration, etc; and 2) diffusive factors such as 
muscle capillarity, mitochondria density, and the arteriovenous oxygen difference (Wagner, 
1988, 1996). As evidenced previously (Rossman et al., 2012, 2014) and in the present thesis 
(Chapter 6), the cardiovascular response to single-limb exercise does not reach near-maximal 
values, implying that the limitation to oxygen-dependent variables (e.g. CP) would lie within 
the diffusive capacity of exercising muscle(s). This puts females at an advantage when 
compared with male counterparts during exercise of this modality with the knee-extensors. 
Ample evidence exists to suggest that females have a greater proportional area of type I 
muscle fibres in the VL (Staron et al., 2000; Roepstorff et al., 2006), which possess a superior 
phenotype for oxidative metabolism and fatigue resistance compared to type II fibres 
(Schiaffino & Reggiani, 2011). For instance, in the internal muscle structure, type I fibres 
demonstrate a greater density and volume of mitochondria, and greater rate of oxidative 
enzyme activity (e.g. succinate dehydrogenase, Rivero et al., 1998); and with regard to the 
extracellular surroundings, type I fibres have a greater capillary-to-fibre ratio (Andersen, 
1975). These factors combine to permit metabolic differences between fibres, such as a 
greater ability to regenerate ATP via the TCA (Krebs) cycle and therefore an ability to match 
ATP consumption with regeneration in type I fibres, an occurrence that is not possible in type 
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II fibres (Schiaffino & Reggiani 2011). This matching of consumption and aerobic regeneration 
is the underlying physiological principle behind critical power; thus it is conceivable that due 
to a greater proportion of type I fibres, critical power, in tasks not limited by oxygen delivery, 
is greater in females (Chapter 6). 
 
During high intensity whole-body exercise, the cardiovascular demand is elevated as more 
active muscle mass is recruited. When multiple muscle groups are active, the required skeletal 
muscle blood flow can exceed the pumping capacity (cardiac output) of the heart (Calbet et 
al., 2004). Blood flow is distributed to different muscles and physiological systems during 
exercise by sympathetically-mediated vasoconstriction in an attempt to maintain adequate 
perfusion pressures (Sheel et al., 2018). As a result, the physiological challenges during 
whole-body exercise are multi-factorial, when compared to single-limb exercise where the 
quantity and magnitude of muscles recruited is far less. As mentioned, critical power during 
whole-body exercise is dependent on oxygen delivery, as well as the capacity for consumption 
(Monod & Scherrer, 1965; Jones et al., 2010). This is demonstrated with careful experimental 
work that shows complete blood flow occlusion reduces CP to zero (Broxterman et al., 2015a), 
whilst manipulating the degree of occlusion via changing contraction duty cycle shows a 
positive association between rest period duration (non-occlusion) and CP (Broxterman et al., 
2014). Additionally, individuals with impaired oxygen delivery (e.g. those with central 
limitations such as chronic obstructive pulmonary disorder patients) exhibit a severely reduced 
CP (Van Der Vaart et al., 2014). When this information is considered in the context of sex 
differences, it is important to consider the fact that females have smaller lung volumes 
(Schwartz et al., 1988), and lower haemoglobin concentrations (Cureton et al., 1986) 
compared to males. These factors amalgamate to a greater risk of exercise-induced arterial 
hypoxemia in females during high-intensity whole-body exercise (Harms et al., 1998), 
reducing oxygen delivery to the working muscle(s). It is therefore possible, that the beneficial 
fatigue-resistance and metabolic properties of female skeletal muscle (diffusive capacity) are 
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counteracted by an impaired ability to deliver oxygen (convective capacity), and when both 
factors are considered, CP is equal between sexes, when expressed relevant to a maximum. 
 
Despite no difference in the whole-body power-duration relationship, females demonstrated 
less muscle fatigue during exercise normalised to CP (Chapters 6 and 8). As explained, the 
contractile and metabolic properties of type I muscle fibres likely contribute to this 
phenomenon; however, what is of interest is that this greater peripheral fatigue-resistance did 
not elicit any performance enhancement in females compared to males. The sensory tolerance 
limit (Hureau et al., 2018), and critical threshold theory (Amann, 2011) would suggest that in 
the severe intensity domain, exercise performance is terminated at the point at which 
metabolic disturbance in the skeletal muscles reaches an intolerable point. Indeed, W’ is also 
considered to be an amount of work do-able before this intolerable metabolic environment is 
attained. However, as stated by Poole et al. (2016), a physiological equivalent of W’ is 
unknown, and the nature of W’ cannot be limited to a single physiological process. It is possible 
that the depletion of W’ reflects a balance of cardiopulmonary and neuromuscular ‘strain’, 
which is akin to the sensory tolerance limit in suggesting that the maximum tolerable sensation 
of fatigue is composed of afferent information from multiple physiological systems. As Poole 
et al. (2016, p2331) suggested, “W’ will depend on the mode and conditions of the exercise 
and the participants involved”. Therefore, based upon the data presented in Chapter 8, it could 
be postulated that the magnitude of the constituent parts of W’ differ between males and 
females during whole-body exercise. As visually demonstrated in Figure 9-1, the muscular 
component of W’ (or sensory tolerance limit) is reduced in females compared to males, 
however, the elevated Wb and concurrent sensations of dyspnea (Schaeffer et al., 2014; Cory 
et al., 2015; Dominelli et al., 2015) are greater in females. When combined, the quantity of W’, 
or the maximum tolerable sensation of fatigue is similar between sexes as demonstrated by 
equal performance during metabolically matched whole-body exercise (Chapter 8). The 
implications of this are subsequently discussed. 
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Figure 9-1: A conceptual model to demonstrate that whilst the maximum tolerable degree of fatigue is similar 
between males and females, the magnitudes of its constituent parts are different. Figure adapted from Thomas et 
al. (2018). 
 
9.4. Considerations for Acute and Chronic Exercise Prescription 
Whilst whole-body exercise performance did not differ between sexes in Chapter 8, this thesis 
has demonstrated that the mechanisms of task failure differ between males and females. The 
difference in the integrative response to acute exercise is of importance, particularly when 
exercise prescription is considered. Optimising the function of relevant physiological systems 
over the course of a training cycle is key to enhancing endurance exercise performance, but 
this process relies upon the delivery of consistent optimal adaptive stimuli. Evidence presented 
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in this thesis would suggest that for the same ‘dosage’ of exercise, the adaptive stimulus for 
different physiological systems is not equal for males and females.  
 
Metabolic stress, the result of non-oxidative ATP synthesis, consists of an accumulation of 
metabolites, and depletion of high-energy phosphate stores (Allen et al., 2008a). These 
metabolites and the associated intracellular hypoxia are potent stimuli for activation of AMP-
activated protein kinase (AMPK) and hypoxia-inducible factor (HIF- α) pathways, that are 
crucial stages in mitochondrial biogenesis and angiogenesis (Marcinko & Steinberg, 2014). 
Indeed, a recent training study aiming to maximise metabolic stress using exercises such as 
sprint interval training combined with blood flow restriction demonstrated greater HIF-α 
activation following an acute bout of exercise, and greater V̇O2max adaptation following a four-
week training programme in when blood flow was restricted (Taylor et al., 2016). Similarly, the 
production of ROS is thought to stimulate peroxisome proliferator-activated receptor gamma 
coactivator (PGC-1α) and p38 mitogen-activated protein kinase (p38MAPK) pathways (Ji, 
2007), responsible for expression of genes involved in mitochondrial biogenesis, troponin I, 
and myoglobin content in mice (Lin et al., 2002) and humans (Olesen et al., 2010). Essentially, 
metabolic stress elicits an adaptive response that promotes the enhancement of oxidative 
capacity when repeated over time. In the context of this thesis, the utilisation of exercise 
normalised to the intensity-duration relationship allows confidence regarding the metabolic 
response to exercise. The severe intensity is associated with what is described above as 
metabolic stress, and disruption to the metabolic environment within the muscle could be 
inferred from the post-exercise reduction in Qtw.pot. Consistently throughout Chapters 6 and 8, 
it was demonstrated that for an equivalent duration of high-intensity exercise, females 
experienced less peripheral fatigue than males, potentially indicative of less disruption to the 
muscle metabolic environment, and perhaps less of an adaptive stimulus for an equivalent 
amount of work. Indeed, evidence from 31P-MRS techniques during isometric exercise 
modalities would support this notion (Russ et al., 2005), however, equivalent data during 
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locomotor exercise is difficult to obtain, and as yet, it is unknown if this same phenomenon 
occurs. 
 
The work incorporated in this thesis could help to inform recent suggestions that females are 
‘less trainable’ than males (Howden et al., 2015; Diaz-Canestro & Montero, 2019). When 
V̇O2max increases in response to training are compared between sexes, males demonstrate 
greater absolute and relative increases. The authors speculated that a combination of genetic 
differences, lower blood volumes, and impaired cardiac adaptation in females contribute to 
this phenomenon (Diaz-Canestro & Montero, 2019). Perhaps one other explanatory factor 
could be that if females experience less metabolic stress for the same amount of high-intensity 
exercise, the aforementioned pathways leading to greater oxidative capacity might be less 
activated. When this is repeated over the course of a training programme, female V̇O2max 
adaptation could be lower in comparison to males as a result of less mitochondrial biogenesis 
and angiogenesis within the skeletal muscle. Indeed, Scalzo et al. (2014) demonstrated 
greater mitochondrial biogenesis in males compared to females after 4 weeks of interval 
training. Future research could investigate the acute responses of these adaptive pathways, 
and further interrogate the plasticity of skeletal muscle in both sexes in response to both acute 
and chronic high-intensity exercise protocols. 
 
Other considerations for acute exercise prescription stem from Chapter 6, specifically, females 
demonstrated a greater rate of recovery for peripheral fatigue post-exercise compared to 
males. Other evidence corroborates this finding, Senefeld et al. (2018) demonstrated quicker 
recovery of contractile function in the immediate (10 minute) post-exercise window, whilst 
Chapter 6 extended this finding to 45 minutes. Forms of interval exercise relying on repeated 
activity close to, or exceeding the intensity eliciting V̇O2max are based upon the notion that 
repeatedly disrupting the metabolic environment of the exercising muscle(s) will augment 
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aerobic and anaerobic adaptation (Gibala, 2009). The possibility exists that females require 
less rest between intense interval exertions for adequate metabolic recovery; if standard 
training recommendations based predominately on male research are applied to both sexes, 
females might not be receiving an optimal stimulus for adaptation.  
 
9.5. The Influence of the Menstrual Cycle on Acute and Chronic 
Exercise  
To neglect the influence of the menstrual cycle on exercise physiology would be remiss of a 
thesis concerning sex differences. Chapter 4 specifically focussed on this inherent 
chronobiological occurrence. In terms of acute exercise, Chapter 4 demonstrated an influence 
of endogenous hormone concentrations on pre-exercise neuromuscular function, and fatigue-
resistance during metabolically-challenging exercise. The literature surrounding these topics 
is equivocal, with certain physiological responses such as cardiovascular strain (Pivarnik et 
al., 1992), substrate utilisation (Campbell et al., 2001), and the ventilatory response (Dombovy 
et al., 1987) all demonstrating menstrual cycle effects. However, data concerning high-
intensity exercise performance is conflicting (Janse De Jonge, 2003). Chapter 4 adds to the 
body of literature on this topic, using quantification of endogenous hormone concentrations to 
validate menstrual cycle phases. Such a tight experimental control has recently been 
recommended as best practice when conducting female physiological research to attempt to 
reduce the ambiguity in understanding hormonal influences on physiological systems (Sims & 
Heather, 2018; Janse de Jonge et al., 2019).  
 
The conclusions from Chapter 4 were that high-intensity, isometric exercise performance was 
greatest in the luteal phase. The intensity-duration relationship was not profiled across the 
menstrual cycle, however, in the discussion of Chapter 4 we proposed that the elevated 
progesterone concentrations induced a state of ‘luteal analgesia’ (Vincent et al., 2018). The 
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data in Chapter 4 would suggest that the sensory tolerance limit was increased in the luteal 
phase, as females were able to exercise for longer once a nadir in Qtw.pot had been reached. 
High levels of metabolic disturbance are associated with sensations of pain and fatigue (Pollak 
et al., 2014), therefore if the sensory tolerance limit and W’ are linked to a maximal tolerable 
degree of metabolic disturbance, the menstrual cycle could potentially augment W’ in the luteal 
phase. The sensory tolerance limit in this scenario provides a more attractive explanation than 
the critical threshold hypothesis. Once a nadir in contractile function was reached, time to task 
failure was not immediate, indicating that a maximum degree of peripheral fatigue (Amann 
2013) was not the primary determinant of task failure. Rather, it could be speculated that task 
failure/fatigability was ultimately determined by the perceptual aspects of fatigability, rather 
than the aforementioned neuromuscular adjustments. These assertions should be 
investigated directly, and the use of a five-minute ‘all-out’ test (Burnley, 2010) would permit 
immediate assessment of the isometric intensity-duration relationship in each phase of the 
menstrual cycle, something that is challenging with four repeated constant-load trials. 
Additionally, as highlighted in previous sections of this discussion, Chapter 4 identified 
changes in single-limb exercise performance, the conclusions of which do not necessarily 
translate to whole-body exercise. Therefore, it could be suggested that the current evidence 
base is not sufficient to propose manipulation of training intensity, duration and volume around 
the fluctuations in endogenous hormone concentrations. 
 
Chapter 4 also identified large changes in neurotransmission (SICI), of a similar magnitude to  
anti-convulsant drugs, where this physiological change is the goal (Ziemann et al., 1996a). 
Indeed, evidence from patients using these forms of pharmacological intervention 
demonstrate similar decreases in voluntary activation of the knee-extensors as Chapter 4, 
without changes in maximal strength (Cabibel et al., 2019). To further probe this acute change 
in neuromuscular function, longitudinal tracking of motor neurons using high-density EMG (Del 
Vecchio & Farina, 2019) combined with non-invasive neurostimulation, could allow a more 
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detailed interrogation into the influence of hormonal concentrations on synaptic input and 
neural drive, as well as intrinsic motor neuron properties. This change in neurotransmission is 
also relevant to long-term adaptation of the CNS. Motor neuroplasticity, both in health and 
disease, is thought to be mediated by reduced inhibition within the motor cortex (Stagg et al., 
2011; Kolasinski et al., 2018). This is thought to enable a necessary increase in excitability 
and neural firing rates, permitting the coding of motor skills. It has recently been suggested 
that cortical inhibition could present a ‘barrier’ to motor plasticity (Kolasinski et al., 2018), and 
evidence shows that when cortical inhibition is pharmacologically upregulated, neuroplasticity 
is impaired (McDonnell et al., 2007). In this context of Chapter 4, it could be the case that at 
time points of the menstrual cycle such as the luteal phase, when SICI is elevated, adaptation 
might be harder to achieve. How the chronic downregulation of endogenous hormone 
concentrations via the use of exogenous hormonal contraceptives affects neural function and 
plasticity is also unknown. Considering 73% of women in the general population have used 
hormonal contraceptives at some stage in their life (Cea-Soriano et al., 2014), this information 
would be pertinent to those seeking to optimise neural health across the female lifespan. 
 
9.6. Concluding Remarks 
This thesis has studied the sex difference in fatigability by profiling the intensity-duration 
relationship across different modalities of exercise in an attempt to gain mechanistic insight 
into the underpinnings of the phenomenon. Combining non-invasive neurostimulation, 
haemodynamic, cardiopulmonary, and muscle oxygenation monitoring, has enabled the 
integrative physiological response to metabolically-matched exercise to be compared between 
males and females. The summaries of each study are presented above, however, the 
overarching theme of the individual Chapters’ conclusions is that data regarding male 
responses to exercise should not be generalised to female populations. As discussed here, 
such generalisations could potentially be causing sub-optimal prescription of exercise for 
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females and as a result, poorer training outcomes. The data presented in this Thesis, including 
future comprehensive investigations into how biological context (i.e. sex and hormonal status) 
influence acute and chronic physiological responses, will enable the most optimal training 
patterns to be identified, promoting athletic excellence and health outcomes in all humans. 
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APPENDICES 
Appendix 1 – Example of a participant information sheet 
 
 
 
Faculty of Health & Life Sciences 
 
 
Study Title:  Is there a sex difference in fatigability following cycling exercise above 
and below critical power? 
 
Investigator:  Paul Ansdell 
 
Participant Information Sheet 
 
You are being invited to take part in this research study.  Before you decide it is important 
for you to read this leaflet so you understand why the study is being carried out and what it 
will involve. 
 
Reading this leaflet, discussing it with others or asking any questions you might have will 
help you decide whether or not you would like to take part. 
 
 
What is the Purpose of the Study 
Females have shown to be less fatigable than males during certain exercise conditions. Some 
research has shown that females have more aerobic, fatigue-resistant muscles, and that they 
can last longer on endurance tasks than males. The literature on this topic typically bases the 
intensity of endurance tasks on a percentage of maximum capacity. Very rarely do researchers 
take into account factors like anaerobic threshold/critical intensity (the point at which your 
muscles can’t cope with the build-up of acid, and other negative by-products of exercise). 
Therefore, in order to create a more well-rounded picture of the sex difference in fatigability, 
we aim to work out your cycling ‘critical power’ and base two fatiguing tasks around it (+10% 
and -10%). We will use magnetic and electrical stimulation of the nervous system to assess 
how fatigued your muscles and central nervous system get during and following exercise; and 
we will also use non-invasive techniques to see how your cardiovascular system delivers 
oxygen to the muscles, and how the muscles utilise the oxygen. 
 
Why have I been invited? 
You have been invited to take part in this study as you are a male or female aged 18-35. If you 
are female, you have taking the monophasic hormonal contraceptive pill for the past 6 
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months. You have no history of neurological, cardiovascular or respiratory illness, and do not 
have any metal plates in the skull. 
 
Do I have to take part? 
Your participation is entirely voluntary. It is up to you whether you take part in the study. This 
information sheet is given to you to help you make that decision. If you decide to take part, 
you can stop testing and discontinue participation at any point without any need for 
explanation. You are completely free to decide whether or not to take part, or to take part 
and then leave the study before completion. 
 
What will happen if I take part? 
Prior to the data collection procedure, we will ask you to fill out pre-screening and health 
questionnaire in which you will be required to disclose information about your general health, 
history of contraceptive use and menstrual cycles (if female). Following this, you will be 
required to attend the laboratory 6 times. The first will be a familiarisation session, followed 
by 3 trials required to estimate your critical power. Then two final trials (+10% and -10%) 
based around your critical intensity. Sessions will take in the neurophysiology laboratory in 
Northumberland building in the centre of Newcastle. The times and dates of each laboratory 
session will be arranged with the principal investigator. In the 24-hours prior to each session, 
you will be asked to avoid strenuous exercise and the consumption of alcohol. On the day of 
each session, you will also be asked to avoid the consumption of caffeine. 
 
Visit 1: Familiarisation & Ramp test 
During this session, you will be habituated with the study protocol and the techniques used; 
these involve transcranial magnetic stimulation of the brain, and electrical stimulation of the 
spine, and nerve that causes your quadriceps to activate. Your maximal leg strength during 
an isometric knee extension exercise will be tested. This will involve you sitting in a chair with 
your ankle attached to a rigid cuff, and performing a maximal contraction of your quadriceps. 
You will also practice sub-maximal contractions, and maintaining force at a certain percentage 
of you maximum. The magnetic stimulations will involve single and paired pulses being 
delivered directly above the scalp. The spinal and peripheral nerve stimulation will involve an 
electrical current being discharged through electrodes placed towards the top of your groin, 
invoking an involuntary contraction causing the foot to kick out. A small amount of discomfort 
may be experienced during this procedure however; this is only short lived. Both electrical 
and magnetic stimulation are safe and painless techniques that are routinely used in our 
laboratories. You will also complete maximum inspiratory and expiratory manouvres, in which 
you maximal breathing force is measured. This gives us an indication of how the function of 
your lung muscles changes with fatigue. Following this you will perform a ramp test, which is 
a commonly used cycling test to work out the maximum power you can produce aerobically. 
During this test, we will measure your expired gas using a mask that will analyse the oxygen 
and carbon dioxide content of the air you breathe out. This test will involve gradually 
increasing the intensity you cycle at until you cannot maintain a constant cadence. The 
familiarisation session is estimated to take 60 minutes. Providing that you meet certain 
criteria of a maximum oxygen consumption at the end of the ramp test (VO2max) greater 55 
ml.kg-1.min-1 for males and 48 ml.kg-1.min-1 for females, participants will move onto the 
remainder of the experimental visits. 
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Visits 2-4: Estimation trials 
Using your maximum power from the ramp test, we will set three power outputs for you to 
cycle at (one per visit, separated by 24 hours minimum). Again, during these trials we will 
measure your expired gas using the mask. You will cycle to ‘exhaustion’ in these trials, 
meaning that you maintain the cadence until you physically cannot any longer. Using the 
duration of these trials and the amount of ‘work’ you perform, we can enter these variables 
into a formula that will predict your maximal sustainable intensity (critical power). These 
sessions will take approximately 30-45 minutes. 
 
Visits 5 and 6: Supra- and sub-critical power trials 
When you arrive in labs, you will complete a neuromuscular and respiratory assessment (as 
described above), then a cycling trial to exhaustion. During this trial, we will stimulate the 
nervous system at regular intervals to see how the brain and spinal cord respond to fatiguing 
cycling. Immediately following this, a post-exercise neuromuscular assessment will be 
performed. During the cycling your expired gas will be measured through the mask, your 
cardiovascular (e.g. heart rate, blood pressure) will be continuously monitored via an infrared 
cuff around your middle finger, and the amount of oxygen in your quadriceps will be assessed 
using an LED ‘optode’ attached to your leg. All procedures are non-invasive and pain-free. 
These final two visits will take 90-120 minutes. 
 
 
An example of the gas exchange mask and gas analysis setup during cycling. *Not the same equipment used in 
the present study. 
 
What are the possible disadvantages of taking part? 
Aside from taking the time out of your life to participate, which we are grateful for, there are 
relatively few disadvantages. The discomfort associated with TMS and nerve stimulation may 
be unpleasant, but it is short lived and does not last longer than a few milliseconds. Should 
you experience too much discomfort and wish to withdraw then that is perfectly acceptable. 
Additionally, TMS carries a risk of seizures, fainting, or transient hearing alterations; however, 
the risk of adverse events is extremely rare in healthy individuals. A screening questionnaire 
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is used to check for anything that would prevent you from receiving TMS. The fatiguing tasks 
will be to ‘exhaustion’ or the point where you cannot maintain the required cadence. This will 
cause increases in heart rate, blood pressure, and you may feel breathlessness, as well as 
fatigue and discomfort in your quadriceps. There is potential risk of injury, however this is no 
greater than any other form of exercise, and a warm up will be performed prior to any 
exercise. Exhaustive exercise also carries a risk of adverse events such as cardiovascular event 
(e.g. cardiac arrest or heart attack), however the incidence rates are extremely low (1 per 
50,000 athletes, Harmon et al. 2014. British Journal of Sports Medicine). 
 
What are the possible benefits of taking part? 
You will be adding to the under-researched area of sex differences in physiology. How females 
and males differ physiologically is not well understood and an emerging area of biomedical 
research. Data from the present study may also be used to inform athletic training or clinical 
rehabilitation.  
 
How can I withdraw from the study? 
If you do wish to withdraw then you can do so without any judgement or negative 
consequences. Simply email any of the research team informing us that you do not wish to 
continue with testing. You do not have to give any reason.  
 
Will my taking part in this study be kept confidential and anonymous? 
All data will be dealt with under the strictest of guidelines and according to the Data 
Protection Acts of 1984 and 1998. All data will remain anonymous other than to the 
researcher and supervisor. All data collected will be kept on a secure password protected 
computer system.  Your name will not be written on any of the data we collect; the written 
information you provide will have an ID number, not your name. The consent form you have 
signed will be stored separately from your other data. The data collected from you in this 
study will be confidential. 
 
How will my data be stored? 
All data will be stored in accordance with University guidelines and the Data Protection Act 
(1998).  Data will be stored on a USB stick that will be locked in a secure draw in the lead 
researcher’s desk. Data will be stored on a password protected computer and backed up onto 
a password protected cloud storage service that will only be accessible to the lead researcher. 
 
What will happen to the results of the study? 
The results of the study will be used to formulate relevant conclusions. The general findings 
might be reported in a scientific journal or presented at a research conference, however the 
data will be anonymised and you or the data you have provided will not be personally 
identifiable. 
 
Who is Organizing and Funding the Study? 
The study will be organised and funded by Northumbria University. 
 
Who has reviewed this study? 
Before the study can begin, permission will be obtained from Northumbria University. The 
study and its protocol have received full ethical approval from the Chair of the Faculty of 
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Health and Life Sciences Ethics Committee. If you require confirmation of this, please contact 
the Chair of the Faculty of Health and Life Sciences Ethics Committee (Mick Wilkinson 
mic.wilkinson@northumbria.ac.uk) and stating the full title and principal investigator of the 
study. 
 
Contact for further information:  
Paul Ansdell (paul.ansdell@northumbria.ac.uk) 
Dr Stuart Goodall (stuart.goodall@northumbria.ac.uk) 
  
209 
 
Appendix 2 – Example of an informed consent form 
 
 
 
           Faculty of Health & Life Sciences 
INFORMED CONSENT FORM 
Project Title: Is there a sex difference in fatigability following cycling exercise above and below 
critical power? 
Principal Investigator: Paul Ansdell 
               please tick or initial  
  where applicable 
I have carefully read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I have received 
satisfactory answers. 
 
 
I understand I am free to withdraw from the study at any time, without having to give a 
reason for withdrawing, and without prejudice. 
 
 
I agree to take part in this study.  
 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
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Appendix 3 – Example of the screening questionnaire  
The questionnaire will take you approximately 15 minutes to complete. The questionnaire 
consists of tick boxes or one-sentence answers. If you would prefer not to answer certain 
questions, please leave them blank. You are allowed to take the questionnaire away with you 
to allow you to answer the questions in private. If you need any help answering the questions, 
please do not hesitate to contact the lead researcher. Please see contact details at the end of 
the questionnaire.  
Weight:  _____________kg  Height:   ___________ m 
Date of Birth (dd/mm/yy):  __/__/__ 
 
 
 
1. How often do you take part in structured physical activity? 
For example: Jogging, team sports, aerobics etc. 
Please tick one:       How many hours? 
a. Once a week       ____________ 
b. Twice a week       ____________  
c. Three times a week      ____________ 
d. Four times a week      ____________ 
e. More than 5 times a week     ____________ 
f. Never 
 
 
2. Do you suffer from any medical conditions? 
For example: Arthritis, Myositis, Fibromyalgia, Myopathy, Diabetes Mellitus, or 
Hypothyroidism 
 
Yes        No  
 
If yes, please elaborate: 
 
 
 
 
 
 
3. Are you currently taking any medication? 
 
Yes        No  
 
If yes, please elaborate: 
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4. Are you currently taking any supplements or vitamins? 
For example: Protein supplements or vitamin e tablets? 
Yes        No  
 
If yes, please elaborate: 
 
 
5. Are you currently suffering from any musculoskeletal or tendon injury? 
For example: Sore muscles, broken bones or sore tendons 
 
Yes        No  
 
If yes, please describe information regarding the type of injury, injury location, and 
when it occurred (dd/mm/yy): 
 
 
 
 
6. Have you ever severely controlled your diet to achieve a dramatic change in 
weight? 
 
Yes        No  
 
IF MALE PLEASE GO TO QUESTION 19 
 
7. Do you have any children? 
 
Yes No  
  
If no please go to question 9 
  
a. Please list the date/s you had your child/ children (dd/mm/yy): 
   
1) ___/___/___ 
2) ___/___/___ 
3) ___/___/___ 
4) ___/___/___ 
 
8. Have you breast fed in the last year? 
 
Yes No  
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9. At what age did you start your period? 
 
_______ years old 
 
10. On average how long does your menstrual cycle last (how many days between a 
period)? 
 
 _______days 
 
11. On average how long does your period last? 
 
      ______ days 
 
12. Have you had a regular period for the last six months (one period at least every 
month and no spotting in-between periods)?  
 
Yes No  
 
13. Have your periods stopped? 
 
Yes No  
 
If no, please go to question 14 
 
a. What was the date of your last period (dd/mm/yy)? 
___/___/___ 
 
14. Have you ever had a hysterectomy?  
 
Yes No  
 
15. Have you ever had your ovary / ovaries removed? 
 
Yes No 
 
16. Have you ever taken the oral contraceptive pill? 
 
Yes No 
 
If no please go to question 17 
 
 
 
a. What type of pill did / do you take (name and dose of oestrogen and progesterone)? 
Dose values can be found on the medication box. If you are unsure, please bring your 
medication with you. 
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b. When did you start taking the pill (mm/yy)?                     ____/___ 
c. If you have, when did you stop taking the pill (mm/yy)?   ____/___ 
 
 
17. Have you ever used any other form of hormone-based birth control (injection, 
vaginal ring, etc.)? 
 
Yes No 
 
If no please go to question 18 
 
a. What type of hormone-based birth control did / do you take (name and dose of 
oestrogen and progesterone)? 
Dose values can be found on the medication box. If you are unsure, please bring your 
medication with you. 
 
 
 
b. When did you start using the contraception (mm/yy)?                      ____/___ 
c. If you have, when did you stop using the contraception (mm/yy)?   ____/___ 
 
18. Have your ever used hormone replacement therapy? 
 
Yes No 
 
19. Have you ever been diagnosed with a neurological disorder, i.e., epilepsy? 
 
Yes No 
 
20. Have you ever been diagnosed with a brain disorder such as Parkinson’s disease? 
 
Yes No 
 
21. Have you ever had a stroke? 
 
Yes No 
 
22. Do you have metal objects in your head? 
 
Yes No 
 
23. Are you taking any medication that would affect neuronal conductions? 
 
Yes No 
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24. Do you have a pacemaker? 
 
Yes No 
 
 
 
Thank you for your time and honesty whilst completing the questionnaire. All 
questionnaires will remain strictly confidential.  
 
 
Contact details:  
Paul Ansdell (Lead Researcher) 
paul.ansdell@northumbria.ac.uk 
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